CN100379868C - Novel peptide synthase gene - Google Patents

Novel peptide synthase gene Download PDF

Info

Publication number
CN100379868C
CN100379868C CNB038224607A CN03822460A CN100379868C CN 100379868 C CN100379868 C CN 100379868C CN B038224607 A CNB038224607 A CN B038224607A CN 03822460 A CN03822460 A CN 03822460A CN 100379868 C CN100379868 C CN 100379868C
Authority
CN
China
Prior art keywords
ala
lys
phe
thr
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB038224607A
Other languages
Chinese (zh)
Other versions
CN1688698A (en
Inventor
原诚一
横关健三
阿部巧
外内尚人
城岛恭子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of CN1688698A publication Critical patent/CN1688698A/en
Application granted granted Critical
Publication of CN100379868C publication Critical patent/CN100379868C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Abstract

DNA and recombinant DNA that encode a peptide-forming enzyme, a method for producing a peptide-forming enzyme, and a method for producing a dipeptide are disclosed. A method for producing a dipeptide includes producing a dipeptide from a carboxy component and an amine component by using a culture of a microbe belonging to the genus Sphingobacterium and having the ability to form the dipeptide from the carboxy component and the amine component, a microbial cell separated from the culture, treated microbial cell product of the microbe or a peptide-forming enzyme derived from the microbe.

Description

Novel peptide-forming enzyme gene
Technical field
The present invention relates to needn't be by complexity synthetic method can be easily, high productivity and generate the novel enzyme of peptide at an easy rate.More specifically, the present invention relates to the novel enzyme of catalysis, produce the microorganism of this enzyme by the peptide formation reaction of carboxyl composition and amine component, and the method that adopts this enzyme or microorganisms producing dipeptides.
Background technology
Peptide is used in medicine, field of food and multiple other field.For example, because the stability and the water-soluble L-glutaminate that is higher than of L-alanyl-L-glutamine, so it is widely used as the composition of transfusion and serum free medium.
Chemical synthesis (producing the currently known methods of peptide) is not the method that always is easy to.The known embodiment of described method comprises that the method for the L-glutaminate that uses N-carbobenzoxy-(Cbz) L-Ala (hereinafter referred to as " Z-L-Ala ") and protection is (referring to Bull.Chem.Soc.Jpn.; 34; 739 (1961); Bull.Chem.Soc.Jpn.; 35; 1966 (1962)); the method of the L-L-glutamic acid-γ-methyl esters of use Z-L-Ala and protection is (referring to Bull.Chem.Soc.Jpn.; 37; 200 (1964)); use the method (referring to patent document 1) of Z-alanine ester and unshielded L-glutamic acid, comprise that the propionyl halogenide that replaces with 2-is raw material, synthetic N-(2-replacement)-propionyl glutamine derivative is as the method (referring to patent document 2) of intermediate.
But, because protecting group or use optical activity intermediate need be introduced and slough to all these methods, so these methods can not fully satisfy industrial favourable requirement.
On the other hand; use the well-known example of the typical peptide production method of enzyme to comprise to use the N protection with the unshielded carboxyl composition of C and N is unshielded, the condensation reaction of the amine component of C protection (hereinafter referred to as " reaction 1 ") and use the carboxyl composition N protection and the C protection and N is unshielded, the replacement(metathesis)reaction of the amine component of C protection (hereinafter referred to as " reaction 2 ").The example of reaction 1 is to produce Z-aspartyl-phenylalanine methyl ester (referring to patent document 3) by Z-aspartic acid and alanine methyl ester, and react 2 example is to produce phenyl methyl ketone alanyl leucyl amine (referring to Biochemical J. by acetylphenylalanine ethyl ester and leucyl amine, 163,531 (1977)).Relevant use N is unshielded, the research report example of the method for the carboxyl composition of C protection is considerably less.In international monopoly publication WO 90/01555 (patent document 4), the example of the replacement(metathesis)reaction (hereinafter referred to as " reaction 3 ") of using carboxyl composition that N is unshielded, C protects and the amine component that N is unshielded, C protects has been described.For example, the method for producing the arginyl leucyl amine by arginine ethyl ester and leucyl amine has wherein been described.In European patent publication EP 278787A1 (patent document 5) and the European patent publication EP 359399B1 (patent document 6), described and used that N is unshielded, the carboxyl composition of C protection and N is unshielded, the example of the replacement(metathesis)reaction of the unshielded amine component of C (hereinafter referred to as " reaction 4 ").For example, the method that tyrosine ethyl ester and L-Ala are produced the tyrosyl L-Ala has wherein been described.
Patent document 1; Japanese patent application H1-96194 communique.
Patent document 2; Patent application H6-234715 communique.
Patent document 3; Japanese patent application S53-92729 communique.
Patent document 4; International monopoly publication WO 90/01555 communique
Patent document 5; European patent publication EP 278787A1 communique
Patent document 6; European patent publication EP 359399B1 communique
Non-patent document 1; Biochemical J., 163,531 (1977)
Summary of the invention
In the method for above-mentioned reaction 1-4, the most cheap production method belongs to the minimum reaction of protecting group 4 naturally.
But, there is following subject matter in the example (referring to European patent publication EP 278787A1) of reaction 4 in the prior art: (1) peptide production rate is very low, (2) the peptide productive rate is low, (3) producible peptide is limited to and comprises the high relatively amino acid whose peptide of hydrophobicity, (4) add-on of enzyme very big and (5) need come from the relatively costly carboxypeptidase preparation of mould, yeast or plant.In reaction 4, do not see the method for the enzyme that the bacterium of using beyond the Saccharomycodes or yeast source are arranged, and do not see have the Dipeptiven of production and other to have the method for the peptide of high-hydrophilic.Under this background, need a kind of commercial run of producing the cheapness of these peptides of exploitation.
The purpose of this invention is to provide needn't be by complexity synthetic method can be easily, high productivity and generate the novel enzyme of peptide at an easy rate.More specifically, the purpose of this invention is to provide the novel enzyme of catalysis, produce the microorganism of this enzyme and adopt this enzyme or microorganism to produce the method for dipeptides at an easy rate by the peptide formation reaction of carboxyl composition and amine component.
The inventor has carried out big quantity research according to above-mentioned purpose, found that from the bacterium of finding recently that belongs to steady Bacillaceae etc., can effectively generate the novel enzyme of peptide, and determine the sequence of this enzyme gene, has finished the present invention thus.
That is, the present invention as described below:
[1] coding following (A) or (B) shown in protein DNA:
(A) have the protein of the aminoacid sequence of forming by the 23-616 amino acids residue of aminoacid sequence shown in the SEQ ID NO:6 in the sequence table,
(B) has following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in displacement in the aminoacid sequence of being made up of the 23-616 amino acids residue of aminoacid sequence shown in the SEQ ID NO:6 in the sequence table, disappearance, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion.
[2] coding following (C) or (D) shown in protein DNA:
(C) have the protein of the aminoacid sequence of forming by the 21-619 amino acids residue of aminoacid sequence shown in the SEQ ID NO:12 in the sequence table,
(D) has following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in displacement in the aminoacid sequence of being made up of the 21-619 amino acids residue of aminoacid sequence shown in the SEQ ID NO:12 in the sequence table, disappearance, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion.
[3] coding following (E) or (F) shown in protein DNA:
(E) have the protein of the aminoacid sequence of forming by the 23-625 amino acids residue of aminoacid sequence shown in the SEQ ID NO:18 in the sequence table,
(F) has following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in displacement in the aminoacid sequence of being made up of the 23-625 amino acids residue of aminoacid sequence shown in the SEQ ID NO:18 in the sequence table, disappearance, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion.
[4] coding following (G) or (H) shown in protein DNA:
(G) have the protein of the aminoacid sequence of forming by the 23-645 amino acids residue of aminoacid sequence shown in the SEQ ID NO:23 in the sequence table,
(H) has following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in displacement in the aminoacid sequence of being made up of the 23-645 amino acids residue of aminoacid sequence shown in the SEQ ID NO:23 in the sequence table, disappearance, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion.
[5] coding following (I) or (J) shown in protein DNA:
(I) have the protein of the aminoacid sequence of forming by the 26-620 amino acids residue of aminoacid sequence shown in the SEQ ID NO:25 in the sequence table,
(J) has following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in displacement in the aminoacid sequence of being made up of the 26-620 amino acids residue of aminoacid sequence shown in the SEQ ID NO:25 in the sequence table, disappearance, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion.
[6] coding following (K) or (L) shown in protein DNA:
(K) have the protein of the aminoacid sequence of forming by the 18-644 amino acids residue of aminoacid sequence shown in the SEQ ID NO:27 in the sequence table,
(L) has following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in displacement in the aminoacid sequence of being made up of the 18-644 amino acids residue of aminoacid sequence shown in the SEQ ID NO:27 in the sequence table, disappearance, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion.
[7] coding following (M) or (N) shown in protein DNA:
(M) have the protein of aminoacid sequence shown in the SEQ ID NO:6 in the sequence table,
(N) contain the mature protein district, have following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in shown in the SEQ ID NO:6 in the sequence table displacement, disappearance in the aminoacid sequence, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion.
[8] coding following (O) or (P) shown in protein DNA:
(O) have the protein of aminoacid sequence shown in the SEQ ID NO:12 in the sequence table,
(P) contain the mature protein district, have following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in shown in the SEQ ID NO:12 in the sequence table displacement, disappearance in the aminoacid sequence, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion.
[9] coding following (Q) or (R) shown in protein DNA:
(Q) have the protein of aminoacid sequence shown in the SEQ ID NO:18 in the sequence table,
(R) contain the mature protein district, have following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in shown in the SEQ ID NO:18 in the sequence table displacement, disappearance in the aminoacid sequence, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion.
[10] coding following (S) or (T) shown in protein DNA:
(S) have the protein of aminoacid sequence shown in the SEQ ID NO:23 in the sequence table,
(T) contain the mature protein district, have following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in shown in the SEQ ID NO:23 in the sequence table displacement, disappearance in the aminoacid sequence, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion.
[11] coding following (U) or (V) shown in protein DNA:
(U) have the protein of aminoacid sequence shown in the SEQ ID NO:25 in the sequence table,
(V) contain the mature protein district, have following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in shown in the SEQ ID NO:25 in the sequence table displacement, disappearance in the aminoacid sequence, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion.
[12] coding following (W) or (X) shown in protein DNA:
(W) have the protein of aminoacid sequence shown in the SEQ ID NO:27 in the sequence table,
(X) contain the mature protein district, have following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in shown in the SEQ ID NO:27 in the sequence table displacement, disappearance in the aminoacid sequence, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion.
[13] following (a) or (b) shown in DNA:
(a) have the DNA of the base sequence of the 127-1908 bit base of base sequence shown in the SEQ ID NO:5 in the sequence table,
(b) under stringent condition, comprise the mature protein district and have peptide with DNA hybridization with following base sequence and coding and generate active protein DNA, described base sequence and the base sequence complementation of forming by the 127-1908 bit base of base sequence shown in the SEQ ID NO:5 in the sequence table.
[14] following (c) or (d) shown in DNA:
(c) have the DNA of the base sequence of the 121-1917 bit base of base sequence shown in the SEQ ID NO:11 in the sequence table,
(d) under stringent condition, comprise the mature protein district and have peptide with DNA hybridization with following base sequence and coding and generate active protein DNA, described base sequence and the base sequence complementation of forming by the 121-1917 bit base of base sequence shown in the SEQ ID NO:11 in the sequence table.
[15] following (e) or (f) shown in DNA:
(e) have the DNA of the base sequence of the 127-1935 bit base of base sequence shown in the SEQ ID NO:17 in the sequence table,
(f) under stringent condition, comprise the mature protein district and have peptide with DNA hybridization with following base sequence and coding and generate active protein DNA, described base sequence and the base sequence complementation of forming by the 127-1935 bit base of base sequence shown in the SEQ ID NO:17 in the sequence table.
[16] following (g) or (h) shown in DNA:
(g) have the DNA of the base sequence of the 127-1995 bit base of base sequence shown in the SEQ ID NO:22 in the sequence table,
(h) under stringent condition, comprise the mature protein district and have peptide with DNA hybridization with following base sequence and coding and generate active protein DNA, described base sequence and the base sequence complementation of forming by the 127-1995 bit base of base sequence shown in the SEQ ID NO:12 in the sequence table.
[17] following (i) or (j) shown in DNA:
(i) have the DNA of the base sequence of the 104-1888 bit base of base sequence shown in the SEQ ID NO:24 in the sequence table,
(j) under stringent condition, comprise the mature protein district and have peptide with DNA hybridization with following base sequence and coding and generate active protein DNA, described base sequence and the base sequence complementation of forming by the 104-1888 bit base of base sequence shown in the SEQ ID NO:24 in the sequence table.
[18] following (k) or (l) shown in DNA:
(k) have the DNA of the base sequence of the 112-1992 bit base of base sequence shown in the SEQ ID NO:26 in the sequence table,
(l) under stringent condition, comprise the mature protein district and have peptide with DNA hybridization with following base sequence and coding and generate active protein DNA, described base sequence and the base sequence complementation of forming by the 112-1992 bit base of base sequence shown in the SEQ ID NO:26 in the sequence table.
[19] following (m) or (n) shown in DNA:
(m) have the DNA of the base sequence of the 61-1908 bit base of base sequence shown in the SEQ ID NO:5 in the sequence table,
(n) under stringent condition, comprise the mature protein district and have peptide with DNA hybridization with following base sequence and coding and generate active protein DNA, described base sequence and the base sequence complementation of forming by the 61-1908 bit base of base sequence shown in the SEQ ID NO:5 in the sequence table.
[20] following (o) or (p) shown in DNA:
(o) have the DNA of the base sequence of the 61-1917 bit base of base sequence shown in the SEQ ID NO:11 in the sequence table,
(p) under stringent condition, comprise the mature protein district and have peptide with DNA hybridization with following base sequence and coding and generate active protein DNA, described base sequence and the base sequence complementation of forming by the 61-1917 bit base of base sequence shown in the SEQ ID NO:11 in the sequence table.
[21] following (q) or (r) shown in DNA:
(q) have the DNA of the base sequence of the 61-1935 bit base of base sequence shown in the SEQ ID NO:17 in the sequence table,
(r) under stringent condition, comprise the mature protein district and have peptide with DNA hybridization with following base sequence and coding and generate active protein DNA, described base sequence and the base sequence complementation of forming by the 61-1935 bit base of base sequence shown in the SEQ ID NO:17 in the sequence table.
[22] following (s) or (t) shown in DNA:
(s) have the DNA of the 127-1995 bit base sequence of base sequence shown in the SEQ ID NO:22 in the sequence table,
(t) under stringent condition, comprise the mature protein district and have peptide with DNA hybridization with following base sequence and coding and generate active protein DNA, described base sequence and the base sequence complementation of forming by the 127-1995 bit base of base sequence shown in the SEQ ID NO:22 in the sequence table.
[23] following (u) or (DNA v):
(u) have the DNA of the 29-1888 bit base sequence of base sequence shown in the SEQ ID NO:24 in the sequence table,
(v) under stringent condition, comprise the mature protein district and have peptide with DNA hybridization with following base sequence and coding and generate active protein DNA, described base sequence and the base sequence complementation of forming by the 29-1888 bit base of base sequence shown in the SEQ ID NO:24 in the sequence table.
[24] following (w) or (x) shown in DNA:
(w) have the DNA of the 61-1992 bit base sequence of base sequence shown in the SEQ ID NO:26 in the sequence table,
(x) under stringent condition, comprise the mature protein district and have peptide with DNA hybridization with following base sequence and coding and generate active protein DNA, described base sequence and the base sequence complementation of forming by the 61-1992 bit base of base sequence shown in the SEQ ID NO:26 in the sequence table.
[25] according to each DNA of [13]-[24], wherein stringent condition is under the salt concn that is equivalent to 1 * SSC and 0.1%SDS, in 60 ℃ of conditions of washing.
[26] a kind of comprising according to each the recombinant DNA of DNA of [1]-[25].
[27] a kind of transformant that has imported according to the recombinant DNA of [26].
[28] a kind of method of producing peptide-forming enzyme comprises: cultivate the transformant according to [27] in substratum, peptide-forming enzyme is accumulated in substratum and/or transformant.
[29] a kind of method of producing dipeptides comprises: the transformant of cultivating basis [28] in substratum mixes this culture with synthetic dipeptides to obtain culture with carboxyl composition and amine component.
[30] a kind of method of producing dipeptides, comprise: belong to Sphingobacterium and have the culture that generates the active microorganism of dipeptides by carboxyl composition and amine component by use, isolating microorganism cells from this culture, the microorganism cells of this microorganism is handled product or is come from the peptide-forming enzyme of this microorganism, generates dipeptides by carboxyl composition and amine component.
In addition, aminoacid sequence shown in the SEQ ID NO:6 is determined by DNA described in the SEQ ID NO:5 in the sequence table.Aminoacid sequence shown in the SEQ ID NO:12 is determined by DNA described in the SEQID NO:11 in the sequence table.Aminoacid sequence shown in the SEQ ID NO:18 is determined by DNA described in the SEQ ID NO:17 in the sequence table.Aminoacid sequence shown in the SEQ ID NO:23 is determined by DNA described in the SEQ ID NO:22 in the sequence table.Aminoacid sequence shown in the SEQ ID NO:25 is determined by DNA described in the SEQ ID NO:24 in the sequence table.Aminoacid sequence shown in the SEQ ID NO:27 is determined by DNA described in the SEQ ID NO:26 in the sequence table.
The accompanying drawing summary
Fig. 1 is the figure of optimal pH that illustrates the enzyme of steady bacillus of the present invention;
Fig. 2 is the figure of optimum temperuture that illustrates the enzyme of steady bacillus of the present invention;
Fig. 3 illustrates the time-histories figure that is prepared the L-alanyl-L-glutamine by L-alanine methyl ester and L-glutaminate; With
Fig. 4 is the bar graph that illustrates the enzyme amount that exists in kytoplasm part (Cy) and the pericentral siphon part (Pe).
The optimum implementation of invention
It below is the product dipeptides generation enzyme that novel dipeptide of the present invention generates enzyme gene and this gene.
(1) contains the microorganism of DNA of the present invention
Dna encoding of the present invention has the active protein that is generated peptide by carboxyl composition and amine component.In this manual, the carboxyl composition is meant provides the peptide bond (composition in carbonyl site (CO) CONH-), and amine component is meant the composition that amino sites in the peptide bond (NH) is provided.In addition, in this manual, unless refer in particular in addition, term " peptide " is meant the polymer with at least one peptide bond when using separately.In addition, in this manual, " dipeptides " is meant the peptide with a peptide bond.
The example that contains the microorganism of DNA of the present invention comprises and belongs to steady Bacillaceae, Sphingobacterium, soil bacillus (Pedobacter) belongs to, the shaping Bacillaceae, the bacterium that round bar Pseudomonas or Psycloserpens belong to, and its more specifically example comprise short steady bacillus strain ATCC14234 (bacterial strain FERM P-18545, bacterial strain FERM BP-8113), Sphingobacterium sp. bacterial strain FERM BP-8124, separate Vitrum AB soil bacillus (Pedobacter heparinus) bacterial strain IFO 12017, Taxeobacter gelupurpurascens strain DSM Z 11116, sea round bacteria strains A TCC 25205 and Psycloserpens burtonensis strains A TCC700359.Short steady bacillus strain ATCC 14234 (bacterial strain FERM P-18545, bacterial strain FERMBP-8113), Sphingobacterium sp. bacterial strain FERM BP-8124, separate Vitrum AB soil bacillus strain IFO 12017, Taxeobacter gelupurpurascens strain DSM Z 11116, extra large round bacteria strains A TCC 25205 and Psycloserpens burtonensis strains A TCC700359 be the inventor after deliberation and energy the high yield of selecting ground by the microorganism of carboxyl composition and amine component generation peptide.
In the mentioned microorganism bacterial strain, be preserved in Independent Administrative Leged Industrial Technology Complex Inst and speciallyyed permit biological sustenance center (Chuo Dai-6,1-1Higashi 1-Chome with the microorganism of FERM number expression, Tsukuba-shi, Ibaraki-ken Japan), and can obtain with reference to each number.
In the mentioned microorganism bacterial strain, be preserved in American type culture collection (P.O.Box 1549, Manassas, VA 20110, the UnitedStates of America) with the microorganism of ATCC number expression, and can have obtained with reference to each number.
In the mentioned microorganism bacterial strain, with IFO number the expression microorganism be preserved in fermentation research institute, (Osaka-shi Japan), and can obtain with reference to each number Osaka for 2-17-85 Jusohonmachi, Yodogawa-ku.
In the mentioned microorganism bacterial strain, microorganism with NBRC number expression has been preserved in Japanese state-run technology and evaluation study institute Biological resources center (NITE) (5-8 Kazusa-Kamaashi2-Chome, Kisarazu-shi, Chiba-ken, and can obtain Japan), with reference to each number.
In the mentioned microorganism bacterial strain, microorganism with DSMZ number expression has been preserved in DeutcheSammlung von Mikroorganismen und Zellkulturen GmbH (German microorganism and cell culture preservation center) (Mascheroder Weg 1b, 38124Braunschweig, and can obtain Germany), with reference to each number.
Short steady bacillus strain ATCC 14234 (bacterial strain FERM P-18545, bacterial strain FERM BP-8113) is preserved in Independent Administrative Leged Industrial Technology Complex Inst October 1 calendar year 2001 and speciallys permit biological sustenance center (Chuo Dai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, and to specify its preserving number be FERM P-18545 Japan).Subsequently, regulation according to budapest treaty, on July 8th, 2002 Independent Administrative Leged Industrial Technology Complex Inst that is transferred to of this bacterial strain is speciallyyed permit biological sustenance center, and to specify its preserving number be FERM BP-8113 (microorganism performance: short steady bacillus strain AJ 13933).
Sphingobacterium sp. strains A J 110003 is preserved in Independent Administrative Leged Industrial Technology Complex Inst on July 22nd, 2002 and speciallys permit biological sustenance center, and to specify its preserving number be FERM BP-8124.By following qualification test, strains A J 110003 (FERM BP-8124) is accredited as above-mentioned Sphingobacterium sp..Bacterial strain FERM BP-8124 is gram negative bacillus (0.7-0.8 * 1.5-2.0 μ m), does not generate gemma, no mobility.Its bacterium colony is circular, and the edge is smooth fully, comprises low projection, and is glossy, light yellow.This organism is 30 ℃ of growths, the superoxide enzyme positive, and oxidase positive, OF tests (glucose) feminine gender, according to these features it is accredited as the bacterium that belongs to Sphingobacterium.In addition, because following characteristic: nitrate reduction feminine gender, indoles produces negative, derive from the acid product feminine gender of glucose, the arginine dihydrolase feminine gender, the urase positive, the Vitamin C2 hydrolysis positive, the gelatin hydrolysis feminine gender, the beta-galactosidase enzymes positive, the glucose assimilation is positive, the L-arabinose assimilation is negative, the assimilation of D-seminose is positive, the assimilation of D-N.F,USP MANNITOL is negative, N-acetyl-D-glucosamine assimilation is positive, the maltose assimilation is positive, the Potassium Gluconate feminine gender, the n-capric acid assimilation is negative, the hexanodioic acid assimilation is negative, the assimilation of dl-oxysuccinic acid is negative, the Sodium Citrate assimilation is negative, negative and the Terminal oxidase positive of toluylic acid assimilation can determine that it has the characteristic similar to Sphingobacterium multivorum or Sphingobacterium spiritivorum.In addition, though the homology analysis result of the base sequence of 16S rRNA gene shows that it has the homology (98.8%) with the Sphingobacterium multivorum height, the bacterial isolates that mates fully with this bacterial isolates not.Therefore, this bacterial isolates can be accredited as Sphingobacterium sp.
(2) microorganism culturing
For the microorganism cells of the microorganism that obtains containing DNA of the present invention, this microorganism can be cultivated on the suitable culture base and is grown.The substratum that is used for this purpose there is not special restriction, as long as can make this microorganism growth.This substratum can be the ordinary culture medium that contains common carbon source, nitrogenous source, phosphorus source, sulphur source, mineral ion and organotrophy source as required.
For example, as long as can be utilized, can use any carbon source by mentioned microorganism.The specific examples of spendable carbon source comprises that sugar is such as glucose, fructose, maltose and amylose starch, alcohol is such as Sorbitol Powder, ethanol and glycerine, organic acid such as fumaric acid, citric acid, acetate and propionic acid and salt thereof are such as the hydrocarbon polymer of paraffin and their mixture.
The example of spendable nitrogenous source comprises the ammonium salt such as the mineral acid of ammonium sulfate and ammonium chloride, organic acid ammonium salt such as ammonium fumarate and ammonium citrate, such as the nitrate of SODIUMNITRATE and saltpetre, such as the organic nitrogen compound of peptone, yeast extract, meat extract and corn steep liquor and their mixture.
In addition, also the nutrition source such as inorganic salt, trace metal salts and VITAMIN that is used for ordinary culture medium suitably can be mixed use.
Also have no particular limits on culture condition, for example, can make pH and temperature suitably be controlled at the scope that pH is 5-8 under aerobic conditions, temperature be in 15-40 ℃ the scope, to cultivate about 12-about 48 hours.
The purifying of enzyme
Dna encoding peptide-forming enzyme of the present invention.For example, this peptide-forming enzyme can be subordinated to purifying in the bacterium of steady Bacillaceae.The method of separation and purifying peptide-forming enzyme will be described as the example of purifying enzyme from short steady bacillus.
At first, by adopting physical method such as ultrasonication or using the enzyme process smudge cells of molten cell walls enzyme and remove insoluble part by method such as centrifugal, thereby from short steady bacillus, for example (preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center to bacterial strain FERM BP-8113, preservation mechanism address: Chuo Dai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation is passed on the date: preparation microorganism cells extract in the microorganism cells on July 8th, 2002).By associating common method of purifying protein such as anion-exchange chromatography, cation-exchange chromatography or gel permeation chromatography,, the microorganism cells extract solution available from aforesaid method comes the purifying peptide-forming enzyme then through being carried out fractionation.
The example that is used as the carrier of anion-exchange chromatography is Q-Sepharose HP (Amersham production).When the cell extract process that will comprise enzyme has been filled the post of carrier, under the condition of pH 8.5, can from non-absorbed portion, reclaim enzyme.
The example that is used as the carrier of cation-exchange chromatography is MonoS HR (Amersham production).Thereby make enzyme be adsorbed on the post by the cell extract that will comprise enzyme through the post of having filled carrier and subsequently after the washing column, with buffered soln wash-out enzyme with high salt concentration.At this moment, salt concn can be increased continuously and maybe concentration gradient can be adopted.For example, under the situation of using MonoS HR, be adsorbed on enzyme on the post with the NaCl wash-out of the about 0.5M of about 0.2-.
Enzyme with the aforesaid method purifying further can be carried out even purifying by gel permeation chromatography etc. then.The example that is used for the carrier of gel permeation chromatography is Sephadex 200pg (Amersham production).
In above-mentioned purification process, can generate activity by the peptide that detects each several part according to the described method of following embodiment, thereby confirm to comprise the part of enzyme.Shown internal amino acid sequence among SEQ ID NO:1 in the sequence table and the SEQ ID NO:2 with the enzyme of aforesaid method purifying.
(4) DNA of the present invention and transformant
(4-1) DNA of the present invention
(preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center from short steady bacillus strain FERM BP-8113, preservation mechanism address: Chuo Dai-6,1-1Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation is passed on the date: on July 8th, 2002), isolate the DNA of the present invention that has at the base sequence of 61-1908 bit base described in the SEQ ID NO:5.The DNA that contains 61-1908 bit base described in the SEQ ID NO:5 is coding region sequence (hereinafter referred to as " CDS ") part.The base sequence of 61-1908 bit base comprises signal sequence district and mature protein district.The signal sequence district is made up of the 61-126 bit base, and ripe protein district is made up of the 127-1908 bit base.That is, the invention provides the peptase protein gene that comprises signal sequence and the peptase protein gene of mature protein form.The signal sequence that comprises in the sequence described in the SEQ ID NO:5 is a kind of leader sequence type, and the major function of inferring the leading peptide that this leader sequence is coded is the secretion in the outside from the cytolemma inboard to cytolemma.By the coded protein of 127-1908 bit base (i.e. site except that leading peptide) is mature protein, but infers that the peptide of its apparent altitude generates active.
(preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center from Sphingobacterium sp. bacterial strain FERM BP-8124, preservation mechanism address: Chuo Dai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation date: on July 22nd, 2002), isolate the DNA with base sequence of 61-1917 bit base described in the SEQ ID NO:11, it also is DNA of the present invention.DNA with base sequence of being made up of the 61-1917 bit base is encoding sequence (CDS) part.The base sequence of being made up of the 61-1917 bit base comprises signal sequence district and mature protein district.The signal sequence district is the zone of 61-120 bit base, and ripe protein district is the zone of 121-1917 bit base.That is, the invention provides the peptase protein gene that comprises signal sequence and the peptase protein gene of mature protein form.The signal sequence that comprises in the sequence described in the SEQ ID NO:11 is the leader sequence type.The major function of inferring the leading peptide that this leader sequence is coded is the secretion in the outside from the cytolemma inboard to cytolemma.By the coded protein of 121-1917 bit base (i.e. part except that leading peptide) is mature protein, but infers that the peptide of its apparent altitude generates active.
From separating Vitrum AB soil bacillus strain IFO 12017 (preservation mechanism: fermentation research institute, Osaka, preservation mechanism address: 2-17-85 Jusohonmachi, Yodogawa-ku, Osaka-shi, Japan) in, isolate the DNA of the present invention of base sequence with the described 61-1935 bit base of SEQ ID NO:17.The DNA that is made up of described 61-1935 bit base among the SEQ ID NO:17 is the CDS part.Comprise signal sequence district and mature protein district in the base sequence of forming by the 61-1935 bit base.The signal sequence district is made up of the 61-126 bit base, and ripe protein district is made up of the 127-1935 bit base.That is, the invention provides the peptase protein gene that comprises signal sequence and the peptase protein gene of mature protein form.The signal sequence that comprises in the sequence described in the SEQ ID NO:17 is the leader sequence type, and the major function of inferring the leading peptide that this leader sequence is coded is the secretion in the outside from the cytolemma inboard to cytolemma.The coded protein of 127-1935 bit base (i.e. site except that leading peptide) is mature protein, but infers that the peptide of its apparent altitude generates active.
From Taxeobacter gelupurpurascens strain DSM Z 11116 (preservation mechanism: Deutche Sammlung von Mikroorganismen und Zellkulturen GmbH (German microorganism and cell culture preservation center), preservation mechanism address: Mascheroder Weg1b, 38124 Braunschweig isolate the DNA of the present invention with base sequence of 61-1995 bit base described in the SEQ ID NO:22 in Germany).The DNA that is made up of 61-1995 bit base described in the SEQ ID NO:22 is the CDS part.Comprise signal sequence district and mature protein district in the base sequence by the 61-1995 bit base.The signal sequence district is made up of the 61-126 bit base, and ripe protein district is made up of the 127-1995 bit base.That is, the invention provides the peptase protein gene that comprises signal sequence and the peptase protein gene of mature protein form.The signal sequence that comprises in the sequence described in the SEQ ID NO:22 is the leader sequence type, and the major function of inferring the leading peptide that this leader sequence is coded is the secretion in the outside from the cytolemma inboard to cytolemma.By the coded protein of 127-1995 bit base (i.e. site except that leading peptide) is mature protein, but infers that the peptide of its apparent altitude generates active.
From extra large round bacteria strains A TCC 25205 (preservation mechanisms: American type culture collection, preservation mechanism address: P.O.Box 1549, Manassas, VA 20110, the UnitedStates of America) in, isolates DNA of the present invention with base sequence of 29-1888 bit base described in the SEQ ID NO:24.The DNA that is made up of 29-1888 bit base described in the SEQ ID NO:24 is the CDS part.Contain in the base sequence of 29-1888 bit base and comprise signal sequence district and mature protein district.The signal sequence district is made up of the 29-103 bit base, and ripe protein district is made up of the 104-1888 bit base.That is, the invention provides the peptase protein gene that comprises signal sequence and the peptase protein gene of mature protein form.The signal sequence that is comprised in the described sequence of SEQ ID NO:24 is the leader sequence type, and the major function of inferring the leading peptide that this leader sequence is coded is the secretion in the outside from the cytolemma inboard to cytolemma.By the coded protein of 104-1888 bit base (i.e. site except that leading peptide) is mature protein, but infers that the peptide of its apparent altitude generates active.
From Psycloserpens burtonensis strains A TCC 700359 (preservation mechanisms: American type culture collection, preservation mechanism address: P.O.Box 1549, Manassas, VA 20110, the United States of America) in, isolates the DNA of the present invention of base sequence with the described 61-1992 bit base of SEQ ID NO:26.The DNA that is made up of 61-1992 bit base described in the SEQ ID NO:26 is the CDS part.Contain in the base sequence of 61-1992 bit base and comprise signal sequence district and mature protein district.The signal sequence district is by the 61-111 bit base, and ripe protein district is made up of the 112-1992 bit base.That is, the invention provides the peptase protein gene that comprises signal sequence and the peptase protein gene of mature protein form.The signal sequence that comprises in the sequence described in the SEQ ID NO:26 is the leader sequence type, and the major function of inferring the leading peptide that this leader sequence is coded is the secretion in the outside from the cytolemma inboard to cytolemma.The coded protein (i.e. site except that leading peptide) of 112-1992 bit base is mature protein, but infers that the peptide of its apparent altitude generates active.
In addition, according to such as Molecular Cloning, 2nd edition, the description in the publication of Cold SpringHarbor Press (1989) can be implemented following several genes recombinant technology.
DNA of the present invention can pass through polymerase chain reaction (hereinafter referred to as " PCR ") (referring to PCR; White T.J. etc., Trends Genet., 5,185 (1989)) or by the hybridization of lacking steady bacillus, Sphingobacterium sp., the chromosomal DNA of separating Vitrum AB soil bacillus, Taxeobactergelupurpurascens, extra large round bacteria or Psycloserpens burtonensis or DNA library obtain.The PCR primer can be according to based on designing by the determined internal amino acid sequence of peptide-forming enzyme of carrying out purifying described in above-mentioned (3) joint.In addition, because the present invention has clearly determined the base sequence (SEQ IDNO:5, SEQ ID NO:11, SEQ ID NO:22, SEQ ID NO:24 and SEQ ID NO:26) of peptide-forming enzyme gene, so can be designed for the primer or the probe of hybridization according to these base sequences, also can adopt this gene of probe separates.If will have primer with 5 ' non-translational region and the corresponding sequence of 3 ' non-translational region as PCR primer, the total length of the coding region of the enzyme of the present invention that then can increase.For example, when amplification comprises leader sequence described in the SEQ ID NO:5 and mature protein coding region regional, specifically, the example of 5 ' side primer is the primer with base sequence of the upstream region of 61 bit bases among the SEQ ID NO:5, and the example of 3 ' side primer is the primer that has with the base sequence complementary sequence of 1908 bit base downstream areas.
For example, the 380B type dna synthesizer that can adopt Applied Biosystems to produce according to a conventional method is by phosphoamidite method (referring to Tetrahedron Letters (1981), 22,1859) synthetic primer.For example, can adopt Gene Amp PCR System 9600 (Perkin-Elmer production) and TakaraLA PCR body outer clone test kit (Takara Shuzo production) enforcement PCR to react according to by provider's illustrated method of manufacturers for example.
No matter whether comprise leader sequence, also comprise among the DNA of the present invention with sequence table in SEQID NO:5 described in the same basically DNA of DNA of CDS.That is, the DNA of enzyme of the present invention that can be by having sudden change from coding or contain the cell of this DNA, be separated under the stringent condition with have with sequence table in SEQ ID NO:5 described in the DNA hybridization of CDS complementary base sequence, or with probe hybridization from the preparation of identical base sequence, and coding has peptide and generates active protein DNA and obtain the DNA same basically with DNA of the present invention.
No matter whether comprise leader sequence, also comprise among the DNA of the present invention with sequence table in SEQID NO:11 described in the same basically DNA of DNA of CDS.That is, the DNA of enzyme of the present invention that can be by having sudden change from coding or contain the cell of this DNA, be separated under the stringent condition with have with sequence table in SEQ ID NO:11 described in the DNA hybridization of CDS complementary base sequence, or with probe hybridization from the preparation of identical base sequence, and coding has peptide and generates active protein DNA and obtain the DNA same basically with DNA of the present invention.
No matter whether comprise leader sequence, also comprise among the DNA of the present invention with sequence table in SEQID NO:17 described in the same basically DNA of DNA of CDS.That is, the DNA of enzyme of the present invention that can be by having sudden change from coding or contain the cell of this DNA, be separated under the stringent condition with have with sequence table in SEQ ID NO:17 described in the DNA hybridization of CDS complementary base sequence, or with probe hybridization from the preparation of identical base sequence, and coding has peptide and generates active protein DNA and obtain the DNA same basically with DNA of the present invention
No matter whether comprise leader sequence, also comprise among the DNA of the present invention with sequence table in SEQID NO:22 described in the same basically DNA of DNA of CDS.That is, the DNA of enzyme of the present invention that can be by having sudden change from coding or contain the cell of this DNA, be separated under the stringent condition with have with sequence table in SEQ ID NO:22 described in the DNA hybridization of CDS complementary base sequence, or with probe hybridization from the preparation of identical base sequence, and coding has peptide and generates active protein DNA and obtain the DNA same basically with DNA of the present invention.
No matter whether comprise leader sequence, also comprise among the DNA of the present invention with sequence table in SEQID NO:24 described in the same basically DNA of DNA of CDS.That is, the DNA of enzyme of the present invention that can be by having sudden change from coding or contain the cell of this DNA, be separated under the stringent condition with have with sequence table in SEQ ID NO:24 described in the DNA hybridization of CDS complementary base sequence, or with probe hybridization from the preparation of identical base sequence, and coding has peptide and generates active protein DNA and obtain the DNA same basically with DNA of the present invention.
No matter whether comprise leader sequence, also comprise among the DNA of the present invention with sequence table in SEQID NO:26 described in the same basically DNA of DNA of CDS.That is, the DNA of enzyme of the present invention that can be by having sudden change from coding or contain the cell of this DNA, be separated under the stringent condition with have with sequence table in SEQ ID NO:26 described in the DNA hybridization of CDS complementary base sequence, or with probe hybridization from the preparation of identical base sequence, and coding has peptide and generates active protein DNA and obtain the DNA same basically with DNA of the present invention
For example, can be according to fixed method, prepare probe according to the base sequence described in the SEQ ID NO:5 in the sequence table for example.In addition, also can be according to fixed method, implement by using probe to find DNA with probe hybridization, thus the method that is used to separate target DNA.For example, dna probe can be sheared the base sequence that needs as probe with Restriction Enzyme by the base sequence that increases and clone in plasmid or phage vector, extract required base sequence then and prepare.The part that cuts off can be adjusted according to target DNA.
Term used herein " under stringent condition " is meant the so-called specific hybrid of formation under this condition, and does not form non-specific hybridization.Represent accurately that with numerical value this condition is difficult.For example, these conditions can be, the high DNA of homology (for example, 50% or higher, preferred 80% or higher, more preferably 90% or higher) can hybridize each other and condition that homology can not be hybridized each other than these low DNA, or the usual terms of washing in the Southern hybridization, wherein hybridize with 1 * SSC and 0.1%SDS, under the corresponding salt concn of preferred 0.1 * SSC and 0.1%SDS, carry out in 60 ℃.Though under the described conditions Za Jiao gene comprise occur on the specific position in the sequence terminator or since the active centre in sudden change and those genes of loss of activity, but can be by being connected to commercially available expression vector, thereby the enzymic activity of it being expressed in suitable host and adopting following method to detect expression product is removed it at an easy rate.
But, when base sequence is hybridized under above-mentioned stringent condition, under this base sequence encoded protein condition that is selected in 50 ℃ and pH 8 of fine quality, keep have by as the proteinic pact of the coded aminoacid sequence of the original base sequence that keeps half or higher, preferred 80% or higher, more preferably 90% or higher enzymic activity.For example, when being described as follows situation, during the base sequence that for example illustrates under stringent condition and have with the DNA hybridization of the base sequence complementary base sequence of the 127-1908 bit base of base sequence shown in the SEQ ID NO:5, under this base sequence encoded protein condition that is selected in 50 ℃ and pH 8 of fine quality, keep the 23-616 amino acids residue with aminoacid sequence shown in the SEQ IDNO:6 aminoacid sequence proteinic pact half or higher, preferred 80% or higher, more preferably 90% or higher enzymic activity.
Shown among the SEQ ID NO:6 in the sequence table by the coded aminoacid sequence of the described CDS of SEQ ID NO:5 in the sequence table.Shown among the SEQ ID NO:12 in the sequence table by the coded aminoacid sequence of the described CDS of SEQ ID NO:11 in the sequence table.Shown among the SEQ ID NO:18 in the sequence table by the coded aminoacid sequence of the described CDS of SEQ ID NO:17 in the sequence table.Shown among the SEQ ID NO:23 in the sequence table by the coded aminoacid sequence of the described CDS of SEQ ID NO:22 in the sequence table.Shown among the SEQ IDNO:25 in the sequence table by the coded aminoacid sequence of the described CDS of SEQ ID NO:24 in the sequence table.Shown among the SEQ ID NO:27 in the sequence table by the coded aminoacid sequence of the described CDS of SEQ ID NO:26 in the sequence table.
Complete amino acid sequence comprises leading peptide and mature protein district described in the SEQ ID NO:6, and wherein 1-22 amino acids residue constitutes leading peptide, and 23-616 amino acids residue constitutes the mature protein district.In addition, complete amino acid sequence comprises leading peptide and mature protein district described in the SEQ ID NO:11, and wherein 1-20 amino acids residue constitutes leading peptide, and 21-619 amino acids residue constitutes the mature protein district.
Complete amino acid sequence comprises leading peptide and mature protein district described in the SEQ ID NO:18, and wherein 1-22 amino acids residue constitutes leading peptide, and 23-625 amino acids residue constitutes the mature protein district.
Complete amino acid sequence described in the SEQ ID NO:23 comprises leading peptide and mature protein district, and wherein 1-22 amino acids residue constitutes leading peptide, and 23-645 amino acids residue constitutes the mature protein district.
Complete amino acid sequence described in the SEQ ID NO:25 comprises leading peptide and mature protein district, and wherein 1-25 amino acids residue constitutes leading peptide, and 26-620 amino acids residue constitutes the mature protein district.
Complete amino acid sequence described in the SEQ ID NO:27 comprises leading peptide and mature protein district, and wherein 1-17 amino acids residue constitutes leading peptide, and 18-644 amino acids residue constitutes the mature protein district.
The coded protein of DNA of the present invention is that wherein mature protein has peptide and generates active protein, comprise also among the DNA of the present invention that coding and the protein with aminoacid sequence shown in SEQ ID NO:6, SEQ ID NO:12, SEQ ID NO:18, SEQ ID NO:23, SEQ ID NO:25 or the SEQ ID NO:27 in the sequence table goes up same protein DNA substantially, no matter whether it comprises leading peptide (is noted, according to universal code, base sequence is determined by aminoacid sequence).That is, the invention provides protein DNA shown in the coding following (A)-(X):
(A) have the protein of the aminoacid sequence of forming by the 23-616 amino acids residue of aminoacid sequence shown in the SEQ ID NO:6 in the sequence table,
(B) has following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in displacement in the aminoacid sequence of being made up of the 23-616 amino acids residue of aminoacid sequence shown in the SEQ ID NO:6 in the sequence table, disappearance, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion
(C) have the protein of the aminoacid sequence of forming by the 21-619 amino acids residue of aminoacid sequence shown in the SEQ ID NO:12 in the sequence table,
(D) has following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in displacement in the aminoacid sequence of being made up of the 21-619 amino acids residue of aminoacid sequence shown in the SEQ ID NO:12 in the sequence table, disappearance, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion
(E) have the protein of the aminoacid sequence that the 23-625 amino acids residue of aminoacid sequence shown in the SEQ ID NO:18 in the sequence table forms,
(F) has following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in displacement in the aminoacid sequence of being made up of the 23-625 amino acids residue of aminoacid sequence shown in the SEQ ID NO:18 in the sequence table, disappearance, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion
(G) have the protein of the aminoacid sequence of forming by the 23-645 amino acids residue of aminoacid sequence shown in the SEQ ID NO:23 in the sequence table,
(H) has following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in displacement in the aminoacid sequence of being made up of the 23-645 amino acids residue of aminoacid sequence shown in the SEQ ID NO:23 in the sequence table, disappearance, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion
(I) have the protein of the aminoacid sequence of forming by the 26-620 amino acids residue of aminoacid sequence shown in the SEQ ID NO:25 in the sequence table,
(J) has following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in displacement in the aminoacid sequence of being made up of the 26-620 amino acids residue of aminoacid sequence shown in the SEQ ID NO:25 in the sequence table, disappearance, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion
(K) have the protein of the aminoacid sequence of forming by the 18-644 amino acids residue of aminoacid sequence shown in the SEQ ID NO:27 in the sequence table,
(L) has following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in displacement in the aminoacid sequence of being made up of the 18-644 amino acids residue of aminoacid sequence shown in the SEQ ID NO:27 in the sequence table, disappearance, inserts, adds, and/or the aminoacid sequence of the one or more amino acid gained of inversion
(M) contain the protein of aminoacid sequence shown in the SEQ ID NO:6 in the ordered list,
(N) contain the mature protein district, have following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in shown in the SEQ ID NO:6 in the sequence table in the aminoacid sequence, comprise displacement, disappearance, insertion, add, and/or the aminoacid sequence of the one or more amino acid gained of inversion
(O) have the protein of aminoacid sequence shown in the SEQ ID NO:12 in the sequence table,
(P) contain the mature protein district, have following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in shown in the SEQ ID NO:12 in the sequence table in the aminoacid sequence, comprise displacement, disappearance, insertion, add, and/or the aminoacid sequence of the one or more amino acid gained of inversion
(Q) have the protein of aminoacid sequence shown in the SEQ ID NO:18 in the sequence table,
(R) contain the mature protein district, have following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in shown in the SEQ ID NO:18 in the sequence table in the aminoacid sequence, comprise displacement, disappearance, insertion, add, and/or the aminoacid sequence of the one or more amino acid gained of inversion
(S) have the protein of aminoacid sequence shown in the SEQ ID NO:23 in the sequence table,
(T) contain the mature protein district, have following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in shown in the SEQ ID NO:23 in the sequence table in the aminoacid sequence, comprise displacement, disappearance, insertion, add, and/or the aminoacid sequence of the one or more amino acid gained of inversion
(U) have the protein of aminoacid sequence shown in the SEQ ID NO:25 in the sequence table,
(V) contain the mature protein district, have following aminoacid sequence and have peptide and generate active protein, described aminoacid sequence is included in shown in the SEQ ID NO:25 in the sequence table in the aminoacid sequence, comprise displacement, disappearance, insertion, add, and/or the aminoacid sequence of the one or more amino acid gained of inversion
(W) have aminoacid sequence shown in the SEQ ID NO:27 in the sequence table protein and
(X) contain the mature protein district, have aminoacid sequence shown in the SEQ ID NO:27 in the sequence table and have peptide and generate active protein.
Herein, though the implication of term " a plurality of " changes according to the position and the type of amino-acid residue in the proteinic three-dimensional structure, its scope comprises the number that can significantly not damage the amino-acid residue of three-dimensional structure and protein active, is specially 2-50, be preferably 2-30, more preferably 2-10.But, in (B), (D), (F), (H), (J), (L), (N), (P), (R), (T), (V) or proteinic aminoacid sequence (X), comprise displacement, disappearance, insertion, add, and/or under the situation of the aminoacid sequence of the one or more amino acid gained of inversion, protein is preferably under the condition of 50 ℃ and pH 8, keep the proteinic pact be under the state that does not comprise sudden change half or higher, preferred 80% or higher, more preferably 90% or higher enzymic activity.For example, the situation to (B) provides explanation; When aminoacid sequence (B) is shown in the SEQ ID NO:6 in sequence table in the aminoacid sequence, comprise displacement, disappearance, insertion, add, and/or under the one or more amino acid whose situations of inversion, this protein is preferably under the condition of 50 ℃ and pH 8, keep aminoacid sequence shown in the SEQ ID NO:6 have in the sequence table proteinic pact half or higher, preferred 80% or higher, more preferably 90% or higher enzymic activity.
Amino acid mutation shown in similar above-mentioned (B) etc. can obtain by the following method, for example by the site-directed mutagenesis method, and the base sequence that the amino acid of the privileged site of this enzyme gene is replaced, lack, inserts, adds change.In addition, the DNA of above-mentioned change also can obtain by known mutagenic treatment.Mutagenic treatment is meant, for example, with azanol etc. in the encode method of DNA of this enzyme of extracorporeal treatment, and, handle the method for the Escherichia bacterium of the DNA that comprises this enzyme of encoding such as uviolizing, N-methyl-N '-nitro-N-nitrosoguanidine (NTG) or nitrous acid with the mutagenic compound that are generally used for induced mutations.
In addition, the displacement of above-mentioned base, disappearance, insertion, interpolation and/or inversion comprise that also naturally occurring sudden change is such as because the difference that microbial species or bacterial strain cause.By in suitable cell, expressing DNA with described sudden change and the enzymic activity that detects expression product, can obtain to encode with sequence table in SEQ ID NO:6 or 12 described in protein go up same protein DNA substantially.
(4-2) production of the preparation of transformant and peptide-forming enzyme
Peptide-forming enzyme can by DNA of the present invention is imported suitable host and in this host expressible dna produce.
The example that can be used for expressing by the determined proteinic host of DNA of the present invention comprises that multiple prokaryotic cell prokaryocyte is such as belonging to Escherichia such as intestinal bacteria, steady bacillus, Sphingobacterium, the bacterium of Flavobacterium and Bacillaceae such as Bacillus subtilus, and multiple eucaryon is such as yeast saccharomyces cerevisiae, pichia and aspergillus oryzae.
Be used for the recombinant DNA that DNA imports the host can be inserted with the corresponding carrier of type that will express the host of this DNA by the DNA that will need to import and prepare, can be expressed by the coded protein of this DNA in this mode.Under promotor to the function of peptide-forming enzyme gene in host cell of short steady bacillus etc. was unique situation, this promotor can be used as the promotor of expressing DNA of the present invention.In addition, another promotor that works in host cell can be connected with DNA of the present invention, can under the control of this promotor, express this DNA on demand then.
The example that recombinant DNA is imported the method for transformation of host cell comprises that the method for D.M.Morrison is (referring to Methods in Enzymology, 68,326 (1979)) or by handling the recipient microorganism cell increase the method for DNA permeability (referring to Mandel with calcium chloride, H. and Higa, A., J.Mol.Biol., 53,159 (1970)).
Using under the proteinic situation of recombinant DNA technology mass production, also is to implement preferred implementation of the present invention with the protein bound that produces in the proteinic transformant to form the protein inclusion body.The advantage of this expression and production method comprises the digestion of the proteolytic enzyme that the protection target protein is avoided existing in the microorganism cells, and by the cracking microorganism cells, the centrifugal then simple and easy ground purifying target protein etc. that gets final product.
The protein inclusion body that obtains in this mode dissolves with protein denaturant, by the active regeneration step dissolved protein transduction is turned to suitable fold, physiologically active protein matter, described active regeneration step mainly comprises with protein denaturant crack protein matter, removes denaturing agent then.This process has a lot of examples, comprises Human Inter Leukin-2's active regeneration (opening clear S61-257931 referring to the Japanese Patent spy).
In order from the protein inclusion body, to obtain active protein, need carry out sequence of operations, comprise the dissolving and active regeneration, this method steps than direct preparation active protein complexity many.But, in microorganism cells, microorganism growth is had under the proteinic situation of large volume of deleterious effect producing, can suppress described effect with the protein of the inclusion body form of inactive protein matter by accumulation in microorganism cells.
The example of the method for the large volume target protein of mass production inclusion body form is included in the down independent method of expressing target protein of control of potent promotor, and the method for target protein to express with the form of the fused protein of known large volume expressed protein.
Below, will more specifically explain the present invention as example with preparation intestinal bacteria that transform and the method for using microorganism transformed to produce peptide-forming enzyme.In addition, microorganism such as intestinal bacteria in preparation during peptide-forming enzyme, can mix the DNA of coding precursor protein matter (comprising leader sequence), maybe can mix the DNA that forms by the mature protein district that does not comprise leader sequence, and can be suitable for the DNA of protein coding sequence according to selections such as the working condition of the enzyme that will produce, form, working conditionss.
The promotor that is often used in production heterologous protein in the intestinal bacteria can be used as the promotor of the DNA that expresses the coding peptide-forming enzyme.The example of described promotor comprises T7 promotor, lac promotor, trp promotor, trc promotor, tac promotor, lambda phage PR promotor, PL promotor and other strong promoter.In addition, the example of spendable carrier comprises pUC19, pUC18, pBR322, pHSG299, pHSG298, pHSG399, pHSG398, RSF1010, pMW119, pMW118, pMW219 and pMW218.In addition, can also use the carrier of phage DNA.And, can use the expression vector that comprises promotor and can express the dna sequence dna (comprising the available promotor) that inserts.
In order to produce the peptide-forming enzyme of fused protein inclusion body form, another protein of will encoding (preferred hydrophilic peptide) thus the gene upstream or the downstream that are connected to peptide-forming enzyme gene obtain the fusion rotein plasmagene.In this mode, another proteinic gene of encoding can be the amount that can increase the cumulative fused protein, and strengthens the deliquescent any gene of fused protein after sex change and regeneration step.Candidate's example of described gene comprises T7 gene 10, beta-galactosidase gene, dihydrofolate reductase gene, gamma-interferon gene, interleukin-2 gene and prochymosin gene.
When these genes are connected with the gene of coding peptide-forming enzyme, full gene is connected so that make the reading frame unanimity of its codon.This gene can be connected to suitable restriction enzyme sites, maybe can use the synthetic DNA that contains suitable sequence.
In addition, in order to increase the output of peptide-forming enzyme, preferably in some cases terminator (transcription termination sequence) is connected to the downstream of fusion rotein plasmagene.This terminator comprises, for example, and T7 terminator, fd phage terminator, T4 terminator, tetracycline resistance gene terminator and intestinal bacteria trpA gene terminator.
In intestinal bacteria, import the preferred so-called multiple copied type carrier of carrier of the gene of the fused protein between coding peptide-forming enzyme or peptide-forming enzyme and other protein; the example comprise have the replication orgin that comes from ColE1 plasmid; for example; based on the plasmid of pUC, and based on the plasmid or derivatives thereof of pBR322." derivative " as used herein is meant those plasmids that displacement, disappearance, insertion, interpolation and/or the inversion by base modified.Should be noted that modification as used herein comprises by the modification with the mutagenic treatment of mutagenic compound or UV irradiation, or the modification by spontaneous mutation.
Be the screening transformant, carrier preferably contains the marker such as the Ampicillin Trihydrate resistant gene.Described plasmid comprise can the commercial expression vector that contains effectively start that obtains (based on the carrier (production of Takara Shuzo company) of pUC, based on the carrier (production of ClonetechLaboratories company) of pRROK, pKK233-2 (production of Clonetech Laboratories company) etc.
Obtain recombinant DNA by dna fragmentation being connected to carrier DNA; In described dna fragmentation, connect promotor in the following sequence, coding L-amino acid amide lytic enzyme or comprise the gene (according to circumstances) of L-amino acid amide lytic enzyme and another proteinic fused protein, terminator.
When cultivating the gained intestinal bacteria then with the recombinant DNA transformed into escherichia coli, peptide-forming enzyme or comprise peptide-forming enzyme and another proteinic fused protein and expressed and produce.Can be used as and transform the host though be generally used for the bacterial strain of expression of heterologous genes, preferred, coli strain JM109 for example.The method that the method that implement to transform and being used to filters out transformant is described in Molecular Cloning, and 2nd Edition is in Cold Spring Harbor Press (1989) and other publication.
When the peptide-forming enzyme of expressed fusion protein matter form, can use with peptide-forming enzyme, come the cracking peptide-forming enzyme such as non-existent sequence in factor Xa or the kallikrein as the restricted proteolytic enzyme of recognition sequence.
Can be with being generally used for cultivating colibacillary substratum, such as M9-casamino acids substratum or LB substratum, as producing substratum.In addition, wait according to marker, promotor, the host microorganism type of used carrier and select the suitable culture condition and produce inductive condition.
Following method can be used to reclaim peptide-forming enzyme and comprise peptide-forming enzyme and another proteinic fused protein.If this peptide-forming enzyme or its fused protein are dissolved in microorganism cells, then reclaim this microorganism cells, then with its fragmentation or cracking so that used as crude enzyme liquid.And, can carry out purifying by ordinary skill such as precipitation, filtration or column chromatography to this peptide-forming enzyme or its fused protein as required before using.At this moment, also can use the purifying antibody method that adopts peptide-forming enzyme or its fused protein.
Under the situation that forms the protein inclusion body, dissolve this inclusion body with denaturing agent.Though it can dissolve with microorganism cells protein, considers purification step subsequently, so the preferred inclusion body that takes out dissolves then.Can adopt conventional currently known methods from microorganism cells, to reclaim inclusion body.For example, thus can be by the centrifugal then recovery of cracking microorganism cells inclusion body.The example that can dissolve the denaturing agent of inclusion body comprises that Guanidinium hydrochloride (for example, 6M, pH 5-8) and urea are (for example, 8M) etc.
Having active protein waits by dialysis and removes these denaturing agents and regenerated.The Tris-HCl damping fluid, phosphate buffer solutions etc. can be used as dialyzate used in the dialysis, and its concentration can be, for example, 20mM-0.5M, and its pH can be, and for example, 5-8.
Protein concn during the regeneration step preferably is maintained at about 500 μ g/ml or lower.The dialysis temperature is preferably 5 ℃ or lower so that prevent regenerated peptide-forming enzyme generation self-crosslinking.In addition, except dialysing, the method for removing denaturing agent comprises dilution or ultrafiltration, and which kind of denaturing agent activity no matter expection use all can be reproduced.
(5) characteristic of the coded enzyme of DNA of the present invention
For example, can react in comprising amino acid ester and the amine borate buffer solution as substrate by making enzyme, the peptide that quantitatively generates detects the activity of the coded enzyme of DNA of the present invention then.In embodiment more specifically, adopt the borate buffer solution (pH 9.0) that comprises 100mM L-alanine methyl ester and 200mM L-glutaminate, implement the reaction some minutes at 25 ℃.
The definition of the activity unit of used enzyme is among the present invention, 1 unit (U) is the 100mM borate buffer solution (pH9.0) that comprises 100mM L-alanine methyl ester and 200mM L-glutaminate in use, under 25 ℃ the reaction conditions, produce the enzyme amount of 1 micromole (μ mole) peptide in 1 minute.
The coded protein of DNA of the present invention is peptide-forming enzyme protein.Peptide generates the active activity that is generated peptide by carboxyl composition and amine component that is meant.Below, will the characteristic of the preferred implementation of the coded enzyme of DNA of the present invention be described.
A kind of preferred implementation of the enzyme that DNA of the present invention is coded comprises having following active enzyme, and dipeptides productivity is as its indicator.That is, a kind of preferred implementation of enzyme of the present invention comprises having the activity that is generated peptide by carboxyl composition and amine component, and under the condition of following (i)-(iv), in the dipeptides formation reaction, has the 0.03mM/min of being preferably or higher, more preferably 0.3mM/ minute or higher, the enzyme of the productivity of preferred especially 1.0mM/min or higher L-alanyl-L-glutamine.The condition of dipeptides formation reaction is as follows:
(i) the carboxyl composition is a L-alanine methyl ester hydrochloride (100mM);
(ii) amine component is L-glutaminate (200mM);
(iii) pH is 9.0; With,
(iv) according to protein mass, evenly the add-on of the enzyme of purifying is lower than 0.61mg/ml.
Above-mentioned productivity is far above the conventional productivity of using the enzymic synthesis peptide, and enzyme of the present invention has the catalysis peptide with very fast speed synthetic ability.
The above-mentioned add-on indication of enzyme adds the final quantity of the enzyme of reactive system, and by required zymoprotein quality, the enzyme add-on is 0.01mg/ml or higher, preferred 0.02mg/ml or higher.Term " protein mass " is meant by adopting protein determination CBB solution (Nakarai production) and bovine serum albumin as reference material, by the shown value of Xylene Brilliant Cyanine G colorimetry.
In the specific examples of the method for measuring enzymic activity, can in comprising amino acid ester and amine borate buffer solution, react by making enzyme, and the peptide that quantitatively obtains detects enzymic activity as substrate.In example more specifically, method comprises uses the 100mM borate buffer solution (pH 9.0) that comprises 100mM L-alanine methyl ester and 200mM L-glutaminate, makes the enzyme reaction some minutes in 25 ℃.
In addition, the preferred implementation of the coded enzyme of DNA of the present invention comprises that have can be with amino acid ester and amino acid amide all as the enzyme of the ability of the substrate of carboxyl composition.Word " with amino acid ester and amino acid amide all as substrate " be meant at least one class or more multiclass amino acid ester and at least one class or more the multiclass amino acid amide can be used as substrate.In addition, a kind of preferred implementation of enzyme of the present invention has the amino acid of all amino acid, C protection and the amine enzyme as the ability of the substrate of amine component.Word " amino acid of amino acid, C protection and amine are as substrate " is meant at least one class or multiclass amino acid more, the amino acid of at least one class or more multiclass C protection and at least one class or more multiclass amine can be used as substrate.Owing to have the substrate specificity widely of carboxyl composition or amine component, enzyme of the present invention is preferred, wherein can select raw material widely, and it is beneficial in the industrial production needs to expense and production unit successively.
The specific examples of carboxyl composition comprises the L-amino acid ester, D-amino acid ester, L-amino acid amide and D-amino acid amide.In addition, amino acid ester not only comprises and the corresponding amino acid ester of naturally occurring amino acid, also comprises the corresponding amino acid ester of amino acid or derivatives thereof that exists with non-natural.In addition, the example of amino acid ester comprise α-An Jisuanzhi and β-, γ-and omega-amino-acid esters etc., it has different amino binding sites.The representative instance of amino acid ester comprises amino acid whose methyl esters, ethyl ester, n-propyl, isopropyl ester, positive butyl ester, isobutyl ester and the tert-butyl ester.
The specific examples of amine component comprises L-amino acid, the L-amino acid of C protection, D-amino acid, the D-amino acid and the amine of C protection.In addition, the example of amine not only comprises naturally occurring amine, also comprises the amine or derivatives thereof that non-natural exists.In addition, amino acid whose example not only comprises naturally occurring amino acid, also comprises the amino acid or derivatives thereof that non-natural exists.It comprises a-amino acid and β-, γ-and omega-amino acid etc., it has different amino binding sites.
In addition, on the other hand, a kind of preferred implementation of the enzyme that DNA of the present invention is coded comprises that the pH scope of catalysis peptide formation reaction is the enzyme of 6.5-10.5.Preferably can be in above-mentioned wide in range pH scope the enzyme of the present invention of catalyzed reaction, it can adapt to the industrial production that multiple restriction may occur neatly.But in the actual generation of peptide, when using enzyme, preferably further be adjusted to the corresponding optimal pH of gained enzyme so that with the katalysis maximization of enzyme.
And on the other hand, a kind of preferred implementation of the enzyme that DNA of the present invention is coded comprises that the temperature range of catalysis peptide formation reaction is 0-60 ℃ a enzyme.Because endonuclease capable of the present invention is catalyzed reaction in above-mentioned wide in range temperature range, so it is preferred, it can adapt to the industrial production that multiple restriction may occur neatly.But in the actual generation of peptide, when using enzyme, preferably further be adjusted to the corresponding optimum temperuture of gained enzyme so that with the katalysis maximization of enzyme.
(6) two peptide production methods
Two peptide production methods of the present invention are included in when having above-mentioned enzyme, the reaction between carboxyl composition and the amine component.Two peptide production methods of the present invention comprise making to have the enzyme that is generated the ability of peptide by carboxyl composition and amine component, thereby or contain the enzyme thing and act on carboxyl composition and the synthetic dipeptides of amine component.
Making the used enzyme of the present invention or contain method that the enzyme thing acts on carboxyl composition and amine component can be to be mixed with each other enzyme or contain the enzyme thing, carboxyl composition and amine component.More specifically, can adopt enzyme or contain the enzyme thing and add the method that the solution that contains carboxyl composition and amine component makes its reaction then.Alternatively, under the situation of the microorganism that use to produce this enzyme, can use to comprise and cultivate the microorganism that produces this enzyme, in microorganism or microbial culture medium, produce and the accumulation enzyme, then carboxyl composition and amine component be added the method for nutrient solution.Collect the dipeptides that produces by fixed method then, and carry out purifying as required.
Term " contains the enzyme thing " and is meant any material that comprises enzyme, the example of its specific form comprises the culture of the microorganism that can produce enzyme, from the isolating microorganism cells of culture with by handling the product (hereinafter referred to as, " microorganism cells processing product ") that microorganism cells obtains.The culture of microorganism is meant by culturing micro-organisms resulting, more specifically, is meant microorganism cells, is used for the substratum of culturing micro-organisms and the mixture of the material that produced by cultured microorganism etc.In addition, can wash microorganism cells, and use with the form of microorganism cells of washing.In addition, microorganism cells is handled product and is comprised cracking, dissolving or freeze dried microorganism cells etc., also comprise by handling thick enzyme that microorganism cells reclaims etc., and the enzyme of the purifying that obtains by the thick enzyme of purifying etc.The partially purified enzyme that obtains by multiple purification process can be used as the enzyme of purifying, maybe can use by method fixed immobilized enzyme such as covalent attachment method, absorption method, entrapping methods.In addition, because certain micro-organisms can generating unit divide cracking (depending on employed microorganism) in the training period, culture supernatant also can be used as and contain the enzyme thing at this moment.
In addition, wild strain can be used as the microorganism that comprises enzyme, or also can use the gene recombination bacterial strain of expressing this enzyme.Microorganism is not limited to complete microorganism cells, can also use the microorganism cells of acetone treatment, cryodesiccated microorganism cells or other treated microorganism cells.Can also use by covalent attachment method, absorption method, entrapping method or other method fixation of microbe cell and microorganism cells and handle fixation of microbial cell and the fixation of microbial cell processing product that product obtains, and the fixation of microbial cell of handling.
In addition, when handling product, wherein can occur not participating in the enzyme that peptide generates usually and decompose the peptide that generates when the microorganism cells that uses culture, cultured microorganism cell, washing or by the microorganism cells that fragmentation or cracking microorganism cells obtain.At this moment, preferred inhibitors of metalloproteinase such as the ethylenediamine tetraacetic acid (EDTA) (EDTA) of adding under some situation.Add-on is 0.1 mmole (mM)-300mM, preferred 1mM-100mM.
The preferred implementation of two peptide production methods of the present invention is following methods, cultivates above-mentioned (4-2) described transformant in substratum, and peptide-forming enzyme is accumulated in substratum and/or transformant.Because by using transformant can easily produce peptide-forming enzyme in a large number, so can be in a large number and produce dipeptides apace.
Reach the target effect if enzyme or the usage quantity that contains the enzyme thing demonstrate, then this amount is enough (significant quantity), and those of ordinary skills can easily determine this significant quantity by simple preliminary experiment.For example, under the situation of using enzyme, usage quantity is the about 100U of about 0.01U-, and under the situation of the microorganism cells that uses washing, usage quantity is the about 500g/L of about 1g/L-.
Any carboxyl composition is spendable, as long as it can generate peptide by the condensation with other material of amine component form.The example of carboxyl composition comprises the L-amino acid ester, D-amino acid ester, L-amino acid amide and D-amino acid amide and the organic acid acetic that does not contain amino.In addition, the example of amino acid ester not only comprises and the corresponding amino acid ester of naturally occurring amino acid, also comprises the corresponding amino acid ester of amino acid or derivatives thereof that exists with non-natural.In addition, the example of amino acid ester comprise α-An Jisuanzhi and β-, γ-and omega-amino-acid esters etc., it has different amino binding sites.The representative instance of amino acid ester comprises amino acid whose methyl esters, ethyl ester, n-propyl, isopropyl ester, positive butyl ester, isobutyl ester and the tert-butyl ester.
Any amine component is spendable, as long as it can generate peptide by the condensation with other material of amine component form.The example of amine component comprises L-amino acid, the L-amino acid of C protection, D-amino acid, the D-amino acid and the amine of C protection.In addition, the example of amine not only comprises naturally occurring amine, also comprises the amine or derivatives thereof that non-natural exists.In addition, amino acid whose example not only comprises naturally occurring amino acid, also comprises the amino acid or derivatives thereof that non-natural exists.It comprises a-amino acid and β-, γ-and omega-amino acid etc., it has different amino binding sites.
Be respectively 1mM to 10M as the carboxyl composition of raw material and the concentration of amine component, be preferably 0.05M to 2M; But, in some cases, preferably to add amine component with carboxyl become to grade mole or the amount of molar excess.In addition, under the situation of the material inhibited reaction of high density, can after being adjusted to the concentration that does not cause suppressing, it during reaction it be added step by step.
Allow that peptide synthetic temperature of reaction is 0-60 ℃, preferred 5-40 ℃.In addition, allow that peptide synthetic reaction pH is 6.5-10.5, preferred 7.0-10.0.
Embodiment
Below, explain the present invention by embodiment.But the present invention is not limited to these embodiment.Except the triketohydrindene hydrate dyeing (qualitative) with membrane chromatographic confirms, implement detection by quantitative so that measure product by following high performance liquid chromatography.Post: Inertsil ODS-2 (production of GLScience company), elutriant: phosphate aqueous solution, wherein comprise 5.0mM 1-perfluorooctane sulfonate (pH 2.1): methyl alcohol=100: 15-50, flow velocity: 1.0mL/ minute, detect: 210 nanometers (hereinafter referred to as " nm ").
(embodiment 1) microorganism culturing (short steady bacillus strain FERM BP-8113)
In 500ml slope Kou Shi bottle, add 50mL every liter (L) and contain the substratum (pH 6.2) of 5 gram (g) glucose, 5g ammonium sulfate, 1g potassium primary phosphate, 3g dipotassium hydrogen phosphate, 0.5g sal epsom, 10g yeast extract and 10g peptone, 115 ℃ of sterilizations 15 minutes.Contained on the same substratum at inoculation 1 platinum loop on this substratum then, cultivated 16 hours the steady bacillus strain FERM of weak point BP-8113 (preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst has speciallyyed permit biological sustenance center for 30 ℃, preservation mechanism address: Chuo Dai-6,1-1Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation is passed on the date: cell on July 8th, 2002), at 30 ℃, 120 reciprocal/minute following concussions were cultivated 16 hours then.
(embodiment 2) produce peptide with microorganism cells
To the medium centrifugal (10,000 rev/mins (rpm), 15 minutes) that obtains among the embodiment 1, collect microorganism cells, then it being suspended to concentration in containing the 100mM borate buffer solution of 10mM EDTA (pH 9.0) is 100g/L.Contain in following carboxyl composition of 10mM EDTA, 200mM and the following amino acid whose 100mM borate buffer solution of 400mM (pH9.0) at each 1mL, add this suspension of 1ml respectively, make total amount, 18 ℃ of reactions 2 hours to 2mL.Shown the peptide that this reaction result generated in the table 1.
Table 1
Figure C0382246000321
Figure C0382246000331
(all carboxyl compositions are all used hydrochloride.)
The purifying of (embodiment 3) enzyme
Step after centrifugal is on ice or 4 ℃ of enforcements.(preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center to cultivate short steady bacillus strain FERM BP-g113 according to the method identical with embodiment 1, preservation mechanism address: Chuo Dai-6,1-1 Higashi1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation is passed on the date: on July 8th, 2002), collect microorganism cells by centrifugal (10,000rpm, 15 minutes).After with 50mM Tris-HCl damping fluid (pH 8.0) washing 16g microorganism cells, it is suspended in 40 milliliters of (ml or mL) same buffer, carry out ultrasonic degradation with 195 watts then and handled 45 minutes.Centrifugal then this ultrasonic degradation liquid (10,000rpm, 30 minutes) to remove cell debris, obtains ultrasonic degradation liquid supernatant., remove insoluble part by ultracentrifugation (50,000rpm, 30 minutes) then, thereby obtain the soluble part of supernatant liquor form this ultrasonic degradation liquid supernatant dialysed overnight with 50mM Tris-HCl damping fluid (pH8.0).The soluble part adding that obtains is used in Tris-HCl damping fluid (pH 8.0) the equilibrated Q-Sepharose HP post (Amersham production) in advance, from non-absorbed portion, collected active part then.With 50mM acetate buffer (pH 4.5) to this active part dialysed overnight, then by centrifugal (10,000rpm, 30 minutes) thus remove the part that insoluble part obtains the dialysis of supernatant liquor form.The part that to dialyse then adds to be used in 50mM acetate buffer (pH 4.5) the equilibrated Mono S post (Amersham production) in advance, with the linear concentration gradient wash-out enzyme of the same buffer that contains 0-1M NaCl.The part that contains minimum level contaminating protein matter in the active part is added in advance with containing in 50mM acetate buffer (pH 4.5) the equilibrated Superdex 200pg post (Amersham product) of 1M NaCl, by making same buffer (pH 4.5) post of flowing through that contains 1M NaCl implement gel-filtration, obtain active part solution.The result of aforesaid operations confirmed, according to electrophoretic experimental result, used peptide-forming enzyme is by purifying equably among the present invention.The enzyme rate of recovery in the above-mentioned purification step is 12.2%, and purification degrees is 707 times.
(embodiment 4) detect the molecular weight of enzyme
(SDS-gel electrophoresis)
0.3 microgram (μ g) equivalent to the enzyme part of the method gained purifying by embodiment 3 carries out polyacrylamide gel electrophoresis.With 0.3% (w/v) Tris, 1.44% (w/v) glycine and 0.1% (w/v) Sulfuric acid,monododecyl ester, sodium salt are as electrophoretic buffer, gel (the Multigel 10-20 that will have the concentration gradient of 10-20% gel strength, Daiichi Pure Chemicals produces) as polyacrylamide gel, Pharmacia molecular weight marker thing is used as the molecular weight marker thing.After electrophoresis is finished, to gel-colored, find the homogeneous band in the molecular weight position of about 75 kilodaltons (kDa) with Xylene Brilliant Cyanine G R-250.
(gel-filtration)
The enzyme of method gained purifying that will be by embodiment 3 partly adds in advance with containing in 50mM acetate buffer (pH 4.5) the equilibrated Superdex 200pg post (Amersham product) of 1M NaCl, by making the same buffer (pH 4.5) that contains 1M NaCl thus the post of flowing through is implemented gel-filtration detection molecules amount.The molecular weight marker thing that Pharmacia molecular weight marker thing is used as the known molecular amount is to make working curve.As a result, the molecular weight of this enzyme is about 150kDa.
According to the result of SDS-gel electrophoresis and gel-filtration, pointing out this enzyme is the homodimer with molecular weight of about 75kDa.
The optimal pH of (embodiment 5) enzyme reaction
Generating in the reaction of L-alanyl-L-glutamine, detect the influence of pH by L-alanine methyl ester hydrochloride and L-glutaminate.With acetate buffer (pH 3.9-5.4), MES damping fluid (pH 5.4-6.4), phosphate buffered saline buffer (pH 6.0-7.9), borate buffer solution (pH 7.8-9.3), CAPS damping fluid (pH 9.3-10.7), and K 2HPO 4-NaOH damping fluid (pH 10.8-11.6) is as damping fluid.1 microlitre (μ l) the Mono S enzyme part (about 180U/ml) that obtains among the embodiment 3 is added 100 μ l contain 100mM L-alanine methyl ester, in each damping fluid (100mM) of 200mM L-glutaminate and 10mM EDTA, make it 18 ℃ of reactions 5 minutes, detect the influence of pH reaction.Shown among Fig. 1 that the value by will use borate buffer solution (pH 9.3) time is decided to be 100% result who represents.As a result, find that optimal pH is 8-9.5.
The optimum temperuture of (embodiment 6) enzyme reaction
Generating in the reaction of L-alanyl-L-glutamine the influence of detected temperatures by L-alanine methyl ester hydrochloride and L-glutaminate.1 μ l is partly added 100 μ l with embodiment 5 used identical enzymes contain 100mM L-alanine methyl ester, in the 100mM borate buffer solution of 200mM L-glutaminate and 10mM EDTA (pH 9.0), it was reacted 5 minutes under each temperature, and detected temperatures is to the influence of reaction.Shown among Fig. 2 by being decided to be 100% result who represents at the activity value under 34 ℃.As a result, optimum temperuture is 30-40 ℃.
(embodiment 7) enzyme inhibitors
Adopt L-alanine methyl ester hydrochloride and L-glutaminate as substrate, detect inhibitor producing the influence of L-alanyl-L-glutamine.2 μ l are partly added 50 μ l with embodiment 5 used identical enzymes contain in the 100mM borate buffer solution (pH 9.0) of each enzyme inhibitors shown in the 10mM table 2, make it 25 ℃ of reactions 5 minutes.Notice that before use, with phenanthrolene, phenylmethylsulfonyl fluoride and p-nitrophenyl-p '-guanidine benzoate are dissolved in the methyl alcohol, concentration is 50mM.L-alanyl-L-glutamine generation value when not having inhibitor peptides is decided to be 100, and the enzymic activity under each condition provides with relative reactivity.The result is as shown in table 2.As a result, in the serinase inhibitor that is detected, enzyme is not suppressed by phenylmethyl sulfonylfluoride, but it is suppressed by p-nitrophenyl-p '-guanidine benzoate.
Table 2
Figure C0382246000361
(embodiment 8) produce the L-alanyl-L-glutamine by L-alanine methyl ester and L-glutaminate
3 μ l are partly added 100 μ l with embodiment 5 used identical enzymes contain 100mM L-alanine methyl ester hydrochloride, 200mM L-glutaminate and 10mM EDTA 100mM borate buffer solution (pH 9.0) in, make it 18 ℃ of reactions.The result generates 83mM L-alanyl-L-glutamine (L-Ala-L-Gln) as shown in Figure 3 in adding the enzyme district, the concentration of by product L-Ala-L-Ala-L-Gln is 1.3mM.On the other hand, almost do not observe any generation of L-Ala-L-Gln in not adding the enzyme district, enzyme concn only is about 0.07mM after 120 minutes and react.
(embodiment 9) L-glutaminate concentration is to producing the influence of L-alanyl-L-glutamine
1 μ l is partly added 100 μ l with embodiment 5 used identical enzymes contain 100mM L-alanine methyl ester hydrochloride, in the 100mM borate buffer solution of the L-glutaminate of concentration shown in the table 3 and 10mM EDTA (pH 9.0), make it 18 ℃ of reactions 2 hours.The result is as shown in table 3.
Table 3
Figure C0382246000371
The substrate specificity (1) of (embodiment 10) enzyme
As under the situation of carboxyl composition, detect the ester specificity at the L-amino acid ester.2 μ l are partly added 100 μ l with embodiment 5 used identical enzymes contain the carboxyl composition shown in the 100mM table 4, in the 100mM borate buffer solution of 200mM L-glutaminate and 10mM EDTA (pH 9.0), make it 25 ℃ of reactions 2 hours.The growing amount (HCl represents hydrochloric acid in the table 4) that has shown L-Ala-L-Gln in this reaction in the table 4.
Table 4
The carboxyl composition The L-Ala-L-Gln (mM) that generates
L-alanine methyl ester HCl L-alanine ethyl ester HCl L-L-Ala isopropyl ester HCl L-L-Ala-tert-butyl ester HCl 84.3 91.5 78.9 7.5
The substrate specificity (2) of (embodiment 11) enzyme
Be used as under the situation of amine component as carboxyl composition and multiple L-amino acid at the L-alanine methyl ester, detection of peptides generates.2 μ l are partly added 100 μ l with embodiment 5 used identical enzymes contain 100mM L-alanine methyl ester hydrochloride, in the 100mM borate buffer solution of L-amino acid shown in the 150mM table 5 and 10mM EDTA (pH 9.0), make it 25 ℃ of reactions 3 hours.The growing amount that has shown multiple peptide in this reaction in the table 5.(generation of mark "+" expression peptide is confirmed but can not be by quantitatively owing to lack standard, and " tr " expression trace).
Table 5
Figure C0382246000381
The substrate specificity (3) of (embodiment 12) enzyme
Be used as under the situation of amine component as carboxyl composition and L-glutaminate at multiple L-amino acid methyl ester, detection of peptides generates.2 μ l are partly added 100 μ l with embodiment 5 used identical enzymes contain the L-amino acid methyl ester hydrochloride (AA-OMeHCl) shown in the 100mM table 6, in the 100mM borate buffer solution of 150mM L-glutaminate and 10mM EDTA (pH 9.0), make it 25 ℃ of reactions 3 hours.The growing amount that has shown multiple peptide in this reaction in the table 6.(generation of mark "+" expression peptide is confirmed but can not be by quantitatively owing to lack standard, and " tr " expression trace).In addition, when using L-Trp-OMe and L-Tyr-Ome, in reactive system, add Tween-80 to final concentration be 0.1%.
Table 6
Figure C0382246000391
(all carboxyl compositions are all used hydrochloride.)
(embodiment 13) enzyme substrates specificitys (4)
Be used as under the situation of amine component as carboxyl composition and multiple L-amino acid at multiple L-amino acid methyl ester, detection of peptides generates.2 μ l are partly added 100 μ l with embodiment 5 used identical enzymes contain the L-amino acid methyl ester hydrochloride (AA-OMeHCl) shown in the 100mM table 7, in the 100mM borate buffer solution of 150mM L-glutaminate and 10mM EDTA (pH 9.0), make it 25 ℃ of reactions 3 hours.The growing amount that has shown each peptide that is generated in this reaction in the table 7.(" tr " represents trace).In addition, when using L-Trp-OMe, in reactive system, add Tween-80 to final concentration be 0.1%.(generation of mark "+" expression peptide is confirmed but can not be by quantitatively owing to lack standard).
Table 7
(all carboxyl compositions are all used hydrochloride.)
(embodiment 14) enzyme substrates specificitys (5)
Be used as carboxyl composition and L or D type multiple amino acids as under the situation of amine component at L or D type multiple amino acids methyl esters, detection of peptides generates.With 2 μ l and embodiment 5 used identical enzymes partly add 100 μ l contain the L-amino acid methyl ester hydrochloride shown in the 100mM table 8 (from-OMeHCl), in the 100mM borate buffer solution of multiple amino acids shown in the 150mM table 8 and 10mM EDTA (pH 9.0), make it 25 ℃ of reactions 3 hours.The growing amount that has shown multiple peptide in this reaction in the table 8.(" tr " represents trace).
Table 8
Figure C0382246000411
(all carboxyl compositions are all used hydrochloride.)
The substrate specificity (6) of (embodiment 15) enzyme
Be used as under the situation of amine component as carboxyl composition and multiple L-amino acid at multiple L-amino acid amide, detection of peptides generates.2 μ l are partly added 100 μ l with embodiment 5 used identical enzymes contain the L-amino acid amide hydrochloride (AA-NH shown in the 100mM table 9 2HCl), in the 100mM borate buffer solution of L-amino acid shown in the 150mM table 9 and 10mM EDTA (pH 9.0), make it 25 ℃ of reactions 3 hours.The growing amount that has shown multiple peptide in this reaction in the table 9.
Table 9
The carboxyl composition Amine component The peptide that generates (mM)
L-Phe-NH 2 L-Gln L-Phe-L-Gln 0.2
L-Phe-NH 2 L-Ser L-Phe-L-Ser 0.6
L-Ala-NH 2 L-Gln L-Ala-L-Gln 7.6
L-Ala-NH 2 L-Met L-Ala-L-Met 3.4
L-Ala-NH 2 L-His L-Ala-L-His 3.9
L-Thr-NH 2 L-Gln L-Thr-L-Gln 0.3
The substrate specificity (7) of (embodiment 16) enzyme
Be used as under the situation of amine component at the L-amino acid of multiple L-alanine methyl ester as carboxyl composition and C protection, detection of peptides generates.2 μ l are partly added 100 μ l with embodiment 5 used identical enzymes contain the L-alanine methyl ester hydrochloride (Ala-OMeHCl) shown in the 100mM table 10, in the 100mM borate buffer solution of L-amino acid amide hydrochloride shown in the 150mM table 10 and 10mM EDTA (pH 9.0), make it 25 ℃ of reactions 3 hours.The growing amount that has shown multiple peptide in this reaction in the table 10.
Table 10
Figure C0382246000431
The substrate specificity (8) of (embodiment 17) enzyme
Be used as under the situation of amine component as carboxyl composition and methylamine at the multiple amino acids methyl esters, detection of peptides generates.2 μ l are partly added 100 μ l with embodiment 5 used identical enzymes contain the L-amino acid methyl ester hydrochloride (AA-OMeHCl) shown in the 100mM table 11, in the 100mM borate buffer solution of methylamine shown in the 150mM table 11 and 10mM EDTA (pH 9.0), make it 25 ℃ of reactions 3 hours.The growing amount that has shown multiple peptide in this reaction in the table 11.
Table 11
Figure C0382246000432
The substrate specificity (9) of (embodiment 18) enzyme
Be used as under the situation of amine component as carboxyl composition and beta-amino acids at beta-amino acid esters, detection of peptides generates.2 μ l are partly added 100 μ l with embodiment 5 used identical enzymes contain the carboxyl composition shown in the 100mM table 12, in the 100mM borate buffer solution of amine component shown in the 150mM table 12 and 10mMEDTA (pH 9.0), make it 25 ℃ of reactions 3 hours.The growing amount that has shown multiple peptide in this reaction in the table 12.(" tr " represents trace).
Table 12
The carboxyl composition Amine component The peptide that generates (mM)
Gly-OMe β-Ala Gly-β-Ala 2.2
Gly-OMe β-Phe Gly-β-Phe 0.4
L-Ala-OMe β-Ala Ala-β-Ala 7.7
L-Ala-OMe β-Phe Ala-β-Phe 1.4
L-Thr-OMe β-Ala Thr-β-Ala 3.2
L-Thr-OMe β-Phe Thr-β-Phe 1.4
β-Ala-OMe L-α-Ala β-Ala-L-α-Ala tr
β-Ala-OMe β-Ala β-Ala-β-Ala 0.2
β-Ala-OMe L-Gln β-Ala-L-Gln 0.6
β-Ala-OMe L-Ser β-Ala-L-Ser 3.2
All carboxyl compositions are all used hydrochloride.
The substrate specificity (10) of (embodiment 19) enzyme
Be used as under the situation of amine component as carboxyl composition and peptide at the L-amino acid ester, detect oligopeptides and generate.2 μ l are partly added 100 μ l with embodiment 5 used identical enzymes contain the carboxyl composition shown in the 100mM table 13, in the 100mM borate buffer solution of amine component shown in the 150mM table 13 and 10mM EDTA (pH 9.0), make it 25 ℃ of reactions 3 hours.The growing amount that has shown multiple peptide in this reaction in the table 13.The result clearly shows enzyme of the present invention can not only generate dipeptides, can also be by peptide is generated the long-chain peptide as amine component.
Shown in above-mentioned embodiment 9-20, the enzyme of the present invention that is obtained by short steady bacillus strain FERM BP-18545 is determined has substrate specificity very widely.
Table 13
Figure C0382246000451
(*: because the solubleness of L-Ala-L-Ala-L-Ala-L-Ala-L-Ala is low, so the concentration of the carboxyl composition that uses in this reactive system is 10mM, the concentration of the amine component that uses is 15mM.Other condition identical with described in the foregoing description.All carboxyl compositions are all used hydrochloride)
(embodiment 20) compare the ability that the catalysis peptide generates with known enzyme
Enzyme of the present invention and known enzyme are compared the ability that the catalysis peptide generates.Sulfydryl endopeptidase described in carboxypeptidase y described in the EP 278787A1 and the EP 359399B1 (ficin, papoid, bromeline and Disken) is used as known enzyme, and its form with the enzyme of purifying is used (Sigma production).The enzyme of even purifying is used as the source of enzyme of the present invention among the embodiment 3.These enzymes are added in the reactive system with the proteinic amount shown in the table 14.Enzyme is added 100 μ l contain in the borate buffer solution (pH 9.0) of 100mM L-alanine methyl ester hydrochloride and 200mM L-glutaminate, make gains 25 ℃ of reactions.Note, used carboxypeptidase is dissolved in the 10mM acetate buffer (pH 5.0) that contains 1mM EDTA, contain 2mM EDTA and used sulfydryl endopeptidase is dissolved in, in the 10mM acetate buffer of 0.1M KCl and 5mM dithiothreitol (DTT) (pH 5.0).The ratio that has shown the L-alanyl-L-glutamine productivity of these enzymes in the table 14.
As a result,, and compare, in the district that adds carboxypeptidase or sulfydryl endopeptidase, observe the slight increase of productivity with the district that does not add enzyme even in the generation of the L-alanyl-L-glutamine that does not have also to observe under the situation of enzyme utmost point trace.On the contrary, observe high relatively L-alanyl-L-glutamine productivity in adding the district of enzyme of the present invention, the productivity of this productivity ratio carboxypeptidase y and sulfydryl endopeptidase is high about 5,000-100,000 times.As mentioned above, enzyme of the present invention is proved and has the high peptide productivity different with known enzyme in the prior art.In addition, enzyme of the present invention is the dimer with molecular weight of about 75,000.On the contrary, it is about 61,000 that the molecular weight of carboxypeptidase y has been reported as, and that the molecular weight of sulfydryl endopeptidase has been reported as is about 23,000-36,000.Therefore, as shown in the Examples, compare with the L-alanyl-L-glutamine productivity of carboxypeptidase y and sulfydryl endopeptidase, even the situation that the L-alanyl-L-glutamine survival rate of enzyme of the present invention also is higher than it when productivity is represented with every molal weight when representing with per unit weight.
Table 14
Enzyme The add-on of enzyme (protein mg/ml) L-Ala-L-Gln productivity (mM/min) The ratio of L-Ala-L-Gln productivity/unit of enzyme weight
No enzyme 0 0.0006
Carboxypeptidase y 0.61 0.0257 0.0191
Ficin 2.60 0.0096 0.0017
Papoid 2.30 0.0106 0.0021
Bromeline 2.80 0.0062 0.0010
Chymopapain 3.60 0.0100 0.0013
Enzyme of the present invention 0.02 4.4000 100.0
(embodiment 21) produce the L-alanyl-L-glutamine with the microorganism cells of Sphingobacterium sp.
In 500ml slope Kou Shi bottle, add 50mL every liter (L) and contain 5g glucose, 5g ammonium sulfate, the 1g potassium primary phosphate, the 3g dipotassium hydrogen phosphate, 0.5g sal epsom, the substratum of 10g yeast extract and 10g peptone (pH 6.2), (preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center to be used to cultivate Sphingobacterium sp. bacterial strain FERM BP-8124 in 15 minutes 115 ℃ of sterilizations, preservation mechanism address: Chuo Dai-6,1-1Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation date: on July 22nd, 2002).That inoculates 1 platinum loop cell then on this substratum contains 5g glucose at every liter (L), the 10g yeast extract, slant agar substratum (the agar: 20g/L of 10g peptone and 5g NaCl, pH 7.0) on, cultivated 24 hours Sphingobacterium sp. bacterial strain FERM BP-8124 (preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst has speciallyyed permit biological sustenance center for 30 ℃, preservation mechanism address: Chuo Dai-6,1-1 Higashi1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation date: on July 22nd, 2002), at 30 ℃, 120 reciprocal/minute following concussions were cultivated 20 hours then.Then this nutrient solution of 1ml is added above-mentioned substratum (50mL/500ml slope Kou Shi bottle), cultivated 18 hours in 30 ℃.After cultivation is finished, by centrifugal from nutrient solution the separate microorganism cell, then it is suspended in the 0.1M borate buffer solution (pH 9.0) that contains 10mM EDTA, its concentration is 100g/L, in wet microorganism cells.In this microorganism cells suspension of 0.1ml, add 0.1ml then and contain 10mM EDTA, in the 100mM borate buffer solution of 200mM L-alanyl methyl ester hydrochloride and 400mM L-glutaminate (pH 9.0).0.2mL gained mixture was reacted 120 minutes at 25 ℃.The concentration of the L-alanyl-L-glutamine that produce this moment is 62mM.
(embodiment 22) are from the purifying of the enzyme of Sphingobacterium sp.
Following steps after centrifugal are on ice or 4 ℃ of enforcements.(preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center to cultivate Sphingobacterium sp. bacterial strain FERM BP-8124 according to the method identical with embodiment 21, preservation mechanism address: Chuo Dai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation date: on July 22nd, 2002), collect microorganism cells by centrifugal (10,000rpm, 15 minutes).Behind 20mM Tris-HCl damping fluid (pH 7.6) washing 2g microorganism cells, it is suspended in the 8ml same buffer, carry out ultrasonic degradation with 195W then and handled 45 minutes.Centrifugal then this ultrasonic degradation liquid (10,000rpm, 30 minutes) to remove cell debris, obtains ultrasonic degradation liquid supernatant.With 20mM Tris-HCl damping fluid (pH 7.6) to this ultrasonic degradation liquid supernatant dialysed overnight, then by ultracentrifugation (50,000rpm, 30 minutes) thus remove the soluble part that insoluble part obtains the supernatant liquor form.The soluble part adding that obtains is used in Tris-HCl damping fluid (pH 7.6) the equilibrated Q-Sepharose HP post (Amersham production) in advance, from non-absorbed portion, collected active part.With 20mM acetate buffer (pH 5.0) to this active part dialysed overnight, then by centrifugal (10,000rpm, 30 minutes) thus remove the part that insoluble part obtains the dialysis of supernatant liquor form.The part of this dialysis added use in advance in 20mM acetate buffer (pH 5.0) the equilibrated SP-Sepharose HP post (Amersham production), with the linear concentration gradient wash-out enzyme of the same buffer that contains 0-1M NaCl.
(embodiment 23) use enzyme part producing L-alanyl-L-glutamine
SP-Sepharose HP part (about 27U/ml) the adding 90 μ l of purifying among the 10 μ l embodiment 22 are contained 111mM L-alanine methyl ester hydrochloride, 222mM L-glutaminate and 11mMEDTA 111mM borate buffer solution (pH 9.0) in, make its 25 ℃ the reaction 120 minutes.As a result, in the district that adds enzyme, generate 73mM L-alanyl-L-glutamine.On the other hand, almost do not observe any generation of L-Ala-L-Gln in not adding the district of enzyme, enzyme concn only is about 0.07mM after 120 minutes and react.
The substrate specificity (11) of (embodiment 24) enzyme
Detection comes from Sphingobacterium sp. bacterial strain FERM BP-8124, and (preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center, preservation mechanism address: ChuoDai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation date: the substrate specificity of enzyme on July 22nd, 2002).100 μ l are comprised multiple carboxyl composition shown in the table 15-1 to 15-4 that final concentration is 100mM and final concentration is the various kinds of amine composition of 150mM, the SP-Sepharose HP enzyme of purifying part among the embodiment 22 (adding 0.33 unit in the reaction solution) and the 100mM borate buffer solution (pH 9.0) of 10mM EDTA reacted 1.5 hours at 25 ℃.The growing amount that has shown multiple peptide in this reaction in the table 15.(generation of mark "+" expression peptide is confirmed but can not be by quantitatively owing to lack standard, and " tr " expression trace).In addition, when using L-Tyr-Ome, in reactive system, add Tween-80 to final concentration be 0.1%.In addition, all use hydrochloride for all carboxyl compositions.
Table 15-1
Figure C0382246000491
Table 15-2
Table 15-3
Figure C0382246000511
Table 15-4
Figure C0382246000521
All amino acid amides are all used hydrochloride.
The substrate specificity (12) of (embodiment 25) enzyme
Detection comes from Sphingobacterium sp. bacterial strain FERM BP-8124, and (preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center, preservation mechanism address: ChuoDai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation date: the substrate specificity about the oligopeptides generation of enzyme on July 22nd, 2002).100 μ l are comprised the various kinds of amine composition shown in the table 16 that multiple carboxyl composition that final concentration is 100mM and final concentration be 150mM, and the SP-Sepharose HP enzyme of purifying part among the embodiment 22 (adding 0.33 unit in the reaction solution) and the 100mM borate buffer solution (pH 9.0) of 10mM EDTA reacted 1.5 hours at 25 ℃.The growing amount that has shown each oligopeptides in this reaction in the table 16.(generation of mark "+" expression peptide is confirmed but can not be by quantitatively owing to lack standard, and " tr " expression trace).In addition, all use hydrochloride for all carboxyl compositions.
Table 16
Figure C0382246000531
The substrate specificity (13) of (embodiment 26) enzyme
Adopt with embodiment 5 employed identical enzyme parts and further estimate substrate specificity.
Figure C0382246000541
100 μ l are comprised reaction soln with the 100mM borate buffer solution (pH 9.0) of each the carboxyl composition of final concentration shown in the table 17 and amine component and 10mM EDTA in the reaction times shown in 25 ℃ of reaction tables 17.The growing amount that has shown multiple peptide in this reaction in the table 17.(generation of mark "+" expression peptide is confirmed but can not be by quantitatively owing to lack standard, and " tr " expression trace).
(abbreviation)
H-Ala-Ome:L-alanine methyl ester hydrochloride
H-p-F-Phe-Ome:p-fluoro-L-phenylalanine methyl ester hydrochloride
H-Cl-F-Phe-Ome:p-chloro-L-phenylalanine methyl ester hydrochloride
H-p-NO 2-Phe-Ome:p-nitro-L-phenylalanine methyl ester hydrochloride
H-t-Leu-Ome: uncle-L-leucine methyl ester hydrochloride
H-2-Nal-OMe:3-(2-naphthyl)-L-alanine methyl ester hydrochloride
H-Aib-Ome: α-An Jiyidingsuan methyl ester hydrochloride
H-N-Me-Ala-OMe:N-methyl-L-alanine methyl ester hydrochloride
H-CHA-Ome: β-cyclohexyl-L-alanine methyl ester hydrochloride
H-Ser (the tBu)-Ome:O-tertiary butyl-L-serine methyl ester hydrochloride
H-Asp (OtBu)-Ome:L-Aspartic Acid β-tertiary butyl ester α-methyl ester hydrochloride
H-Lys (Boc)-Ome:N-ε-uncle-butoxy carbonyl-L-lysine methyl ester hydrochloride
H-p-F-Phe-OH:p-fluoro-L-phenylalanine
H-Cl-F-Phe-OH:p-chloro-L-phenylalanine
H-p-NO 2-Phe-OH:p-nitro-L-phenylalanine
The H-t-Leu-OH:tert-L-leucine
H-2-Nal-OH:3-(2-naphthyl)-L-L-Ala
The H-Gln-OH:L-glutamine
The H-Phe-OH:L-phenylalanine
H-Ser (the tBu)-OH:O-tertiary butyl-L-Serine
H-Asp (OtBu)-OH:L-Aspartic Acid β-tertiary butyl ester
H-Lys (Boc)-OH:N-ε-uncle-butoxy carbonyl-L-Methionin
The substrate specificity (14) of (embodiment 27) enzyme
Adopt the substrate specificity of enzyme part (the come from short steady bacillus) assessment identical about the oligopeptides generation with embodiment 5.To comprise final concentration each carboxyl composition and amine component as shown in Table 18,100 μ l reaction solns of the 100mM borate buffer solution (pH 9.0) of enzyme (Board Lot that adds in the reaction soln is shown in table 18) and 10mM EDTA were 25 ℃ of reactions 3 hours.The growing amount that has shown multiple oligopeptides in this reaction in the table 18.(generation of mark "+" expression peptide is confirmed but can not be by quantitatively owing to lack standard, and " tr " expression trace).Should be noted that for all carboxyl compositions and all use hydrochloride.
Table 18
The carboxyl composition Amine component Enzyme amount (unit) The peptide that generates (mM)
Gly-OMe L-Phe-L-Met 1.0 Gly-Phe-Met 13.3
L-Ala-OMe L-Phe-L-Met 0.2 L-Ala-L-Phe-L-Met +
L-Tyr-OMe Gly-Gly-L-Phe-L-Met 1.0 L-Tyr-Gly-Gly-L-Phe-L-Met 2.7
L-Ala-OMe Gly-Gly-L-Phe-L-Met 0.2 L-Ala-Gly-Gly-L-Phe-L-Met +
Gly-OMe Gly-L-Phe 0.1 Gly-L-Phe 17.3
L-Ala-OMe Gly-L-Phe 0.1 L-Ala-Gly-L-Phe +
D-Ala-OMe Gly-L-Phe 0.1 D-Ala-Gly-L-Phe Tr
(embodiment 28) come from the separation of the peptide-forming enzyme gene of short steady bacillus
Below, will the separation of peptide-forming enzyme gene have been described.(preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center to short steady bacillus strain FERM BP-8113, preservation mechanism address: Chuo Dai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation is passed on the date: on July 8th, 2002) be used as microorganism.In the separation of gene, intestinal bacteria JM-109 is used as the host, and pUC118 is used as carrier.
(1) prepares the PCR primer according to the aminoacid sequence of determining
Based on, (preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center to come from short steady bacillus strain FERM BP-8113 according to the EdmanShi decomposition method by the digestion of lysyl endopeptidase, preservation mechanism address: Chuo Dai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation is passed on the date: the determined aminoacid sequence of lysyl endopeptidase digestion product (SEQ ID NOs:1 and 2) that peptide-forming enzyme on July 8th, 2002) obtains, preparation has the mix primer of base sequence shown in SEQ ID NO:3 and the SEQ ID NO:4 respectively.
(2) preparation of microorganism cells
(preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center will to lack steady bacillus strain FERM BP-8113, preservation mechanism address: Chuo Dai-6,1-1Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation is passed on the date: on July 8th, 2002) (contain 50g/l glucose, 10g/l yeast extract, 10g/l peptone, 5g/l sodium-chlor and 20g/l agar at the CM2G nutrient agar, pH 7.0) on, cultivated 24 hours in 30 ℃.Inoculation 1 platinum loop gained microorganism cells in the 500ml slope Kou Shi bottle that contains 50ml CM2G liquid nutrient medium (the above-mentioned substratum except that agar) is then 30 ℃ of shaking culture.
(3) from microorganism cells, prepare chromosomal DNA
At first, with 50mL medium centrifugal (12,000rpm, 4 ℃, 15 minutes), collect microorganism cells.Then, adopt QIAGEN Genomic-Tip System (Qiagen),, from microorganism cells, obtain chromosomal DNA according to step described in its specification sheets.
(4) contain the dna fragmentation of the part of peptide-forming enzyme gene by PCR preparation
Adopt LA-Taq (Takara Shuzo production), pass through PCR method, acquisition contains and comes from short steady bacillus strain FERM BP-8113 (preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center, preservation mechanism address: Dai-6,1-1 Higashi1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation is passed on the date: the dna fragmentation of the part of peptide-forming enzyme gene on July 8th, 2002).Adopt the primer of the base sequence that contains SEQ ID NOs:3 and 4 then, (preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center to coming from short steady bacillus strain FERMBP-8113, preservation mechanism address: Chuo Dai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation is passed on the date: chromosomal DNA on July 8th, 2002) carries out PCR.
Adopt Takara PCR Thermal Cycler PERSONAL (Takara Shuzo production), implement 30 round-robin PCR reactions by following condition.
94 ℃ 30 seconds
52 ℃ 1 minute
72 ℃ 1 minute
After the reaction, carry out 0.8% agarose electrophoresis with 3 μ l reaction solutions.As a result, confirm that the dna fragmentation that increases is about 1.5 kilobase (kb).
(5) by gene library clone peptide-forming enzyme gene
In order to obtain the total length peptide-forming enzyme gene, adopt the dna fragmentation that in the PCR step, increases to carry out Southern hybridization as probe.Molecular Cloning, 2nd edition has described the step that Southern is hybridized among the ColdSpring Harbor Press (1989).
About 1.5kb dna fragmentation by the amplification of PCR step separates by 0.8% agarose electrophoresis.Downcut the target band then, purifying DNA fragment.Adopt DIG High Prime (Boehringer-Mannheim production), according to step described in the specification sheets of test kit, with probe digoxin (digoxinigen) labeled dna fragment.
Behind the chromosomal DNA of the steady bacillus of weak point that is obtained in the step (3) of complete digestion present embodiment 28 (3), gained DNA was being carried out electrophoresis 37 ℃ of reactions 16 hours with Restriction Enzyme HindIII on 0.8% sepharose.Behind the electrophoresis, electrophoretic chromosomal DNA trace from the sepharose is comprised that then alkaline denaturation, neutralization and fixed handle on the nylon leaching film (Roche Diagnostics production) of positively charged.Adopt EASY HYB (Boehringer-Mannheim production) to implement hybridization.In 50 ℃, the filter prehybridization after 1 hour, is added the probe with digoxigenin labeled by above-mentioned preparation, in 50 ℃ of hybridization 16 hours.Subsequently, with the 2 * SSC that contains 0.1%SDS washing nozzle 20 minutes under room temperature.In addition, again by 0.1 * SSC, 65 ℃, 15 minutes, washed twice.
Adopt DIG kit for detecting nucleic acid (Boehringer-Mannheim production), detect according to step described in the specification sheets of test kit pair band with probe hybridization.As a result, can detect band with about 3kb of probe hybridization.
Then, the chromosomal DNA for preparing in the step (3) with HindIII complete digestion present embodiment 28 (3).By 0.8% agarose gel electrophoresis, isolate the DNA of about 4kb, adopt Gene Clean II test kit (Funakoshi production) purify DNA then, then DNA is dissolved among the 10 μ l TE.Then 4 these products of μ l are mixed with pUC118 HindIII/BAP (Takara Shuzo production), adopt dna ligation kit Ver.2 (Takara Shuzo production) to carry out ligation.Mix 5 μ l ligation mixtures and 100 μ l escherichia coli jm109 competent cells (Toyobo production) thereby transformed into escherichia coli.The transformant that will obtain thus places on the suitable solid medium and produces chromosomal dna library then.
In order to obtain the peptide-forming enzyme gene of total length, adopt above-mentioned probe, by colony hybridization screening chromosomal dna library.Molecular Cloning, 2nd edition has described the step of colony hybridization among the Cold SpringHarbor Press (1989).
The clone of chromosomal dna library is gone to nylon leaching film (nylon membrane that is used for bacterium colony and plaque hybridization, (Roche Diagnostics production)), comprise alkaline denaturation, neutralization and fixed processing then.Adopt EASY HYB (Boehringer-Mannheim production) to implement hybridization.In 37 ℃, the filter prehybridization after 1 hour, is added above-mentioned probe with digoxigenin labeled, in 50 ℃ of hybridization 16 hours.Subsequently, with the 2 * SSC that contains 0.1%SDS washing nozzle 20 minutes under room temperature.In addition, again by 0.1 * SSC, 65 ℃, 15 minutes, washed twice.
Adopt DIG kit for detecting nucleic acid (Boehringer-Mannheim production),, the clone with the probe hybridization of mark is detected according to the explanation described in the specification sheets of test kit.The result confirms to have the probe hybridization of two clones and mark.
(6) come from the base sequence of the peptide-forming enzyme gene of short steady bacillus
The plasmid that e. coli jm109 contained is proved two clones with the probe hybridization of mark by adopting Wizard Plus Minipreps dna purification system (Promega productions) preparation by above-mentioned, determines with probe the part of hybridizing and the base sequence of neighbouring part to take place.Adopt CEQ DTCS-Quick Start Kit (Beckman-Coulter production), implement sequencing reaction according to step described in the specification sheets of test kit.In addition, adopt CEQ 2000-XL (Beckman-Coulter production) to implement electrophoresis.
The result confirms that the proteinic opening code-reading frame that coding comprises the internal amino acid sequence (SEQ ID NOs:1 and 2) of peptide-forming enzyme exists really.Therefore, opening code-reading frame is confirmed to be the gene of coding peptide-forming enzyme.The base sequence and the amino acid sequence corresponding that have shown the total length peptide-forming enzyme gene among the SEQ ID NO:5.With BLASTP the result of the homology analysis of gained opening code-reading frame is shown, have homology between two kinds of enzymes; It demonstrates on amino acid sequence level alpha-Amino acid ester hydrolase with Pasteur's bacillus aceticus (Acetobacter pasteurianus) and has 34% homology (referring to Appl.Environ.Microbiol.; 68 (1); 211-218 (2002)); and on amino acid sequence level, has 26% homology (referring to J.Bacteriol. with glutaryl-7ACA acyltransferase of side spore bacillus pumilus (Brevibacillus laterosporum); 173 (24), 7848-7855 (1991)).
(embodiment 29) come from the expression of peptide-forming enzyme gene in intestinal bacteria of short steady bacillus
With oligonucleotide described in SEQ ID NOs:7 and 8 as primer, by implementing increase target gene district on the promoter region of tryptophan operon on the chromosomal DNA of intestinal bacteria W3110 of PCR, the gained dna fragmentation is connected to pGEM-Teasy carrier (Promega production).Transform e. coli jm109 then in this connection liquid, select to contain the bacterial strain of target plasmid from the resistant strain of Ampicillin Trihydrate, the direction of insertion of the trp promotor of inserting in the described target plasmid is opposite with the direction of lac promotor.Then, will handle product (Takara production) with the EcoO109I/EcoRI of pUC19 and be connected by handle the dna fragmentation that comprises the trp promotor that this plasmid obtains with EcoO109I/EcoRI.Connect liquid transformed into escherichia coli JM109 with this then, from the resistant strain of Ampicillin Trihydrate, select to contain the bacterial strain of target plasmid.Then, will with HindIII/PvuII handle this plasmid and the dna fragmentation that obtains the dna fragmentation that comprises the rrnB terminator that obtains is connected with handle pKK223-3 (Amersham Pharmacia production) with HindIII/HincII.Connect liquid transformed into escherichia coli JM109 with this then, from the resistant strain of Ampicillin Trihydrate, select to contain the bacterial strain of target plasmid, this plasmid called after pTrpT.
(preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center to use short steady bacillus strain FERM BP-8113, preservation mechanism address: Chuo No ChuoDai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation is passed on the date: chromosomal DNA on July 8th, 2002) is as template, oligonucleotide shown in the SEQ IDNO:9 and 10 is as primer, by the pcr amplification target gene.Handle this dna fragmentation with NdeI/PstI then, then the gained dna fragmentation is handled product with the NdeI/PstI of pTrpT and be connected.Connect liquid transformed into escherichia coli JM109 with this then, from the resistant strain of Ampicillin Trihydrate, select to contain the bacterial strain of target plasmid, this plasmid called after pTrpT_Gtg2.
The e. coli jm109 that will contain pTrpT_Gtg2 is in containing the LB substratum of 100mg/l Ampicillin Trihydrate, in 30 ℃ of pre-cultivations 24 hours.1ml gained nutrient solution is seeded in contains 50ml substratum (2g/l D glucose, 10g/l yeast extract, 10g/l casamino acids, 5g/l ammonium sulfate, 3g/l potassium primary phosphate, 1g/l dipotassium hydrogen phosphate, 0.5g/l magnesium sulfate heptahydrate, with the 100mg/l Ampicillin Trihydrate) 500ml slope Kou Shi bottle in, cultivated 24 hours at 25 ℃ then.It is the 0.44U/1ml nutrient solution that the L-alanyl-L-glutamine of nutrient solution generates activity, confirms the escherichia coli expression cloned genes.In addition, in the transformant that only imports pTrpT in contrast, find activity.
(prediction signal sequence)
When with the aminoacid sequence of SEQ ID NO:6 described in the Signal P v 1.1 programanalysis sequence tables (referring to Protein Engineering, Vol.12, No.1, pp.3-9,1999), the performance of prediction 1-22 amino acids is secreted semiotic function to the pericentral siphon with peptide, and estimates that mature protein is positioned at the downstream of 23 amino acids.
(excretory checking)
The e. coli jm109 that contains pTrpT_Gtg2 is in containing the LB substratum of 100mg/l Ampicillin Trihydrate, in 30 ℃ of pre-cultivations 24 hours.1ml gained nutrient solution is seeded in contains 50ml substratum (2g/l glucose, 10g/l yeast extract, 10g/l casamino acids, 5g/l ammonium sulfate, 3g/l potassium primary phosphate, 1g/l dipotassium hydrogen phosphate, 0.5g/l magnesium sulfate heptahydrate, with the 100mg/l Ampicillin Trihydrate) 500ml slope Kou Shi bottle in, final cultivate 24 hours at 25 ℃ then to obtain microorganism cells.
With 20 Grams Per Minute liter (g/dl) sucrose solutions, behind osmotic pressure ballistic method lysing cell, the cultured microorganism cell is divided into pericentral siphon part and kytoplasm part.The cracked microorganism cells that immerses in the 20g/dl sucrose solution is immersed 5mM MgSO 4In the aqueous solution.With centrifugal supernatant called after pericentral siphon part (" Pe ").In addition, the centrifugal throw out is resuspended, carry out ultrasonic degradation then.With this resultant called after kytoplasm part (" Cy ").The activity of glucose-6-phosphate dehydrogenase (G6PD) (known being present in the kytoplasm) is used as the separated indicator of confirmation kytoplasm.By, comprising the 1mM G-6-P, 0.4mM NADP, 10mM MgSO4, and add an amount of enzyme in the reaction solution of 50mMTris-Cl (pH 8), under 30 ℃, carry out this detection, thereby detect the generation that the 340nm absorbancy detects NADPH then.
Fig. 4 has shown when the activity value that will separate the cell-free extract of preparation is decided to be 100%, the amount of enzyme in pericentral siphon part and the kytoplasm part.In pericentral siphon, do not find the glucose-6-phosphate dehydrogenase (G6PD) activity.This prompting pericentral siphon part is not sneaked in the kytoplasm part.Recovered about 60% Ala-Gln generation activity in pericentral siphon, as adopting Signal P v 1.1 programs from what aminoacid sequence doped, Ala-Gln generation enzyme is proved to be secreted to pericentral siphon.
(embodiment 30) produce the L-alanyl-L-glutamine with the microorganism cells of Sphingobacterium sp.
In 500ml slope Kou Shi bottle, add 50mL every liter (L) and contain 5g glucose, 5g ammonium sulfate, the 1g potassium primary phosphate, the 3g dipotassium hydrogen phosphate, 0.5g sal epsom, the substratum of 10g yeast extract and 10g peptone (pH 6.2), (preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallyyed permit biological sustenance center in order to cultivate Sphingobacterium sp. bacterial strain FERM BP-8124 115 ℃ of sterilizations 15 minutes, preservation mechanism address: Chuo Dai-6,1-1Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation date: on July 22nd, 2002).Inoculation 1 platinum loop contains 5g glucose at every liter (L) on this substratum then, the 10g yeast extract, slant agar substratum (the agar: 20g/L of 10g peptone and 5g NaCl, pH 7.0) on, cultivated 24 hours Sphingobacterium sp. bacterial strain FERM BP-8124 (preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst has speciallyyed permit biological sustenance center for 30 ℃, preservation mechanism address: Chuo Dai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation date: cell on July 22nd, 2002), at 30 ℃, 120 reciprocal/minute following concussions were cultivated 20 hours then.Then this nutrient solution of 1ml is added in the above-mentioned substratum (50mL/500ml slope Kou Shi bottle), cultivated 18 hours in 30 ℃.After cultivation is finished, by centrifugal from nutrient solution the separate microorganism cell, then it is suspended in the 0.1M borate buffer solution (pH 9.0) that contains 10mM EDTA, concentration is 100g/L, in wet microorganism cells.In this microorganism cells suspension of 0.1ml, add the 100mM borate buffer solution (pH 9.0) that 0.1ml contains 10mM EDTA, 200mM L-alanyl methyl ester hydrochloride and 400mM L-glutaminate then.0.2mL gained mixture was reacted 120 minutes at 25 ℃.The concentration of the L-alanyl-L-glutamine that produce this moment is 62mM.
(embodiment 31) are from the purifying of the enzyme of Sphingobacterium sp.
Following steps after centrifugal are on ice or 4 ℃ of enforcements.(preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center to cultivate Sphingobacterium sp. bacterial strain FERM BP-8124 according to the method identical with embodiment 21, preservation mechanism address: Chuo Dai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation date: on July 22nd, 2002), collect microorganism cells by centrifugal (10,000rpm, 15 minutes).After with 20mM Tris-HCl damping fluid (pH 7.6) washing 2g microorganism cells, it is suspended in the 8ml same buffer, carry out ultrasonic degradation with 195W then and handled 45 minutes.Centrifugal then this ultrasonic degradation liquid (10,000rpm, 30 minutes) to remove cell debris, obtains ultrasonic degradation liquid supernatant., remove insoluble part by ultracentrifugation (50,000rpm, 30 minutes) then, thereby obtain the soluble part of supernatant liquor form this ultrasonic degradation liquid supernatant dialysed overnight with 20mM Tris-HCl damping fluid (pH 7.6).The soluble part adding that obtains is used in Tris-HCl damping fluid (pH 7.6) the equilibrated Q-Sepharose HP post (Amersham production) in advance, from non-absorbed portion, collected active part then., remove insoluble part by centrifugal (10,000rpm, 30 minutes) then, thereby obtain the part of the dialysis of supernatant liquor form this active part dialysed overnight with 20mM acetate buffer (pH 5.0).The part adding of this dialysis is used in 20mM acetate buffer (pH 5.0) the equilibrated SP-Sepharose HP post (Amersham production) in advance, with the linear concentration gradient wash-out enzyme of the same buffer that contains 0-1M NaCl.
(embodiment 32) produce the L-alanyl-L-glutamine with active part
SP-Sepharose HP part (about 27U/ml) the adding 90 μ l of purifying among the 10 μ l embodiment 31 are contained 111mM L-alanine methyl ester hydrochloride, 222mM L-glutaminate and 11mMEDTA 111mM borate buffer solution (pH 9.0) in, make its 25 ℃ the reaction 120 minutes.As a result, in the district that adds enzyme, generate 73mM L-alanyl-L-glutamine.On the other hand, almost do not observe any generation of L-Ala-L-Gln in not adding the district of enzyme, enzyme concn only is about 0.07mM after 120 minutes and react.
(embodiment 33) come from the separation of the peptide-forming enzyme gene of Sphingobacterium sp.
The separation of peptide-forming enzyme gene is described below, (preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center with Sphingobacterium sp. bacterial strain FERMBP-8124, preservation mechanism address: Chuo Dai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation date: on July 22nd, 2002) as microorganism.Adopt bacillus coli DH 5 alpha as the host, pUC118 implements gene isolation as carrier.
(1) preparation of microorganism
(preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center with Sphingobacterium sp. bacterial strain FERM BP-8124, preservation mechanism address: Chuo Dai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation date: on July 22nd, 2002) go up in 25 ℃ of cultivations 24 hours at CM2G nutrient agar (contain 50g/l glucose, 10g/l yeast extract, 10g/l peptone, 5g/l sodium-chlor and 20g/l agar, pH 7.0).Inoculation 1 platinum loop gained microorganism cells in the 500ml slope Kou Shi bottle that contains 50ml CM2G liquid nutrient medium (the above-mentioned substratum except that agar) is cultivated 25 ℃ of concussions then.
(2) from microorganism cells, prepare chromosomal DNA
The 50ml nutrient solution is carried out centrifugal (12,000rpm, 4 ℃, 15 minutes), collect microorganism cells.Adopt Qiagen Genomic-Tip System (Qiagen) from microorganism cells, to obtain chromosomal DNA then.
(3) prepare probe dna fragment by PCR
Adopt LA-Taq (Takara Shuzo production), obtain comprising by PCR method and come from short steady bacillus strain FERM BP-8113 (preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center, preservation mechanism address: Chuo Dai-6,1-1 Higashi1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation is passed on the date: the dna fragmentation of a peptide-forming enzyme gene part on July 8th, 2002).Adopt the primer of the base sequence that contains SEQ ID NOs:3 and 4 then, to (preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center available from short steady bacillus strain FERMBP-8113, preservation mechanism address: Chuo Dai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki 1-Chome, Japan, international preservation is passed on the date: chromosomal DNA on July 8th, 2002) is implemented the PCR reaction.
Adopt Takara PCR Thermal Cycler PERSONAL (Takara Shuzo production), implement 30 round-robin PCR reactions by following condition.
94 ℃ 30 seconds
52 ℃ 1 minute
72 ℃ 1 minute
After the reaction, carry out 0.8% agarose electrophoresis with 3 μ l reaction mixtures.The result confirms that the dna fragmentation that increases is about 1.5kb.
(4) by gene library clone peptide-forming enzyme gene
In order to obtain the total length peptide-forming enzyme gene, adopt the dna fragmentation that in the PCR step, increases to carry out Southern hybridization as probe.Molecular Cloning, 2nd edition has described the step that Southern is hybridized among the ColdSpring Harbor Press (1989).
About 1.5kb dna fragmentation by the amplification of PCR step separates by 0.8% agarose electrophoresis.Downcut the target band then, purifying DNA fragment.Adopt DIG High Prime (Boehringer-Mannheim production), according to step described in the specification sheets of test kit, with probe digoxigenin labeled dna fragmentation.
Behind the chromosomal DNA of the Sphingobacterium sp. that is obtained in the step (2) of complete digestion present embodiment 33, it was being carried out 0.8% agarose gel electrophoresis 37 ℃ of reactions 16 hours with Restriction Enzyme SacI.Behind the electrophoresis, electrophoretic chromosomal DNA trace from the sepharose is comprised that then alkaline denaturation, neutralization and fixed handle on the nylon leaching film (Roche Diagnostics production) of positively charged.Adopt EASY HYB (Boehringer-Mannheim production) to hybridize.In 37 ℃, the filter prehybridization after 1 hour, is added the probe with digoxigenin labeled by above-mentioned preparation, in 37 ℃ of hybridization 16 hours.Subsequently, with the 2 * SSC that contains 0.1%SDS washing nozzle 20 minutes under room temperature.In addition, again with the 0.1 * SSC that comprises 0.1%SDS, 60 ℃, washed twice.
Adopt DIG kit for detecting nucleic acid (Boehringer-Mannheim production), detect according to step described in the specification sheets of test kit pair band with probe hybridization.As a result, can detect band with about 3kb of probe hybridization.
Then, the chromosomal DNA for preparing in the step (2) with SacI complete digestion present embodiment 33.Separate the DNA of about 3kb by 0.8% agarose gel electrophoresis, adopt Gene Clean II test kit (Funakoshi production) purify DNA then, then DNA is dissolved among the 10 μ l TE.Then with 4 these products of μ l and SacI under 37 ℃, reacted 16 hours, so that complete digestion, it is mixed with the pUC118 that uses alkaline phosphatase (intestinal bacteria C75) to handle, 37 ℃, 30 minutes and 50 ℃, 30 minutes, adopt dna ligation kit Ver.2 (Takara Shuzo production) to carry out ligation.Mix this ligation liquid of 5 μ l and 100 μ l bacillus coli DH 5 alpha competent cells (Takara Shuzo production) thereby transformed into escherichia coli.The transformant that will obtain thus places on the suitable solid medium and produces chromosomal dna library then.
In order to obtain the peptide-forming enzyme gene of total length, adopt above-mentioned probe, by colony hybridization screening chromosomal dna library.Molecular Cloning, 2nd edition has described the step of colony hybridization among the Cold SpringHarbor Press (1989).
The clone of chromosomal dna library is gone to nylon leaching film (nylon membrane that is used for bacterium colony and plaque hybridization, (Roche Diagnostics production)), comprise alkaline denaturation, neutralization and fixed processing then.Adopt EASY HYB (Boehringer-Mannheim production) to implement hybridization.In 37 ℃, the filter prehybridization after 1 hour, is added above-mentioned probe with digoxigenin labeled, in 50 ℃ of hybridization 16 hours.Subsequently, with comprising 0.1 * SSC of 1%SDS in 60 ℃ of washed twice.
Adopt DIG kit for detecting nucleic acid (Boehringer-Mannheim production),, the clone with the probe hybridization of mark is detected according to the explanation described in the specification sheets of test kit.As a result, confirm to have the probe hybridization of 6 strain clones and mark.
(5) come from the base sequence of the peptide-forming enzyme gene of Sphingobacterium sp.
Adopt Wizard Plus Minipreps dna purification system (Promega productions) preparation plasmid that bacillus coli DH 5 alpha contained from be proved the above-mentioned six strain microorganism cellss with the probe hybridization of mark, thereby determine and the contiguous base sequence of probe hybridization.Adopt CEQDTCS-Quick Start Kit (Beckman-Coulter production), implement sequencing reaction according to step described in the specification sheets of test kit.In addition, adopt CEQ 2000-XL (Beckman-Coulter production) to implement electrophoresis.
As a result, find to exist the opening code-reading frame of coding peptide-forming enzyme.The base sequence and the amino acid sequence corresponding that have shown the total length peptide-forming enzyme gene that comes from Sphingobacterium sp. among the SEQ ID NO:11.The peptide-forming enzyme that comes from Sphingobacterium sp. has 63.5% homology (shown in the BLASTP program detects) with the peptide-forming enzyme that comes from the steady bacillus of above-mentioned weak point on amino acid sequence level.
(embodiment 34) come from the peptide-forming enzyme gene of Sphingobacterium sp. in colibacillary expression
(preservation mechanism: Independent Administrative Leged Industrial Technology Complex Inst speciallys permit biological sustenance center to adopt Sphingobacterium sp. bacterial strain FERM BP-8124, preservation mechanism address: ChuoDai-6,1-1 Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, Japan, international preservation date: chromosomal DNA on July 22nd, 2002) is as template, oligonucleotide is implemented PCR as primer described in the SEQ ID NOs:13 and 14, the amplified target gene.Handle this dna fragmentation with NdeI/XbaI, the dna fragmentation that obtains is handled product with the NdeI/XbaI of pTrpT be connected.Connect liquid transformed into escherichia coli JM109 with this then, from the resistant strain of Ampicillin Trihydrate, select to contain the bacterial strain of target plasmid, this plasmid called after pTrpT_Sm_aet.
Be seeded in by strain cell and contain 3ml substratum (2g/l glucose, 10g/l yeast extract, 10g/l casamino acids, 5g/l ammonium sulfate, 3g/l potassium primary phosphate, 1g/l dipotassium hydrogen phosphate, 0.5g/l magnesium sulfate heptahydrate a platinum loop, with the 100mg/l Ampicillin Trihydrate) common test tube in mode, the e. coli jm109 that will contain pTrpT_Sm_aet was cultivated 20 hours at 25 ℃.The L-alanyl-L-glutamine generates activity and is proved by escherichia coli expression for the cloned genes of 2.1U/1ml nutrient solution.In addition, in the transformant that only imports pTrpT in contrast, find activity.
(prediction signal sequence)
When with the aminoacid sequence of SEQ ID NO:12 described in the Signal P v 1.1 programanalysis sequence tables (referring to Protein Engineering, Vol.12, No.1, pp.3-9,1999), the performance of prediction 1-20 amino acids is secreted semiotic function to the pericentral siphon with peptide, and estimates that mature protein is positioned at the downstream of 21 amino acids.
(confirmation of signal sequence)
Be seeded in by strain cell and contain 50ml substratum (2g/l glucose, 10g/l yeast extract, 10g/l casamino acids, 5g/l ammonium sulfate, 3g/l potassium primary phosphate, 1g/l dipotassium hydrogen phosphate, 0.5g/l magnesium sulfate heptahydrate a platinum loop, with the 100mg/l Ampicillin Trihydrate) common test tube in mode, the e. coli jm109 that will contain pTrpT_Sm_aet was cultivated 20 hours at 25 ℃.
Following steps after centrifugal are on ice or 4 ℃ of enforcements.After cultivation is finished, by centrifugal from nutrient solution the separate microorganism cell, with the 100mM phosphate buffered saline buffer (pH 7) washing after, it is suspended in the identical damping fluid.Then this microorganism cells is carried out ultrasonic degradation with 195W and handled 20 minutes, centrifugal then this ultrasonic degradation liquid (12,000rpm, 30 minutes) to remove cell debris, obtains soluble part.The soluble part adding that obtains is used in 100mM phosphate buffered saline buffer (pH 7) the equilibrated CHT-II post (Biorad production) in advance, used the 500mM phosphoric acid buffer with linear concentration gradient wash-out enzyme.The solution that the 2M ammonium sulfate of mixed active part and 5 times of volumes and 100mM phosphate buffered saline buffer are obtained, add and use in advance in 2M ammonium sulfate and the 100mM phosphoric acid buffer equilibrated Resource-PHE post (Amersham), with 0-2M ammonium sulfate with linear concentration gradient wash-out enzyme, thereby obtain active part solution.According to the result of these steps, confirmed by electrophoretic mode peptide-forming enzyme purifying equably.
When determining the aminoacid sequence of above-mentioned peptide-forming enzyme, obtain the aminoacid sequence of SEQ ID NO:15, as predicting that by Signal P v 1.1 programs mature protein is proved the downstream that is positioned at 21 amino acids by the EdmanShi decomposition method.
(embodiment 35) come from the separation of the peptide-forming enzyme gene of separating Vitrum AB soil bacillus IFO 12017
Below, will the separation of peptide-forming enzyme gene be described.Microorganism used therefor for separate Vitrum AB soil bacillus strain IFO 12017 (preservation mechanism: fermentation research institute, preservation mechanism address: 2-17-85 Jusohonmachi, Yodogawa-ku, Osaka-shi, Japan).In gene isolation, intestinal bacteria JM-109 is used as the host, and pUC118 is used as carrier.
(1) preparation of microorganism
To separate Vitrum AB soil bacillus strain IFO-12017 (preservation mechanism: fermentation research institute, preservation mechanism address: 2-17-85 Jusohonmachi, Yodogawa-ku, Osaka-shi, Japan) (contain 50g/l glucose, 10g/l yeast extract, 10g/l peptone, 5g/l sodium-chlor and 20g/l agar at the CM2G nutrient agar, pH 7.0) on, cultivated 24 hours in 25 ℃.Inoculation 1 platinum loop gained microorganism cells in the 500ml slope Kou Shi bottle that contains 50ml CM2G liquid nutrient medium (the above-mentioned substratum except that agar) is cultivated 25 ℃ of concussions then.
(2) from microorganism cells, prepare chromosomal DNA
With 50mL medium centrifugal (12,000rpm, 4 ℃, 15 minutes), collect microorganism cells.Then, adopt QIAGEN Genomic-Tip System (Qiagen),, from microorganism cells, obtain chromosomal DNA according to step described in its specification sheets.
(3) prepare probe dna fragment by PCR
Adopt LA-Taq (Takara Shuzo production), pass through PCR method, acquisition contains to come from separates Vitrum AB soil bacillus strain IFO-12017 (preservation mechanism: fermentation research institute, preservation mechanism address: 2-17-85 Jusohonmachi, Yodogawa-ku, Osaka-shi, the dna fragmentation of the part of peptide-forming enzyme gene Japan).Adopt the primer of the base sequence that contains SEQ ID NOs:15 and 16 then, to available from separating Vitrum AB soil bacillus strain IFO-12017 (preservation mechanism: fermentation research institute, preservation mechanism address: 2-17-85 Jusohonmachi, Yodogawa-ku, Osaka-shi, chromosomal DNA Japan) carries out PCR.About 1kb dna fragmentation by pcr amplification separates by 0.8% agarose electrophoresis.Downcut the target band then, the dna fragmentation that purifying obtains.Adopt DIG High Prime (Boehringer-Mannheim production), according to step described in the specification sheets of test kit, with this dna fragmentation of probe digoxigenin labeled.
(4) by gene library clone peptide-forming enzyme gene
In order to obtain the total length peptide-forming enzyme gene, adopt the dna fragmentation that increases in the above-mentioned PCR step to carry out Southern hybridization as probe.Molecular Cloning, 2nd edition has described the step that Southern is hybridized among the Cold Spring Harbor Press (1989).
By with Restriction Enzyme HindIII in 37 ℃ of reactions 16 hours and Vitrum AB soil bacillus strain IFO-12017 (preservation mechanism: fermentation research institute is separated in complete digestion, preservation mechanism address: 2-17-85 Jusohonmachi, Yodogawa-ku, Osaka-shi, Japan) behind the chromosomal DNA, it is carried out 0.8% agarose gel electrophoresis.Behind the electrophoresis, electrophoretic chromosomal DNA trace from the sepharose is comprised then that at the nylon leaching film (Roche Diagnostics production) of positively charged alkaline denaturation, neutralization and fixed handle.Adopt EASY HYB (Boehringer-Mannheim production) to hybridize.In 50 ℃, the filter prehybridization after 1 hour, is added the probe with digoxigenin labeled by above-mentioned preparation, in 50 ℃ of hybridization 16 hours.Subsequently, with the 0.1 * SSC that comprises 0.1%SDS, 60 ℃, washed twice.
Adopt DIG kit for detecting nucleic acid (Boehringer-Mannheim production), detect according to step described in the specification sheets of test kit pair band with probe hybridization.As a result, can detect band with about 5kb of probe hybridization.
Then, separate Vitrum AB soil bacillus strain IFO-12017 (preservation mechanism: fermentation research institute, preservation mechanism address: 2-17-85 Jusohonmachi, Yodogawa-ku, Osaka-shi, chromosomal DNA Japan) with the HindIII complete digestion.Separate the DNA of about 5kb by 0.8% agarose gel electrophoresis, adopt Gene Clean II test kit (Funakoshi production) purify DNA then, then it is dissolved among the 10 μ l TE.Then 4 these products of μ l are mixed with pUC118 HindIII/BAP (Takara Shuzo production), adopt dna ligation kit Ver.2 (Takara Shuzo production) to carry out ligation.Mix this ligation liquid of 5 μ l and 100 μ l e. coli jm109s (Takara Shuzo production), thus transformed into escherichia coli.The transformant that will obtain thus places on the suitable solid medium and produces chromosomal dna library then.
In order to obtain the peptide-forming enzyme gene of total length, adopt above-mentioned probe, by colony hybridization screening chromosomal dna library.Molecular Cloning, 2nd edition has described the step of colony hybridization among the Cold SpringHarbor Press (1989).
The clone of chromosomal dna library is gone to nylon leaching film (nylon membrane that is used for bacterium colony and plaque hybridization, (Roche Diagnostics production)), comprise alkaline denaturation, neutralization and fixed processing then.Adopt EASY HYB (Boehringer-Mannheim production) to implement hybridization.In 37 ℃, the filter prehybridization after 1 hour, is added above-mentioned probe with digoxigenin labeled, in 37 ℃ of hybridization 16 hours.Subsequently, with comprising 0.1 * SSC of 1%SDS in 60 ℃ of washed twice.
Adopt DIG kit for detecting nucleic acid (Boehringer-Mannheim production), the clone with the probe hybridization of mark is detected according to the explanation described in the specification sheets of test kit.As a result, confirm to have the probe hybridization of 1 strain clone and mark.
(5) come from the base sequence of the peptide-forming enzyme gene of separating Vitrum AB soil bacillus strain IFO-12017
The plasmid that e. coli jm109 contained determines to take place with probe the contiguous base sequence of hybridization by the above-mentioned microorganism cells bacterial strain preparation that is proved with the probe hybridization of mark.Adopt CEQDTCS-Quick Start Kit (Beckman-Coulter production), implement sequencing reaction according to step described in the specification sheets of test kit.In addition, adopt CEQ 2000-XL (Beckman-Coulter production) to implement electrophoresis.
As a result, find to exist the opening code-reading frame of coding peptide-forming enzyme.Shown among the SEQ IDNO:17 in the sequence table to come from and separated Vitrum AB soil bacillus strain IFO-12017 (preservation mechanism: fermentation research institute, preservation mechanism address: 2-17-85 Jusohonmachi, Yodogawa-ku, Osaka-shi, the base sequence of total length peptide-forming enzyme gene Japan), and amino acid sequence corresponding.
(embodiment 36) come from the expression of peptide-forming enzyme gene in intestinal bacteria of separating Vitrum AB soil bacillus strain IFO-12017
Vitrum AB soil bacillus strain IFO-12017 (preservation mechanism: fermentation research institute is separated in use, Osaka, preservation mechanism address: 2-17-85 Jusohonmachi, Yodogawa-ku, Osaka-shi, Japan) chromosomal DNA is as template, and the oligonucleotide shown in the SEQ ID NO:19 and 20 is as primer, by the pcr amplification target gene.Handle this dna fragmentation with NdeI/HindIII then, then the gained dna fragmentation is handled product with the NdeI/HindIII of pTrpT and be connected.Connect liquid transformed into escherichia coli JM109 with this then, from the resistant strain of Ampicillin Trihydrate, select to contain the bacterial strain of target plasmid, this plasmid called after pTrpT_Ph_aet.
Be seeded in by strain cell and contain 3ml substratum (2g/l glucose, 10g/l yeast extract, 10g/l casamino acids, 5g/l ammonium sulfate, 3g/l potassium primary phosphate, 1g/l dipotassium hydrogen phosphate, 0.5g/l magnesium sulfate heptahydrate a platinum loop, with the 100mg/l Ampicillin Trihydrate) common test tube in mode, the e. coli jm109 that will contain pTrpT_Ph_aet was cultivated 20 hours at 25 ℃.The L-alanyl-L-glutamine generates activity and is proved by escherichia coli expression for the cloned genes of 0.3U/1ml nutrient solution.In addition, in the transformant that only imports pTrpT in contrast, find activity.
(embodiment 37) are from the separation of the peptide-forming enzyme gene of Taxeobacter gelupurpurascens strain DSM Z11116
Below, will the separation of peptide-forming enzyme gene be described.Employed microorganism is Taxeobacter gelupurpurascens strain DSM Z a 11116 (preservation mechanism: DeutcheSammlung von Mikroorganismen und Zellkulturen GmbH (German microorganism and cell culture preservation center), preservation mechanism address: Mascheroder Weg 1b, 38124Braunschweig, Germany).In gene isolation, intestinal bacteria JM-109 is used as the host, and pUC118 is used as carrier.
(1) preparation of microorganism
With Taxeobacter gelupurpurascens strain DSM Z 11116 (preservation mechanism: Deutche Sammlung von Mikroorganismen und Zellkulturen GmbH (German microorganism and cell culture preservation center), preservation mechanism address: Mascheroder Weg1b, 38124 Braunschweig, Germany) go up in 25 ℃ of cultivations 24 hours at CM2G nutrient agar (contain 50g/l glucose, 10g/l yeast extract, 10g/l peptone, 5g/l sodium-chlor and 20g/l agar, pH 7.0).Inoculation 1 platinum loop gained microorganism cells in the 500ml slope Kou Shi bottle that contains 50ml CM2G liquid nutrient medium (the above-mentioned substratum except that agar) is cultivated 25 ℃ of concussions then.
(2) from microorganism cells, prepare chromosomal DNA
The 50mL nutrient solution is carried out centrifugal (12,000rpm, 4 ℃, 15 minutes), collect microorganism cells.Then, adopt QIAGEN Genomic-Tip System (Qiagen),, from microorganism cells, obtain chromosomal DNA according to step described in its specification sheets.
(3) prepare probe dna fragment by PCR
Adopt LA-Taq (Takara Shuzo production), pass through PCR method, acquisition contains and comes from Taxeobacter gelupurpurascens strain DSM Z 11116 (preservation mechanism: Deutche Sammlung von Mikroorganismen und Zellkulturen GmbH (German microorganism and cell culture preservation center), preservation mechanism address: Mascheroder Weg1b, 38124 Braunschweig, the dna fragmentation of the part of peptide-forming enzyme gene Germany).Adopt the primer of the base sequence that contains SEQ ID NOs:21 and 16 then, to available from Taxeobacter gelupurpurascens strain DSM Z 11116 (preservation mechanism: Deutche Sammlung von Mikroorganismen und Zellkulturen GmbH (German microorganism and cell culture preservation center), preservation mechanism address: Mascheroder Weg1b, 38124 Braunschweig, chromosomal DNA Germany) carries out PCR.To separate by 0.8% agarose electrophoresis by about 1kb dna fragmentation of pcr amplification.Downcut the target band then, the dna fragmentation that purifying obtains.Adopt DIG High Prime (Boehringer-Mannheim production), according to step described in the specification sheets of test kit, with this dna fragmentation of probe digoxigenin labeled.
(4) from gene library clone peptide-forming enzyme gene
In order to obtain the total length peptide-forming enzyme gene, adopt the dna fragmentation that increases in the above-mentioned PCR step to carry out Southern hybridization as probe.Molecular Cloning, 2nd edition has described the step that Southern is hybridized among the Cold Spring Harbor Press (1989).
Reacting 16 hours and complete digestion Taxeobactergelupurpurascens strain DSM Z 11116 (preservation mechanism: Deutche Sammlung vonMikroorganismen und Zellkulturen GmbH (German microorganism and cell culture preservation center) at 37 ℃ with Restriction Enzyme PstI, preservation mechanism address: Mascheroder Weg 1b, 38124Braunschweig, Germany) behind the chromosomal DNA, it is carried out 0.8% agarose gel electrophoresis.Behind the electrophoresis, electrophoretic chromosomal DNA trace from the sepharose is comprised then that at the nylon leaching film (Roche Diagnostics production) of positively charged alkaline denaturation, neutralization and fixed handle.Adopt EASY HYB (Boehringer-Mannheim production) to hybridize.In 50 ℃, the filter prehybridization after 1 hour, is added the probe with digoxigenin labeled by above-mentioned preparation, in 50 ℃ of hybridization 16 hours.Subsequently, with the 0.1 * SSC that comprises 0.1%SDS, 60 ℃, washed twice.
Adopt DIG kit for detecting nucleic acid (Boehringer-Mannheim production), detect according to step described in the specification sheets of test kit pair band with probe hybridization.As a result, can detect band with about 5kb of probe hybridization.
With HindIII complete digestion Taxeobacter gelupurpurascens strain DSM Z11116 (preservation mechanism: Deutche Sammlung von Mikroorganismen undZellkulturen GmbH (German microorganism and cell culture preservation center), preservation mechanism address: Mascheroder Weg 1b, 38124 Braunschweig, chromosomal DNA Germany).Separate the DNA of about 5kb by 0.8% agarose gel electrophoresis, adopt Gene Clean II test kit (Funakoshi production) purify DNA then, it is dissolved among the 10 μ l TE.Then 4 these products of μ l are mixed with pUC118 PstI/BAP (Takara Shuzo production), adopt dna ligation kit Ver.2 (Takara Shuzo production) to carry out ligation.Mix this ligation liquid of 5 μ l and 100 μ l e. coli jm109s (Takara Shuzo production) and transformed into escherichia coli.The transformant that will obtain thus places on the suitable solid medium and produces chromosomal dna library then.
In order to obtain the peptide-forming enzyme gene of total length, adopt above-mentioned probe, by colony hybridization screening chromosomal dna library.Molecular Cloning, 2nd edition has described the step of colony hybridization among the Cold SpringHarbor Press (1989).
The clone of chromosomal dna library is gone to nylon leaching film (nylon membrane that is used for bacterium colony and plaque hybridization, (Roche Diagnostics production)), comprise alkaline denaturation, neutralization and fixed processing then.Adopt EASY HYB (Boehringer-Mannheim production) to implement hybridization.In 37 ℃, the filter prehybridization after 1 hour, is added above-mentioned probe with digoxigenin labeled, in 37 ℃ of hybridization 16 hours.Subsequently, with the 0.1 * SSC that comprises 1%SDS in twice of 60 ℃ of washing nozzle.
Adopt DIG kit for detecting nucleic acid (Boehringer-Mannheim production), the clone with the probe hybridization of mark is detected according to the explanation described in the specification sheets of test kit.As a result, confirm to have the probe hybridization of 1 strain clone and mark.
(5) come from the base sequence of the peptide-forming enzyme gene of Taxeobacter gelupurpurascens strain DSM Z 11116
The plasmid that e. coli jm109 contained determines to take place with probe the contiguous base sequence of hybridization by the above-mentioned microorganism cells bacterial strain preparation that is proved with the probe hybridization of mark.Adopt CEQDTCS-Quick Start Kit (Beckman-Coulter production), implement sequencing reaction according to step described in the specification sheets of test kit.In addition, adopt CEQ 2000-XL (Beckman-Coulter production) to implement electrophoresis.
As a result, find to exist the opening code-reading frame of coding peptide-forming enzyme.Shown among the SBQ IDNO:22 in the sequence table and come from Taxeobacter gelupurpurascens strain DSM Z 11116 (preservation mechanism: Deutche Sammlung von Mikroorganismen undZellkulturen GmbH (German microorganism and cell culture preservation center), preservation mechanism address: Mascheroder Weg 1b, 38124 Braunschweig, the base sequence of total length peptide-forming enzyme gene Germany), and amino acid sequence corresponding.
(embodiment 38) come from the separation of the peptide-forming enzyme gene of extra large round bacteria strains A TCC 25205
Below, will the separation of peptide-forming enzyme gene be described.Used microorganism is extra large round bacteria strains A TCC 25205 (a preservation mechanism: American type culture collection, preservation mechanism address: P.O.Box 1549, Manassas, VA 20110, the United States of America).In gene isolation, intestinal bacteria JM-109 is used as the host, and pUC118 is used as carrier.
(1) preparation of microorganism cells
With extra large round bacteria strains A TCC 25205 (preservation mechanisms: American type culture collection, preservation mechanism address: P.O.Box 1549, Manassas, VA 20110, the UnitedStates of America) (contains 50g/l glucose, 10g/l yeast extract, 10g/l peptone, 5g/l sodium-chlor and 20g/l agar at the CM2G nutrient agar, pH 7.0) on, cultivated 24 hours in 25 ℃.Inoculation 1 platinum loop gained microorganism cells in the 500ml slope Kou Shi bottle that contains 50ml CM2G liquid nutrient medium (the above-mentioned substratum except that agar) is cultivated 25 ℃ of concussions then.
(2) from microorganism cells, prepare chromosomal DNA
The 50mL nutrient solution is carried out centrifugal (12,000rpm, 4 ℃, 15 minutes), collect microorganism cells.Then, adopt QIAGEN Genomic-Tip System (Qiagen),, from microorganism cells, obtain chromosomal DNA according to step described in its specification sheets.
(3) prepare probe dna fragment by PCR
Adopt LA-Taq (Taka ra Shuzo production), pass through PCR method, acquisition contains and comes from extra large round bacteria strains A TCC 25205 (preservation mechanisms: American type culture collection, preservation mechanism address: P.O.Box 1549, Manassas, VA 20110, the United Statesof America) the dna fragmentation of a part of peptide-forming enzyme gene.Adopt the primer of the base sequence that contains SEQID NOs:15 and 16 then, to available from extra large round bacteria strains A TCC 25205 (preservation mechanisms: American type culture collection, preservation mechanism address: P.O.Box1549, Manassas, VA 20110, the United States of America) chromosomal DNA carry out PCR.About 1kb dna fragmentation by pcr amplification separates by 0.8% agarose electrophoresis.Downcut the target band then, the dna fragmentation that purifying obtains.Adopt DIG HighPrime (Boehringer-Mannheim production), according to step described in the specification sheets of test kit, with this dna fragmentation of probe digoxigenin labeled.
(4) by gene library clone peptide-forming enzyme gene
In order to obtain the total length peptide-forming enzyme gene, adopt the dna fragmentation that increases in the above-mentioned PCR step to carry out Southern hybridization as probe.Molecular Cloning, 2nd edition has described the step that Southern is hybridized among the Cold Spring Harbor Press (1989).
Reacting 16 hours and complete digestion sea round bacteria strains A TCC 25205 (preservation mechanisms: American type culture collection at 37 ℃ with Restriction Enzyme HincII, preservation mechanism address: P.O.Box 1549, Manas sas, VA 20110, the United States of America) behind the chromosomal DNA, it is implemented 0.8% agarose gel electrophoresis respectively.Behind the electrophoresis, electrophoretic chromosomal DNA trace from the sepharose is comprised then that at the nylon leaching film (RocheDiagnostics production) of positively charged alkaline denaturation, neutralization and fixed handle.Adopt EASY HYB (Boehringer-Mannheim production) to hybridize.In 50 ℃, the filter prehybridization after 1 hour, is added the probe with digoxigenin labeled by above-mentioned preparation, in 50 ℃ of hybridization 16 hours.Subsequently, with the 0.1 * SSC that comprises 0.1%SDS, 60 ℃, washed twice.
Adopt DIG kit for detecting nucleic acid (Boehringer-Mannheim production), detect according to step described in the specification sheets of test kit pair band with probe hybridization.As a result, in the PstI digestion product, detect the band with about 7k of probe hybridization, and in the HincII digestion product, detect the band with about 2k of probe hybridization.
With PstI or HincII complete digestion sea round bacteria strains A TCC 25205 (preservation mechanisms: American type culture collection, preservation mechanism address: P.O.Box 1549, Manassas, VA 20110, the United States of America) chromosomal DNA.Isolate the DNA of about 7kb or 2kb by 0.8% agarose gel electrophoresis, adopt Gene CleanII test kit (Funakoshi production) purify DNA then, it is dissolved among the 10 μ l TE.Then 4 these products of μ l are mixed with pUC118 PstI/BAP (Takara Shuzo production) or pUC118HincII/BAP (Takara Shuzo production), adopt dna ligation kit Ver.2 (Takara Shuzo production) to carry out ligation.Mix this ligation liquid of 5 μ l and 100 μ l e. coli jm109s (Takara Shuzo production) respectively and transformed into escherichia coli.The transformant that will obtain thus places on the suitable solid medium and produces chromosomal dna library then.
In order to obtain the peptide-forming enzyme gene of total length, adopt above-mentioned probe, by colony hybridization screening chromosomal dna library.Molecular Cloning, 2nd edition has described the step of colony hybridization among the Cold SpringHarbor Press (1989).
The clone of chromosomal dna library is gone to nylon leaching film (nylon membrane that is used for bacterium colony and plaque hybridization, (Reche Diagnostics production)), comprise alkaline denaturation, neutralization and fixed processing then.Adopt EASY HYB (Boehringer-Mannheim production) to implement hybridization.In 37 ℃, the filter prehybridization after 1 hour, is added above-mentioned probe with digoxigenin labeled, in 37 ℃ of hybridization 16 hours.Subsequently, with comprising 0.1 * SSC of 1%SDS in 60 ℃ of washed twice.
Adopt DIG kit for detecting nucleic acid (Boehringer-Mannheim production), the clone with the probe hybridization of mark is detected according to the explanation described in the specification sheets of test kit.As a result, confirm to have the probe hybridization of 1 strain clone and mark.
(5) come from the base sequence of the peptide-forming enzyme gene of extra large round bacteria strains A TCC 25205
The plasmid that e. coli jm109 contained determines to take place with probe the contiguous base sequence of hybridization by the above-mentioned microorganism cells bacterial strain preparation that is proved with the probe hybridization of mark.Adopt CEQDTCS-Quick Start Kit (Beckman-Coulter production), implement sequencing reaction according to step described in the specification sheets of test kit.In addition, adopt CEQ 2000-XL (Beckman-Coulter production) to implement electrophoresis.
As a result, find to exist the opening code-reading frame of coding peptide-forming enzyme.Shown among the SEQ IDNO:24 in the sequence table and come from extra large round bacteria strains A TCC 25205 (preservation mechanisms: American type culture collection, preservation mechanism address: P.O.Box 1549, Manassas, VA20110, the base sequence of total length peptide-forming enzyme gene the United States of America), and amino acid sequence corresponding.
(embodiment 39) come from the separation of the peptide-forming enzyme gene of Psycloserpens burtonensis strains A TCC 700359
Below, will the separation of peptide-forming enzyme gene be described.Microorganism used therefor is Psycloserpensburtonensis strains A TCC 700359 (preservation mechanisms: American type culture collection, preservation mechanism address: P.O.Box 1549, Manassas, VA 20110, the UnitedStates of America).In isolated genes, intestinal bacteria JM-109 is used as the host, and pUC118 is as carrier.
(1) preparation of microorganism
With Psycloserpens burtonensis strains A TCC 700359 (preservation mechanisms: American type culture collection, preservation mechanism address: P.O.Box 1549, Manassas, VA 20110, the United States of America) goes up in 10 ℃ of cultivations 24 hours at CM2G nutrient agar (contain 50g/l glucose, 10g/l yeast extract, 10g/l peptone, 5g/l sodium-chlor and 20g/l agar, pH 7.0).Inoculation 1 platinum loop gained microorganism cells in the 500ml slope Kou Shi bottle that contains 50ml CM2G liquid nutrient medium (the above-mentioned substratum except that agar) is cultivated 10 ℃ of concussions then.
(2) from microorganism cells, prepare chromosomal DNA
The 50mL nutrient solution is carried out centrifugal (12,000rpm, 4 ℃, 15 minutes), collect microorganism cells.Then, adopt QIAGEN Genomic-Tip System (Qiagen),, from microorganism cells, obtain chromosomal DNA according to step described in its specification sheets.
(3) prepare probe dna fragment by PCR
Adopt LA-Taq (Takara Shuzo production), pass through PCR method, acquisition contains and comes from Psycloserpens burtonensis strains A TCC 700359 (preservation mechanisms: American type culture collection, preservation mechanism address: P.O.Box 1549, Manassas, VA 20110, the United States of America) the dna fragmentation of a part of peptide-forming enzyme gene.Adopt the primer of the base sequence that contains SEQ ID NOs:15 and 16 then, to available from Psycloserpens burtonensis strains A TCC 700359 (preservation mechanisms: American type culture collection, preservation mechanism address: P.O.Box 1549, Manassas, VA 20110, the United States of America) chromosomal DNA carry out PCR.About 1kb dna fragmentation by pcr amplification separates by 0.8% agarose electrophoresis.Downcut the target band then, the dna fragmentation that purifying obtains.Adopt DIG High Prime (Boehringer-Mannheim production), according to step described in the specification sheets of test kit, with this dna fragmentation of probe digoxigenin labeled.
(4) by gene library clone peptide-forming enzyme gene
In order to obtain the total length peptide-forming enzyme gene, adopt the dna fragmentation that in above-mentioned PCR step, increases to carry out Southern hybridization as probe.Molecular Cloning, 2nd edition has described the step that Southern is hybridized among the Cold Spring Harbor Press (1989).
Reacting 16 hours and complete digestion Psycloserpens burtonensis strains A TCC 700359 (preservation mechanism: American type culture collection at 37 ℃ with Restriction Enzyme EcoRI, preservation mechanism address: P.O.Box 1549, Manassas, VA20110, the United States of America) behind the chromosomal DNA, it is carried out 0.8% agarose gel electrophoresis.Behind the electrophoresis, electrophoretic chromosomal DNA trace from the sepharose is comprised then that at the nylon leaching film (Reche Diagnostics production) of positively charged alkaline denaturation, neutralization and fixed handle.Adopt EASY HYB (Boehringer-Mannheim production) to hybridize.In 50 ℃, the filter prehybridization after 1 hour, is added the probe with mark by above-mentioned preparation, in 50 ℃ of hybridization 16 hours.Subsequently, with the 0.1 * SSC that comprises 0.1%SDS, 60 ℃, washed twice.
Adopt DIG kit for detecting nucleic acid (Boehringer-Mannheim production), detect according to step described in the specification sheets of test kit pair band with probe hybridization.As a result, can detect band with about 7kb of probe hybridization.
With EcoRI complete digestion Psycloserpens burtonensis strains A TCC 700359 (preservation mechanisms: American type culture collection, preservation mechanism address: P.O.Box1549, Manassas, VA 20110, the United States of America) chromosomal DNA.Separate the DNA of about 7kb by 0.8% agarose gel electrophoresis, adopt Gene Clean II test kit (Funakoshi production) purify DNA then, it is dissolved among the 10 μ l TE.Then 4 these products of μ l are mixed with pUC118 EcoRI/BAP (Takara Shuzo production), adopt dna ligation kit Ver.2 (Takara Shuzo production) to carry out ligation.Mix this ligation liquid of 5 μ l and 100 μ l e. coli jm109s (Takara Shuzo production) and transformed into escherichia coli.The transformant that will obtain thus places on the suitable solid medium and produces chromosomal dna library then.
In order to obtain the peptide-forming enzyme gene of total length, adopt above-mentioned probe, by colony hybridization screening chromosomal dna library.Molecular Cloning, 2nd edition has described the step of colony hybridization among the Cold SpringHarbor Press (1989).
The clone of chromosomal dna library is gone to nylon leaching film (nylon membrane that is used for bacterium colony and plaque hybridization, (Roche Diagnostics production)), comprise alkaline denaturation, neutralization and fixed processing then.Adopt EASY HYB (Boehringer-Mannheim production) to implement hybridization.In 37 ℃, the filter prehybridization after 1 hour, is added above-mentioned probe with digoxigenin labeled, in 37 ℃ of hybridization 16 hours.Subsequently, with comprising 0.1 * SSC of 1%SDS in 60 ℃ of washed twice.
Adopt DIG Nucleotide Detection Kit (Boehringer-Mannheim production), according to the clone of specification sheets detection with the probe hybridization of mark.As a result, confirm the probe hybridization of 1 strain clone and mark.
(5) come from the base sequence of the peptide-forming enzyme gene of Psycloserpens burtonensis strains A TCC 700359
The plasmid that e. coli jm109 contained determines to take place with probe the contiguous base sequence of hybridization by the above-mentioned microorganism cells bacterial strain preparation that is proved with the probe hybridization of mark.According to the described step of specification sheets, adopt CEQ DTCS-Quick Start Kit (Beckman-Coulter production) to carry out sequencing reaction.In addition, adopt CEQ 2000-XL (Beckman-Coulter production) to implement electrophoresis.
As a result, find to exist the opening code-reading frame of coding peptide-forming enzyme.Shown among the SEQ IDNO:31 in the sequence table and come from Psycloserpens burtonensis strains A TCC 700359 (preservation mechanisms: American type culture collection, preservation mechanism address: P.O.Box1549, Manassas, VA 20110, the base sequence of total length peptide-forming enzyme gene the United States of America), and amino acid sequence corresponding.
Industrial applicability
According to the present invention, provide by reducing such as the complicated synthetic method of introducing and eliminate protecting group, and can be easily, high productivity and produce at an easy rate the novel enzyme of peptide. Use endonuclease capable of the present invention to realize the efficient industrial production of peptide.
Sequence table
SEQ ID NO:3: synthetic primer 1
SEQ ID NO:4: synthetic primer 2
SEQ ID NO:5: the gene of coding peptide-forming enzyme
SEQ ID NO:7: the synthetic primer that is used to prepare pTrpT
SEQ ID NO:8: the synthetic primer that is used to prepare pTrpT
SEQ ID NO:9: the synthetic primer that is used to prepare pTrpT_Gtg2
SEQ ID NO:10: the synthetic primer that is used to prepare pTrpT_Gtg2
SEQ ID NO:11: the gene of coding peptide-forming enzyme
SEQ ID NO:13: the synthetic primer that is used to prepare pTrpT_Sm_aet
SEQ ID NO:14: the synthetic primer that is used to prepare pTrpT_Sm_aet
SEQ ID NO:15: the mix primer 1 that is used for Aet
SEQ ID NO:16: the mix primer 2 that is used for Aet
SEQ ID NO:19: the primer 1 that is used to make up the aet expression vector that comes from Pedobacter.
SEQ ID NO:20: the primer 2 that is used to make up the aet expression vector that comes from Pedobacter.
SEQ ID NO:21: the mix primer 3 that is used for Aet.
Sequence table
<110>AJINOMOTO CO.,LTD.
<120〉novel peptide-forming enzyme gene
<130>PAMA-15377,PAMA-03030
<150>JP2002-218957
<151>2002-07-26
<150>JP2003-016765
<151>2003-01-24
<160>27
<170>PatentIn Ver.2.1
<210>1
<211>9
<212>PRT
<213〉lack steady stalk bacterium
<220>
<223>Inventor:HARA,Seiichi
Inventor:YOKOZEKI,Kenzo
Inventor:ABE,Isao
Inventor:TONOUCHI,Naoto
Inventor:JOJIMA,Yasuko
<400>1
Leu Phe Thr Ala Ile Tyr Gln Pro Lys
1 5
<210>2
<211>9
<212>PRT
<213〉lack steady stalk bacterium
<400>2
Thr Asn Val Thr Tyr Thr Met Pro Asp
1 5
<210>3
<211>20
<212>DNA
<213〉composition sequence
<220>
<223〉artificial sequence description: synthetic primer 1
<400>3
ttyacngcna thtaycarcc 20
<210>4
<211>23
<212>DNA
<213〉composition sequence
<220>
<223〉artificial sequence description: synthetic primer 2
<400>4
tcnggcatng trtangtnac rtt 23
<210>5
<211>2024
<212>DNA
<213〉lack steady stalk bacterium
<220>
<221>CDS
<222>(61)..(1908)
<223〉gene of encoded peptide synthetic enzyme
<400>5
atttcttaat aaaaactgaa atcttaatac atttatacta tcgtaaaatt tattgaacac 60
gtg aaa aaa tta aca tta aaa gta act cta ctt aca ctt ttg ttg gga 108
Val Lys Lys Leu Thr Leu Lys Val Thr Leu Leu Thr Leu Leu Leu Gly
1 5 10 15
agt aca gtt gga ttt gcg caa gat gca aaa gca gat tct gct tat gtg 156
Ser Thr Val Gly Phe Ala Gln Asp Ala Lys Ala Asp Ser Ala Tyr Val
20 25 30
cgc gac aat tac gaa aaa ata gaa caa gta att ccg atg cgc gat ggt 204
Arg Asp Asn Tyr Glu Lys Ile Glu Gln Val Ile Pro Met Arg Asp Gly
35 40 45
aca aag tta ttt aca gct att tat cag cca aaa gat aaa aca aaa caa 252
Thr Lys Leu Phe Thr Ala Ile Tyr Gln Pro Lys Asp Lys Thr Lys Gln
50 55 60
tat ccc gtt ttg tta aat cgt acg cct tat aca gtt gcg cct tat ggt 300
Tyr Pro Val Leu Leu Asn Arg Thr Pro Tyr Thr Val Ala Pro Tyr Gly
65 70 75 80
gta aat gaa tac aag aaa tcg tta gga aat ttt cct aca gaa atg cgc 348
Val Asn Glu Tyr Lys Lys Ser Leu Gly Asn Phe Pro Thr Glu Met Arg
85 90 95
gaa ggt ttt att ttt gtt tac caa gat gtg aga gga aaa tgg atg agc 396
Glu Gly Phe Ile Phe Val Tyr Gln Asp Val Arg Gly Lys Trp Met Ser
100 105 110
gaa ggc gaa ttt gaa gat gtt cga cct ata aat cct tca aaa agt aaa 444
Glu Gly Glu Phe Glu Asp Val Arg Pro Ile Asn Pro Ser Lys Ser Lys
115 120 125
aag gca att gac gaa agc aca gat aca ttt gat acg cta gaa tgg ctt 492
Lys Ala Ile Asp Glu Ser Thr Asp Thr Phe Asp Thr Leu Glu Trp Leu
130 135 140
gct aaa aac ttg aag aat tac acg aaa aaa gct gga att tat gga att 540
Ala Lys Asn Leu Lys Asn Tyr Thr Lys Lys Ala Gly Ile Tyr Gly Ile
145 150 155 160
tcg tat cct ggt ttt tat tcg aca atg agt ttg gtt aat tcg cat cca 588
Ser Tyr Pro Gly Phe Tyr Ser Thr Met Ser Leu Val Asn Ser His Pro
165 170 175
act cta aaa gcc gtt tcg cca caa gcg ccc gtt acc aat tgg ttt tta 636
Thr Leu Lys Ala Val Ser Pro Gln Ala Pro Val Thr Asn Trp Phe Leu
180 185 190
ggt gac gat ttt cat cat aat gga gtt tta ttc ttg aat gat tct ttc 684
Gly AsP Asp Phe His His Asn Gly Val Leu Phe Leu Asn Asp Ser Phe
195 200 205
tca ttt atg act ttt ttt ggt gta aaa cgt ccg caa cca att acg cca 732
Ser Phe Met Thr Phe Phe Gly Val Lys Arg Pro Gln Pro Ile Thr Pro
210 215 220
gat aaa ggt ccg aaa cgt ttt gaa tat cca ata aaa gat aat tat aga 780
Asp Lys Gly Pro Lys Arg Phe Glu Tyr Pro Ile Lys Asp Asn Tyr Arg
225 230 235 240
ttt tat gca agt ggc tct gta aaa gag ttg aaa gat aaa tat ttg caa 828
Phe Tyr Ala Ser Gly Ser Val Lys Glu Leu Lys Asp Lys Tyr Leu Gln
245 250 255
gat aat atc aag ttt tac aat gat tta ttt gcg cat cca gat tac gat 876
Asp Asn Ile Lys Phe Tyr Asn Asp Leu Phe Ala His Pro Asp Tyr Asp
260 265 270
caa ttt tgg caa gat cgt aat gtt tta cca cat tta act aac gtg caa 924
Gln Phe Trp Gln Asp Arg Asn Val Leu Pro His Leu Thr Asn Val Gln
275 280 285
cct gct gta atg acg gtt gga ggt ttt ttt gat gca gaa gat gtc tac 972
Pro Ala Val Met Thr Val Gly Gly Phe Phe Asp Ala Glu Asp Val Tyr
290 295 300
ggc gct ttc gaa acg tat aaa gca att gag aaa caa aat ccg aaa gca 1020
Gly Ala Phe Glu Thr Tyr Lys Ala Ile Glu Lys Gln Asn Pro Lys Ala
305 310 315 320
aca aat att atg gtt gcc gga cct tgg ttt cat ggt ggt tgg gtt cgt 1068
Thr Asn Ile Met Val Ala Gly Pro Trp Phe His Gly Gly Trp Val Arg
325 330 335
agc aac gga agt act ttt gga gat atg caa ttt gca tcg aat aca agt 1116
Ser Asn Gly Ser Thr Phe Gly Asp Met Gln Phe Ala Ser Asn Thr Ser
340 345 350
gag cat tat cag caa gaa ata gaa ttg cct ttt ttt aat tat tac tta 1164
Glu His Tyr Gln Gln Glu Ile Glu Leu Pro Phe Phe Asn Tyr Tyr Leu
355 360 365
aaa gat aaa ggt aat ttt aaa cca acc gaa gct aca att ttt att acg 1212
Lys Asp Lys Gly Asn Phe Lys Pro Thr Glu Ala Thr Ile Phe Ile Thr
370 375 380
gga tct aac gaa tgg aaa caa ttt gat gct tgg cca cca aaa aat gta 1260
Gly Ser Asn Glu Trp Lys Gln Phe Asp Ala Trp Pro Pro Lys Asn Val
385 390 395 400
aca aca caa aaa att tat ttg caa caa aat ggt aaa ata gct ttt aat 1308
Thr Thr Gln Lys Ile Tyr Leu Gln Gln Asn Gly Lys Ile Ala Phe Asn
405 410 415
aaa acc aat aca aca act act ttt gac gaa tat gtt gca gat cca aat 1356
Lys Thr Asn Thr Thr Thr Thr Phe Asp Glu Tyr Val Ala Asp Pro Asn
420 425 430
tct cca gtt cct tat tca gga gga gtt tta gaa act cgt tca aga gaa 1404
Ser Pro Val Pro Tyr Ser Gly Gly Val Leu Glu Thr Arg Ser Arg Glu
435 440 445
tat atg gtc gat gat caa cgc ttt gct tct act cgt cct gat gtt atg 1452
Tyr Met Val Asp Asp Gln Arg Phe Ala Ser Thr Arg Pro Asp Val Met
450 455 460
gtg tat caa tct gat att ttg aca gaa gat att acg ctt gct ggt cct 1500
Val Tyr Gln Ser Asp Ile Leu Thr Glu Asp Ile Thr Leu Ala Gly Pro
465 470 475 480
gtt atc aat cat tta gtg gtt tct act acg gga aca gac gct gat tat 1548
Val Ile Asn His Leu Val Val Ser Thr Thr Gly Thr Asp Ala Asp Tyr
485 490 495
gtt gta aaa ttg att gat gtt tat cct gaa aac acg cca aaa ttt aat 1596
Val Val Lys Leu Ile Asp Val Tyr Pro Glu Asn Thr Pro Lys Phe Asn
500 505 510
aac aaa tta atg gct gga tat caa aat ttg att cgt gca gaa att atg 1644
Asn Lys Leu Met Ala Gly Tyr Gln Asn Leu Ile Arg Ala Glu Ile Met
515 520 525
cgc gga aaa tat aga aat agt ttc tct aac ccc gaa gct atg gtt ccg 1692
Arg Gly Lys Tyr Arg Asn Ser Phe Ser Asn Pro Glu Ala Met Val Pro
530 535 540
aat aaa gaa aca aat gta acg tac acg atg cca gat gtt gga cat aca 1740
Asn Lys Glu Thr Asn Val Thr Tyr Thr Met Pro Asp Val Gly His Thr
545 550 555 560
ttt aag aaa gga cat cgc att atg att caa gtt cag aac agt tgg ttt 1788
Phe Lys Lys Gly His Arg Ile Met Ile Gln Val Gln Asn Ser Trp Phe
565 570 575
cct tta gca gat cgc aat ccg caa caa ttt atg aat gtt tac gaa gca 1836
Pro Leu Ala Asp Arg Asn Pro Gln Gln Phe Met Asn Val Tyr Glu Ala
580 585 590
act tct aaa gat tat tta aaa caa acg caa cga att tat cat act tct 1884
Thr Ser Lys Asp Tyr Leu Lys Gln Thr Gln Arg Ile Tyr His Thr Ser
595 600 605
tat atc gaa att ccg gta ttg aaa taacaaaaaa atccagctaa ttagctggat 1938
Tyr Ile Glu Ile Pro Val Leu Lys
610 615
tttttttata atgttacttt tcctattttt cctttatttc caactaaaat tacatatttt 1998
ttatcgggcg aaaccgtaca agtatg 2024
<210>6
<211>616
<212>PRT
<213〉lack steady stalk bacterium
<400>6
Val Lys Lys Leu Thr Leu Lys Val Thr Leu Leu Thr Leu Leu Leu Gly
1 5 10 15
Ser Thr Val Gly Phe Ala Gln Asp Ala Lys Ala Asp Ser Ala Tyr Val
20 25 30
Arg Asp Asn Tyr Glu Lys Ile Glu Gln Val Ile Pro Met Arg Asp Gly
35 40 45
Thr Lys Leu Phe Thr Ala Ile Tyr Gln Pro Lys Asp Lys Thr Lys Gln
50 55 60
Tyr Pro Val Leu Leu Asn Arg Thr Pro Tyr Thr Val Ala Pro Tyr Gly
65 70 75 80
Val Asn Glu Tyr Lys Lys Ser Leu Gly Asn Phe Pro Thr Glu Met Arg
85 90 95
Glu Gly Phe Ile Phe Val Tyr Gln Asp Val Arg Gly Lys Trp Met Ser
100 105 110
Glu Gly Glu Phe Glu Asp Val Arg Pro Ile Asn Pro Ser Lys Ser Lys
115 120 125
Lys Ala Ile Asp Glu Ser Thr Asp Thr Phe Asp Thr Leu Glu Trp Leu
130 135 140
Ala Lys Asn Leu Lys Asn Tyr Thr Lys Lys Ala Gly Ile Tyr Gly Ile
145 150 155 160
Ser Tyr Pro Gly Phe Tyr Ser Thr Met Ser Leu Val Asn Ser His Pro
165 170 175
Thr Leu Lys Ala Val Ser Pro Gln Ala Pro Val Thr Asn Trp Phe Leu
180 185 190
Gly Asp Asp Phe His His Asn Gly Val Leu Phe Leu Asn Asp Ser Phe
195 200 205
Ser Phe Met Thr Phe Phe Gly Val Lys Arg Pro Gln Pro Ile Thr Pro
210 215 220
Asp Lys Gly Pro Lys Arg Phe Glu Tyr Pro Ile Lys Asp Asn Tyr Arg
225 230 235 240
Phe Tyr Ala Ser Gly Ser Val Lys Glu Leu Lys Asp Lys Tyr Leu Gln
245 250 255
Asp Asn Ile Lys Phe Tyr Asn Asp Leu Phe Ala His Pro Asp Tyr Asp
260 265 270
Gln Phe Trp Gln Asp Arg Asn Val Leu Pro His Leu Thr Asn Val Gln
275 280 285
Pro Ala Val Met Thr Val Gly Gly Phe Phe Asp Ala 6lu Asp Val Tyr
290 295 300
Gly Ala Phe Glu Thr Tyr Lys Ala Ile Glu Lys Gln Asn Pro Lys Ala
305 310 315 320
Thr Asn Ile Met Val Ala Gly Pro Trp Phe His Gly Gly Trp Val Arg
325 330 335
Ser Asn Gly Ser Thr Phe Gly Asp Met Gln Phe Ala Ser Asn Thr Ser
340 345 350
Glu His Tyr Gln Gln Glu Ile Glu Leu Pro Phe Phe Asn Tyr Tyr Leu
355 360 365
Lys Asp Lys Gly Asn Phe Lys Pro Thr Glu Ala Thr Ile Phe Ile Thr
370 375 380
Gly Ser Asn Glu Trp Lys Gln Phe Asp Ala Trp Pro Pro Lys Asn Val
385 390 395 400
Thr Thr Gln Lys Ile Tyr Leu Gln Gln Asn Gly Lys Ile Ala Phe Asn
405 410 415
Lys Thr Asn Thr Thr Thr Thr Phe Asp Glu Tyr Val Ala Asp Pro Asn
420 425 430
Ser Pro Val Pro Tyr Ser Gly Gly Val Leu Glu Thr Arg Ser Arg Glu
435 440 445
Tyr Met Val Asp Asp Gln Arg Phe Ala Ser Thr Arg Pro Asp Val Met
450 455 460
Val Tyr Gln Ser Asp Ile Leu Thr Glu Asp Ile Thr Leu Ala Gly Pro
465 470 475 480
Val Ile Asn His Leu Val Val Ser Thr Thr Gly Thr Asp Ala Asp Tyr
485 490 495
Val Val Lys Leu Ile Asp Val Tyr Pro Glu Asn Thr Pro Lys Phe Asn
500 505 510
Asn Lys Leu Met Ala Gly Tyr Gln Asn Leu Ile Arg Ala Glu Ile Met
515 520 525
Arg Gly Lys Tyr Arg Asn Ser Phe Ser Asn Pro Glu Ala Met Val Pro
530 535 540
Asn Lys Glu Thr Asn Val Thr Tyr Thr Met Pro Asp Val Gly His Thr
545 550 555 560
Phe Lys Lys Gly His Arg Ile Met Ile Gln Val Gln Asn Ser Trp Phe
565 570 575
Pro Leu Ala Asp Arg Asn Pro Gln Gln Phe Met Asn Val Tyr Glu Ala
580 585 590
Thr Ser Lys Asp Tyr Leu Lys Gln Thr Gln Arg Ile Tyr His Thr Ser
595 600 605
Tyr Ile Glu Ile Pro Val Leu Lys
610 615
<210>7
<211>40
<212>DNA
<213〉composition sequence
<220>
<223〉artificial sequence description: be the synthetic primer of preparation pTrpT
<400>7
gtatcacgag gccctagctg tggtgtcatg gtcggtgatc 40
<210>8
<211>40
<212>DNA
<213〉composition sequence
<220>
<223〉artificial sequence description: be the synthetic primer of preparation pTrpT
<400>8
ttcggggatt ccatatgata ccctttttac gtgaacttgc 40
<210>9
<211>38
<212>DNA
<213〉composition sequence
<220>
<223〉artificial sequence description: be the synthetic primer of preparation pTrpT_Gtg2
<400>9
gggaattcca tatgaaaaaa ttaacattaa aagtaact 38
<210>10
<211>36
<212>DNA
<213〉composition sequence
<220>
<223〉artificial sequence description: be the synthetic primer of preparation pTrpT_Gtg2
<400>10
gggggctgca gtacttgtac ggtttcgccc gataaa 36
<210>11
<211>1935
<212>DNA
<213〉Sphingobacterium sp.
<220>
<221>CDS
<222>(61)..(1917)
<223〉peptide synthetase gene
<400>11
gaaaccaagt gtaaaattat aatttacacc aaagaatgta ctgaacaaat aattatctga 60
atg aaa aat aca att tcg tgc cta act tta gcg ctt tta agc gca agc 108
Met Lys Asn Thr Ile Ser Cys Leu Thr Leu Ala Leu Leu Ser Ala Ser
1 5 10 15
cag tta cat gct caa aca gct gcc gac tcg gct tat gtt aga gat cat 156
Gln Leu His Ala Gln Thr Ala Ala Asp Ser Ala Tyr Val Arg Asp His
20 25 30
tat gaa aag acc gaa gta gca att ccc atg cga gat ggg aaa aaa tta 204
Tyr Glu Lys Thr Glu Val Ala Ile Pro Met Arg Asp Gly Lys Lys Leu
35 40 45
ttt act gcg atc tac agt cca aaa gac aaa tcc aag aaa tat cca gtt 252
Phe Thr Ala Ile Tyr Ser Pro Lys Asp Lys Ser Lys Lys Tyr Pro Val
50 55 60
ttg ctc aat aga acg ccc tac acg gtt tca cct tat ggg cag aac gaa 300
Leu Leu Asn Arg Thr Pro Tyr Thr Val Ser Pro Tyr Gly Gln Asn Glu
65 70 75 80
tat aaa aaa agc ttg gga aac ttt ccc caa atg atg cgt gaa ggc tat 348
Tyr Lys Lys Ser Leu Gly Asn Phe Pro Gln Met Met Arg Glu Gly Tyr
85 90 95
att ttc gtt tac cag gat gtc cgt ggc aag tgg atg agc gaa ggt gat 396
Ile Phe Val Tyr Gln Asp Val Arg Gly Lys Trp Met Ser Glu Gly Asp
100 105 110
ttt gaa gat ata cgt ccg acc acg tac agc aaa gat aaa aaa gca atc 444
Phe Glu Asp Ile Arg Pro Thr Thr Tyr Ser Lys Asp Lys Lys Ala Ile
115 120 125
gat gaa agt acg gat acc tat gat gcg ctt gaa tgg tta cag aaa aat 492
Asp Glu Ser Thr Asp Thr Tyr Asp Ala Leu Glu Trp Leu Gln Lys Asn
130 135 140
ctc aaa aac tat aat ggc aaa gcc ggg ctc tat ggg att tcc tat cca 540
Leu Lys Asn Tyr Asn Gly Lys Ala Gly Leu Tyr Gly Ile Ser Tyr Pro
145 150 155 160
ggc ttc tat tct acc gtc gga ttg gtc aaa aca cac ccg agc ttg aag 588
Gly Phe Tyr Ser Thr Val Gly Leu Val Lys Thr His Pro Ser Leu Lys
165 170 175
gca gtc tcc cca cag gct ccc gta aca gac tgg tat atc ggc gac gac 636
Ala Val Ser Pro Gln Ala Pro Val Thr Asp Trp Tyr Ile Gly Asp Asp
180 185 190
ttc cac cat aat ggc gta ttg ttt ctt cag gat gca ttt aca ttc atg 684
Phe His His Asn Gly Val Leu Phe Leu Gln Asp Ala Phe Thr Phe Met
195 200 205
tca acc ttt ggt gtc cct cgt cca aaa ccc att aca ccg gat caa ttt 732
Ser Thr Phe Gly Val Pro Arg Pro Lys Pro Ile Thr Pro Asp Gln Phe
210 215 220
aag ggc aaa att cag atc aaa gaa gcc gat aaa tat aac ttt ttt gca 780
Lys Gly Lys Ile Gln Ile Lys Glu Ala Asp Lys Tyr Asn Phe Phe Ala
225 230 235 240
gaa gca gga aca gcg cgg gaa ctc aaa gaa aag tat ttt ggt gac tcc 828
Glu Ala Gly Thr Ala Arg Glu Leu Lys Glu Lys Tyr Phe Gly Asp Ser
245 250 255
gta caa ttt tgg aat gac ctg ttt aag cat ccc gac tat gat gat ttt 876
Val Gln Phe Trp Asn Asp Leu Phe Lys His Pro Asp Tyr Asp Asp Phe
260 265 270
tgg aaa tcg cgt gtg atc acg aat tct tta cag gag gta aaa cca gct 924
Trp Lys Ser Arg Val Ile Thr Asn Ser Leu Gln Glu Val Lys Pro Ala
275 280 285
gtg atg gtg gtt ggt ggt ttc ttt gac gcg gaa gat gct tat gga aca 972
Val Met Val Val Gly Gly Phe Phe Asp Ala Glu Asp Ala Tyr Gly Thr
290 295 300
ttt aag acc tac caa tcg att gag gat aaa agc aaa aaa aac aac tcg 1020
Phe Lys Thr Tyr Gln Ser Ile Glu Asp Lys Ser Lys Lys Asn Asn Ser
305 310 315 320
att tta gtc gcg gga cct tgg tat cat ggc ggt tgg gtt cgt gca gaa 1068
Ile Leu Val Ala Gly Pro Trp Tyr His Gly Gly Trp Val Arg Ala Glu
325 330 335
gga aac tat tta ggt gat atc caa ttt gag aaa aaa acc agt att act 1116
Gly Asn Tyr Leu Gly Asp Ile Gln Phe Glu Lys Lys Thr Ser Ile Thr
340 345 350
tat cag gaa caa ttt gaa caa cca ttt ttc aaa tat tac cta aaa gat 1164
Tyr Gln Glu Gln Phe Glu Gln Pro Phe Phe Lys Tyr Tyr Leu Lys Asp
355 360 365
gaa gga aac ttc gcc cct tcc gaa gct aac att ttt gtt tca ggc agc 1212
Glu Gly Asn Phe Ala Pro Ser Glu Ala Asn Ile Phe Val Ser Gly Ser
370 375 380
aac gaa tgg aaa cat ttc gaa cag tgg cca cca aaa aat gta gag aca 1260
Asn Glu Trp Lys His Phe Glu Gln Trp Pro Pro Lys Asn Val Glu Thr
385 390 395 400
aaa aaa cta tac ttc caa cct cag ggg aaa ctt gga ttt gac aaa gtt 1308
Lys Lys Leu Tyr Phe Gln Pro Gln Gly Lys Leu Gly Phe Asp Lys Val
405 410 415
caa cgt aca gat tcc tgg gat gaa tat gta aca gac cct aat aaa cct 1356
Gln Arg Thr Asp Ser Trp Asp Glu Tyr Val Thr Asp Pro Asn Lys Pro
420 425 430
gtt ccg cat caa ggt ggg gta att caa aac cga aca cgg gag tat atg 1404
Val Pro His Gln Gly Gly Val Ile Gln Asn Arg Thr Arg Glu Tyr Met
435 440 445
gta gat gat caa cgt ttc gcg gct agt cgc cct gat gtc atg gtt tat 1452
Val Asp Asp Gln Arg Phe Ala Ala Ser Arg Pro Asp Val Met Val Tyr
450 455 460
caa acg gaa ccg ttg acg gag gac ctg acg ata gta ggc cca atc aaa 1500
Gln Thr Glu Pro Leu Thr Glu Asp Leu Thr Ile Val Gly Pro Ile Lys
465 470 475 480
aac ttt ctc aaa gtt tct tca aca gga aca gac gcg gac tat gtt gtc 1548
Asn Phe Leu Lys Val Ser Ser Thr Gly Thr Asp Ala Asp Tyr Val Val
485 490 495
aaa ctg att gac gtt tat ccg aat gat gca gca agt tat caa gga aaa 1596
Lys Leu Ile Asp Val Tyr Pro Asn Asp Ala Ala Ser Tyr Gln Gly Lys
500 505 510
aca atg gct gga tat caa atg atg gta cgt ggt gag atc atg gcg ggg 1644
Thr Met Ala Gly Tyr Gln Met Met Val Arg Gly Glu Ile Met Ala Gly
515 520 525
aaa tac cga aat ggt ttc gat aaa gcg cag gcc ttg act cca ggt atg 1692
Lys Tyr Arg Asn Gly Phe Asp Lys Ala Gln Ala Leu Thr Pro Gly Met
530 535 540
gtc gaa aag gtg aat ttt gaa atg cca gac gtt gcg cat acc ttc aaa 1740
Val Glu Lys Val Asn Phe Glu Met Pro Asp Val Ala His Thr Phe Lys
545 550 555 560
aaa gga cat cgc att atg gtt cag gta caa aac tca tgg ttt ccg ctg 1788
Lys Gly His Arg Ile Met Val Gln Val Gln Asn Ser Trp Phe Pro Leu
565 570 575
gca gaa cga aat cca cag gtg ttt tta gca cct tat aca gct acc aaa 1836
Ala Glu Arg Asn Pro Gln Val Phe Leu Ala Pro Tyr Thr Ala Thr Lys
580 585 590
gct gat ttc cgc aaa gct acc caa cgt att ttt cac gat gtg aac aat 1884
Ala Asp Phe Arg Lys Ala Thr Gln Arg Ile Phe His Asp Val Asn Asn
595 600 605
gcc aca tac atc gaa ttt tct gtc ctc aaa gat tagcaggtaa attcgaaa 1935
Ala Thr Tyr Ile Glu Phe Ser Val Leu Lys Asp
610 615
<210>12
<211>619
<212>PRT
<213〉Sphingobacterium sp.
<400>12
Met Lys Asn Thr Ile Ser Cys Leu Thr Leu Ala Leu Leu Ser Ala Ser
1 5 10 15
Gln Leu His Ala Gln Thr Ala Ala Asp Ser Ala Tyr Val Arg Asp His
20 25 30
Tyr Glu Lys Thr Glu Val Ala Ile Pro Met Arg Asp Gly Lys Lys Leu
35 40 45
Phe Thr Ala Ile Tyr Ser Pro Lys Asp Lys Ser Lys Lys Tyr Pro Val
50 55 60
Leu Leu Asn Arg Thr Pro Tyr Thr Val Ser Pro Tyr Gly Gln Asn Glu
65 70 75 80
Tyr Lys Lys Ser Leu Gly Asn Phe Pro Gln Met Met Arg Glu Gly Tyr
85 90 95
Ile Phe Val Tyr Gln Asp Val Arg Gly Lys Trp Met Ser Glu Gly Asp
100 105 110
Phe Glu Asp Ile Arg Pro Thr Thr Tyr Ser Lys Asp Lys Lys Ala Ile
115 120 125
Asp Glu Ser Thr Asp Thr Tyr Asp Ala Leu Glu Trp Leu Gln Lys Asn
130 135 140
Leu Lys Asn Tyr Asn Gly Lys Ala Gly Leu Tyr Gly Ile Ser Tyr Pro
145 150 155 160
Gly Phe Tyr Ser Thr Val Gly Leu Val Lys Thr His Pro Ser Leu Lys
165 170 175
Ala Val Ser Pro Gln Ala Pro Val Thr Asp Trp Tyr Ile Gly Asp Asp
180 185 190
Phe His His Asn Gly Val Leu Phe Leu Gln Asp Ala Phe Thr Phe Met
195 200 205
Ser Thr Phe Gly Val Pro Arg Pro Lys Pro Ile Thr Pro Asp Gln Phe
210 215 220
Lys Gly Lys Ile Gln Ile Lys Glu Ala Asp Lys Tyr Asn Phe Phe Ala
225 230 235 240
Glu Ala Gly Thr Ala Arg Glu Leu Lys Glu Lys Tyr Phe Gly Asp Ser
245 250 255
Val Gln Phe Trp Asn Asp Leu Phe Lys His Pro Asp Tyr Asp Asp Phe
260 265 270
Trp Lys Ser Arg Val Ile Thr Asn Ser Leu Gln Glu Val Lys Pro Ala
275 280 285
Val Met Val Val Gly Gly Phe Phe Asp Ala Glu Asp Ala Tyr Gly Thr
290 295 300
Phe Lys Thr Tyr Gln Ser Ile Glu Asp Lys Ser Lys Lys Asn Asn Ser
305 310 315 320
Ile Leu Val Ala Gly Pro Trp Tyr His Gly Gly Trp Val Arg Ala Glu
325 330 335
Gly Asn Tyr Leu Gly Asp Ile Gln Phe Glu Lys Lys Thr Ser Ile Thr
340 345 350
Tyr Gln Glu Gln Phe Glu Gln Pro Phe Phe Lys Tyr Tyr Leu Lys Asp
355 360 365
Glu Gly Asn Phe Ala Pro Ser Glu Ala Asn Ile Phe Val Ser Gly Ser
370 375 380
Asn Glu Trp Lys His Phe Glu Gln Trp Pro Pro Lys Asn Val Glu Thr
385 390 395 400
Lys Lys Leu Tyr Phe Gln Pro Gln Gly Lys Leu Gly Phe Asp Lys Val
405 410 415
Gln Arg Thr Asp Ser Trp Asp Glu Tyr Val Thr Asp Pro Asn Lys Pro
420 425 430
Val Pro His Gln Gly Gly Val Ile Gln Asn Arg Thr Arg Glu Tyr Met
435 440 445
Val Asp Asp Gln Arg Phe Ala Ala Ser Arg Pro Asp Val Met Val Tyr
450 455 460
Gln Thr Glu Pro Leu Thr Glu Asp Leu Thr Ile Val Gly Pro Ile Lys
465 470 475 480
Asn Phe Leu Lys Val Ser Ser Thr Gly Thr Asp Ala Asp Tyr Val Val
485 490 495
Lys Leu Ile Asp Val Tyr Pro Asn Asp Ala Ala Ser Tyr Gln Gly Lys
500 505 510
Thr Met Ala Gly Tyr Gln Met Met Val Arg Gly Glu Ile Met Ala Gly
515 520 525
Lys Tyr Arg Asn Gly Phe Asp Lys Ala Gln Ala Leu Thr Pro Gly Met
530 535 540
Val Glu Lys Val Asn Phe Glu Met Pro Asp Val Ala His Thr Phe Lys
545 550 555 560
Lys Gly His Arg Ile Met Val Gln Val Gln Asn Ser Trp Phe Pro Leu
565 570 575
Ala Glu Arg Asn Pro Gln Val Phe Leu Ala Pro Tyr Thr Ala Thr Lys
580 585 590
Ala Asp Phe Arg Lys Ala Thr Gln Arg Ile Phe His Asp Val Asn Asn
595 600 605
Ala Thr Tyr Ile Glu Phe Ser Val Leu Lys Asp
610 615
<210>13
<211>30
<212>DNA
<213〉composition sequence
<220>
<223〉artificial sequence description: be the synthetic primer of preparation pTrpT_Sm_aet
<400>13
gggaattcca tatgaaaaat acaatttcgt 30
<210>14
<211>29
<212>DNA
<213〉composition sequence
<220>
<223〉artificial sequence description: be the synthetic primer of preparation pTrpT_Sm_aet
<400>14
gctctagact aatctttgag gacagaaaa 29
<210>15
<211>17
<212>DNA
<213〉artificial
<220>
<223〉be used for the mix primer 1 of Aet
<400>15
gaygayttyc aycayaa 17
<210>16
<211>20
<212>DNA
<213〉artificial
<220>
<223〉be used for the mix primer 2 of Aet
<220>
<221>misc_feature
<222>(9)..(9)
<223〉any base
<400>16
tgrtcrtcna ccatrtaytc 20
<210>17
<211>1974
<212>DNA
<213〉separate Vitrum AB soil bacillus
<220>
<221>CDS
<222>(61)..(1935)
<223>
<400>17
aaacctatcc cgtattcagc aatcaattcc atatatttat ccttaaaaaa accttcctct 60
atg act cct ttc aaa tcg ttc tcc ttc att ttt ctc ttt att ttt acc 108
Met Thr Pro Phe Lys Ser Phe Ser Phe Ile Phe Leu Phe Ile Phe Thr
1 5 10 15
agt ctt tct gct tct gca caa cag tcc gac tct gct tat ata cgt cag 156
Ser Leu Ser Ala Ser Ala Gln Gln Ser Asp Ser Ala Tyr Ile Arg Gln
20 25 30
aac tat acc aaa ata gaa agg ctg atc cct atg cgg gat ggc att aag 204
Asn Tyr Thr Lys Ile Glu Arg Leu Ile Pro Met Arg Asp Gly Ile Lys
35 40 45
cta ttt aca gcc att tac atc ccc aaa gac aaa agc aag aag tat cct 252
Leu Phe Thr Ala Ile Tyr Ile Pro Lys Asp Lys Ser Lys Lys Tyr Pro
50 55 60
ttt atg ctc aac cgt act cct tat acc gtt tcg cct tat ggc gaa aac 300
Phe Met Leu Asn Arg Thr Pro Tyr Thr Val Ser Pro Tyr Gly Glu Asn
65 70 75 80
aat tat aaa aca agc ctt ggc ccc tct ccg ctc ttt ata aaa gaa ggc 348
Asn Tyr Lys Thr Ser Leu Gly Pro Ser Pro Leu Phe Ile Lys Glu Gly
85 90 95
ttt atc ttt gtt tat cag gat gta agg ggc aaa tgg atg agt gag gga 396
Phe Ile Phe Val Tyr Gln Asp Val Arg Gly Lys Trp Met Ser Glu Gly
100 105 110
aaa ttt gaa gac gta agg ccg caa ata gcc agc aag aaa cgc aaa acg 444
Lys Phe Glu Asp Val Arg Pro Gln Ile Ala Ser Lys Lys Arg Lys Thr
115 120 125
gat att gat gaa agc tcc gat act tat gat acg atc gac tgg ctg atc 492
Asp Ile Asp Glu Ser Ser Asp Thr Tyr Asp Thr Ile Asp Trp Leu Ile
130 135 140
agg aac att cct gga aac aac cgt aaa acc ggt att tac ggt atc tca 540
Arg Asn Ile Pro Gly Asn Asn Arg Lys Thr Gly Ile Tyr Gly Ile Ser
145 150 155 160
tac cca ggc ttt tat gct act gct gcc cta cca gat gcg cat cca tct 588
Tyr Pro Gly Phe Tyr Ala Thr Ala Ala Leu Pro Asp Ala His Pro Ser
165 170 175
tta aag gca gta tcg ccc cag gct ccg gtt acc gac tgg ttt ata ggc 636
Leu Lys Ala Val Ser Pro Gln Ala Pro Val Thr Asp Trp Phe Ile Gly
180 185 190
gat gat ttt cat cac aat ggc acc ttg ttc ctt gca gat atc ttt agc 684
Asp Asp Phe His His Asn Gly Thr Leu Phe Leu Ala Asp Ile Phe Ser
195 200 205
ttc tat tat acc ttc ggg gta ccg cga cct caa cca att acg ccc gac 732
Phe Tyr Tyr Thr Phe Gly Val Pro Arg Pro Gln Pro Ile Thr Pro Asp
210 215 220
aaa cgt cca aaa ccc ttt gat ttc ccg gtt aaa gac aac tac cgt ttt 780
Lys Arg Pro Lys Pro Phe Asp Phe Pro Val Lys Asp Asn Tyr Arg Phe
225 230 235 240
ttt ctt gaa ctg ggc ccc tta aaa aac atc acc aaa aaa tat tat ggc 828
Phe Leu Glu Leu Gly Pro Leu Lys Asn Ile Thr Lys Lys Tyr Tyr Gly
245 250 255
gat acc ata cga ttc tgg aat gat atc aat gcg cat acc aat tat gat 876
Asp Thr Ile Arg Phe Trp Asn Asp Ile Asn Ala His Thr Asn Tyr Asp
260 265 270
gcc ttc tgg aaa gcc cgt aac att acg ccg cat tta att ggt gta aaa 924
Ala Phe Trp Lys Ala Arg Asn Ile Thr Pro His Leu Ile Gly Val Lys
275 280 285
cct gca gtt ttg gta gtt ggc ggc ttc ttt gat gca gaa gac ctt tac 972
Pro Ala Val Leu Val Val Gly Gly Phe Phe Asp Ala Glu Asp Leu Tyr
290 295 300
ggt acg ctt aaa acc tat cag gcc atc gaa aaa caa aat cca tcc tca l020
Gly Thr Leu Lys Thr Tyr Gln Ala lle Glu Lys Gln Asn Pro Ser Ser
305 310 315 320
aaa aac aac ctc gtt atg ggc ccc tgg tac cat ggt ggc tgg gca aga 1068
Lys Asn Asn Leu Val Met Gly Pro Trp Tyr His Gly Gly Trp Ala Arg
325 330 335
agt acg gga agc agt ttc ggg gat att aat ttc gga cag cca acc agt 1116
Ser Thr Gly Ser Ser Phe Gly Asp Ile Asn Phe Gly Gln Pro Thr Ser
340 345 350
act tca tac cag caa aat gtt gag ttc cct ttc ttt atg caa tac ctc 1164
Thr Ser Tyr Gln Gln Asn Val Glu Phe Pro Phe Phe Met Gln Tyr Leu
355 360 365
aaa gag gca ccg gat gca aaa att gca gag gca acc att ttt atc act 1212
Lys Glu Ala Pro Asp Ala Lys Ile Ala Glu Ala Thr Ile Phe Ile Thr
370 375 380
ggc agc aat gaa tgg aag aaa ttt agc tcc tgg cca cct cag gat aca 1260
Gly Ser Asn Glu Trp Lys Lys Phe Ser Ser Trp Pro Pro Gln Asp Thr
385 390 395 400
gaa gaa aga aca tta tac ctg cag ccc aat ggc aaa ctg agc ttt gag 1308
Glu Glu Arg Thr Leu Tyr Leu Gln Pro Asn Gly Lys Leu Ser Phe Glu
405 410 415
aag gta cag cgg acc gac agc tgg gat gaa tat gta agt gat ccc aat 1356
Lys Val Gln Arg Thr Asp Ser Trp Asp Glu Tyr Val Ser Asp Pro Asn
420 425 430
tca cct gtc cct tat cag gat ggc ata caa acc agc aga acc cgg gaa 1404
Ser Pro Val Pro Tyr Gln Asp Gly Ile Gln Thr Ser Arg Thr Arg Glu
435 440 445
tat atg atc gat gac cag cgt ttt gcc tcg cgc aga ccg gat gta agg 1452
Tyr Met Ile Asp Asp Gln Arg Phe Ala Ser Arg Arg Pro Asp Val Arg
450 455 460
gta ttc caa aca gag ccc ctc agt tcc gac ctt aca ctt acc ggc ccg 1500
Val Phe Gln Thr Glu Pro Leu Ser Ser Asp Leu Thr Leu Thr Gly Pro
465 470 475 480
gta ttg gcc aaa ctg gtg gta tca acc aca ggt acg gat gca gat tat 1548
Val Leu Ala Lys Leu Val Val Ser Thr Thr Gly Thr Asp Ala Asp Tyr
485 490 495
gtg gta aaa ctg ata gat gta tat ccg gaa gat aca cca aat cct gta 1596
Val Val Lys Leu Ile Asp Val Tyr Pro Glu Asp Thr Pro Asn Pro Val
500 505 510
cct aac cct aaa aac ctg atc atg ggt ggt tac cag atg ctg gta cgc 1644
Pro Asn Pro Lys Asn Leu Ile Met Gly Gly Tyr Gln Met Leu Val Arg
515 520 525
ggc gag atc atg cgt gga aaa tac cgt aat agc ttt gaa aaa ccc gag 1692
Gly Glu Ile Met Arg Gly Lys Tyr Arg Asn Ser Phe Glu Lys Pro Glu
530 535 540
cct ttt gtt cct gga aca att aca aaa gta aac tat gcc ctt ccg gat 1740
Pro Phe Val Pro Gly Thr Ile Thr Lys Val Asn Tyr Ala Leu Pro Asp
545 550 555 560
gta gcc cat acc ttt aaa aaa ggc cac cgc atc atg atc cag gtc cag 1788
Val Ala His Thr Phe Lys Lys Gly His Arg Ile Met Ile Gln Val Gln
565 570 575
aat tca tgg ttt ccc ctg gcc gac cgg aat cca cag cag ttt atg gac 1836
Asn Ser Trp Phe Pro Leu Ala Asp Arg Asn Pro Gln Gln Phe Met Asp
580 585 590
att tac cag gcc gaa cct ggc gat ttc aga aaa gct acg cat agg atc 1884
Ile Tyr Gln Ala Glu Pro Gly Asp Phe Arg Lys Ala Thr His Arg Ile
595 600 605
ttc cac gat gta cac aat gca tct gca att acg gta aac gta ctg aaa 1932
Phe His Asp Val His Asn Ala Ser Ala Ile Thr Val Asn Val Leu Lys
610 615 620
cct taaaacggat gaaaccagta tattgtgcca tccttactt 1974
Pro
625
<210>18
<211>625
<212>PRT
<213〉separate Vitrum AB soil bacillus
<400>18
Met Thr Pro Phe Lys Ser Phe Ser Phe Ile Phe Leu Phe Ile Phe Thr
1 5 10 15
Ser Leu Ser Ala Ser Ala Gln Gln Ser Asp Ser Ala Tyr Ile Arg Gln
20 25 30
Asn Tyr Thr Lys Ile Glu Arg Leu Ile Pro Met Arg Asp Gly Ile Lys
35 40 45
Leu Phe Thr Ala Ile Tyr Ile Pro Lys Asp Lys Ser Lys Lys Tyr Pro
50 55 60
Phe Met Leu Asn Arg Thr Pro Tyr Thr Val Ser Pro Tyr Gly Glu Asn
65 70 75 80
Asn Tyr Lys Thr Ser Leu Gly Pro Ser Pro Leu Phe Ile Lys Glu Gly
85 90 95
Phe Ile Phe Val Tyr Gln Asp Val Arg Gly Lys Trp Met Ser Glu Gly
100 105 110
Lys Phe Glu Asp Val Arg Pro Gln Ile Ala Ser Lys Lys Arg Lys Thr
115 120 125
Asp Ile Asp Glu Ser Ser Asp Thr Tyr Asp Thr Ile Asp Trp Leu Ile
130 135 140
Arg Asn Ile Pro Gly Asn Asn Arg Lys Thr Gly Ile Tyr Gly Ile Ser
145 150 155 160
Tyr Pro Gly Phe Tyr Ala Thr Ala Ala Leu Pro Asp Ala His Pro Ser
165 170 175
Leu Lys Ala Val Ser Pro Gln Ala Pro Val Thr Asp Trp Phe Ile Gly
180 185 190
Asp Asp Phe His His Asn Gly Thr Leu Phe Leu Ala Asp Ile Phe Ser
195 200 205
Phe Tyr Tyr Thr Phe Gly Val Pro Arg Pro Gln Pro Ile Thr Pro Asp
210 215 220
Lys Arg Pro Lys Pro Phe Asp Phe Pro Val Lys Asp Asn Tyr Arg Phe
225 230 235 240
Phe Leu Glu Leu Gly Pro Leu Lys Asn Ile Thr Lys Lys Tyr Tyr Gly
245 250 255
Asp Thr Ile Arg Phe Trp Asn Asp Ile Asn Ala His Thr Asn Tyr Asp
260 265 270
Ala Phe Trp Lys Ala Arg Asn Ile Thr Pro His Leu Ile Gly Val Lys
275 280 285
Pro Ala Val Leu Val Val Gly Gly Phe Phe Asp Ala Glu Asp Leu Tyr
290 295 300
Gly Thr Leu Lys Thr Tyr Gln Ala Ile Glu Lys Gln Asn Pro Ser Ser
305 310 315 320
Lys Asn Asn Leu Val Met Gly Pro Trp Tyr His Gly Gly Trp Ala Arg
325 330 335
Ser Thr Gly Ser Ser Phe Gly Asp Ile Asn Phe Gly Gln Pro Thr Ser
340 345 350
Thr Ser Tyr Gln Gln Asn Val Glu Phe Pro Phe Phe Met Gln Tyr Leu
355 360 365
Lys Glu Ala Pro Asp Ala Lys Ile Ala Glu Ala Thr Ile Phe Ile Thr
370 375 380
Gly Ser Asn Glu Trp Lys Lys Phe Ser Ser Trp Pro Pro Gln Asp Thr
385 390 395 400
Glu Glu Arg Thr Leu Tyr Leu Gln Pro Asn Gly Lys Leu Ser Phe Glu
405 410 415
Lys Val Gln Arg Thr Asp Ser Trp Asp Glu Tyr Val Ser Asp Pro Asn
420 425 430
Ser Pro Val Pro Tyr Gln Asp Gly Ile Gln Thr Ser Arg Thr Arg Glu
435 440 445
Tyr Met Ile Asp Asp Gln Arg Phe Ala Ser Arg Arg Pro Asp Val Arg
450 455 460
Val Phe Gln Thr Glu Pro Leu Ser Ser Asp Leu Thr Leu Thr Gly Pro
465 470 475 480
Val Leu Ala Lys Leu Val Val Ser Thr Thr Gly Thr Asp Ala Asp Tyr
485 490 495
Val Val Lys Leu Ile Asp Val Tyr Pro Glu Asp Thr Pro Asn Pro Val
500 505 510
Pro Asn Pro Lys Asn Leu Ile Met Gly Gly Tyr Gln Met Leu Val Arg
515 520 525
Gly Glu Ile Met Arg Gly Lys Tyr Arg Asn Ser Phe Glu Lys Pro Glu
530 535 540
Pro Phe Val Pro Gly Thr Ile Thr Lys Val Asn Tyr Ala Leu Pro Asp
545 550 555 560
Val Ala His Thr Phe Lys Lys Gly His Arg Ile Met Ile Gln Val Gln
565 570 575
Asn Ser Trp Phe Pro Leu Ala Asp Arg Asn Pro Gln Gln Phe Met Asp
580 585 590
Ile Tyr Gln Ala Glu Pro Gly Asp Phe Arg Lys Ala Thr His Arg Ile
595 600 605
Phe His Asp Val His Asn Ala Ser Ala Ile Thr Val Asn Val Leu Lys
610 615 620
Pro
625
<210>19
<211>38
<212>DNA
<213〉artificial
<220>
<223〉be used to make up the primer 1 of the aet expression vector that comes from Pedobacter
<400>19
gggaattcca tatgactcct ttcaaatcgt tctccttc 38
<210>20
<211>30
<212>DNA
<213〉artificial
<220>
<223〉be used to make up the primer 2 of the aet expression vector that comes from Pedobacter
<400>20
cccaagcttt taaggtttca gtacgtttac 30
<210>21
<211>17
<212>DNA
<213〉artificial
<220>
<223〉be used for the mix primer 3 of Aet
<220>
<221>misc_feature
<222>(9)..(9)
<223〉any base
<400>21
athttygtnt aycarga 17
<210>22
<211>2018
<212>DNA
<213>Taxeobacter gelupurpurascens
<220>
<221>CDS
<222>(61)..(1995)
<223>
<400>22
ctgaatgtct gctgacgaat tggaactaca ttaggctcgt tcttcaccta cccttccact 60
atg ccc tac tct ttc ccg aaa gtt gcc gcc ctg agt ggc cta ctg gtg 108
Met Pro Tyr Ser Phe Pro Lys Val Ala Ala Leu Ser Gly Leu Leu Val
1 5 10 15
gcc ggt tta tcc ggt gcc cac gcc caa act cct gtt acc tat ccg ctg 156
Ala Gly Leu Ser Gly Ala His Ala Gln Thr Pro Val Thr Tyr Pro Leu
20 25 30
gct tct gag gct gaa aaa gcg cag ctg gcg gtg gta cta gcc gat acg 204
Ala Ser Glu Ala Glu Lys Ala Gln Leu Ala Val Val Leu Ala Asp Thr
35 40 45
gct tac atc aag gag cgc tat acc aaa aca gaa tat cag att ccg atg 252
Ala Tyr Ile Lys Glu Arg Tyr Thr Lys Thr Glu Tyr Gln Ile Pro Met
50 55 60
cgc gat ggg gtg aag ttg tac acc att gtg tac gcg ccc aac gat gcc 300
Arg Asp Gly Val Lys Leu Tyr Thr Ile Val Tyr Ala Pro Asn Asp Ala
65 70 75 80
aac aag gta aag tac cct att ctg ctc aac cgt acc cct tac gct att 348
Asn Lys Val Lys Tyr Pro Ile Leu Leu Asn Arg Thr Pro Tyr Ala Ile
85 90 95
ggc ccc tac ggc ccc ggc aaa tac aag ctc aac ctg ggc ccc agc agc 396
Gly Pro Tyr Gly Pro Gly Lys Tyr Lys Leu Asn Leu Gly Pro Ser Ser
100 105 110
acg atg atg cat gag gga tac atc ttc gcc tac cag gat gtg cgt ggg 444
Thr Met Met His Glu Gly Tyr Ile Phe Ala Tyr Gln Asp Val Arg Gly
115 120 125
cga tat atg tcg gaa gga gag ttt gtg gat gtg cgc ccc gaa aag gac 492
Arg Tyr Met Ser Glu Gly Glu Phe Val Asp Val Arg Pro Glu Lys Asp
130 135 140
atg cac aaa ggc aag aac gac atc gat gaa ggc acc gac acc tac gat 540
Met His Lys Gly Lys Asn Asp Ile Asp Glu Gly Thr Asp Thr Tyr Asp
145 150 155 160
acc att gag tgg ctt ctg aag cac ggg ccc aag aat aac ggc cgc gta 588
Thr Ile Glu Trp Leu Leu Lys His Gly Pro Lys Asn Asn Gly Arg Val
165 170 175
ggc cag tgg ggc atc tcc tac ccc ggc tac tat acc gct act ggc cta 636
Gly Gln Trp Gly Ile Ser Tyr Pro Gly Tyr Tyr Thr Ala Thr Gly Leu
180 185 190
ctg agc cgc cac aag gcc cta aag gca tcc tca ccg cag gcc cct att 684
Leu Ser Arg His Lys Ala Leu Lys Ala Ser Ser Pro Gln Ala Pro Ile
195 200 205
gcc gac tgg ttc tgg gac gat ttt cac cac aac ggc gcg ttc ttc ctg 732
Ala Asp Trp Phe Trp Asp Asp Phe His His Asn Gly Ala Phe Phe Leu
210 215 220
ccg cac gct ttc aac ttc ctg gcc tcc ttt ggg ctg gcc cgc ccc cag 780
Pro His Ala Phe Asn Phe Leu Ala Ser Phe Gly Leu Ala Arg Pro Gln
225 230 235 240
ccc acg cct acc ggc aac ccc ggc ttc aag cac ggc acc ccc gat ggc 828
Pro Thr Pro Thr Gly Asn Pro Gly Phe Lys His Gly Thr Pro Asp Gly
245 250 255
tac gat ttt ttc ctg aag atg ggt ccg ctg aaa aac gct gat gcc aac 876
Tyr Asp Phe Phe Leu Lys Met Gly Pro Leu Lys Asn Ala Asp Ala Asn
260 265 270
tac tac aaa ggc aaa gtg gcc ttc tgg aac gaa atg gcc agc cac ccc 924
Tyr Tyr Lys Gly Lys Val Ala Phe Trp Asn Glu Met Ala Ser His Pro
275 280 285
aac tac gac gaa ttc tgg cag gcc cgt aac cta cgc ccc cac ctc aag 972
Asn Tyr Asp Glu Phe Trp Gln Ala Arg Asn Leu Arg Pro His Leu Lys
290 295 300
aac ctc aac aaa ggc acc gcg gtg ctc acg gtt ggt ggc ttc aat gat 1020
Asn Leu Asn Lys Gly Thr Ala Val Leu Thr Val Gly Gly Phe Asn Asp
305 310 315 320
gcc gag gac ctg ttt ggc gcc ctg aaa acc tac gaa agc arc gag aag 1068
Ala Glu Asp Leu Phe Gly Ala Leu Lys Thr Tyr Glu Ser Ile Glu Lys
325 330 335
caa aac ccc ggc atg cgc aac ggc ctc gtg atg ggg ccg tgg gta cac 1116
Gln Asn Pro Gly Met Arg Asn Gly Leu Val Met Gly Pro Trp Val His
340 345 350
ggt ggc tgg gcc cgc ggc act ggc gaa atg gta ggc aat gtg gcc tac 1164
Gly Gly Trp Ala Arg Gly Thr Gly Glu Met Val Gly Asn Val Ala Tyr
355 360 365
ggc gag tcg ccg tcg ttg tat tac cag aag cag att gaa gcg ccg ttc 1212
Gly Glu Ser Pro Ser Leu Tyr Tyr Gln Lys Gln Ile Glu Ala Pro Phe
370 375 380
ttc aaa tca tat ctg aag gat ggc aaa cct gcc gct acc ccc gag gct 1260
Phe Lys Ser Tyr Leu Lys Asp Gly Lys Pro Ala Ala Thr Pro Glu Ala
385 390 395 400
acc atc ttt gaa agc ggc acc aac cgc tgg cgc agc ttc gaa acc tgg 1308
Thr Ile Phe Glu Ser Gly Thr Asn Arg Trp Arg Ser Phe Glu Thr Trp
405 410 415
ccg ccc aaa gaa gcc aaa gag cgc act ttg tac ttt cag tcg gcc ggg 1356
Pro Pro Lys Glu Ala Lys Glu Arg Thr Leu Tyr Phe Gln Ser Ala Gly
420 425 430
aaa atc ggc ttc gag aag cct gcc agt ggc cta gag tac gac cag ttc 1404
Lys Ile Gly Phe Glu Lys Pro Ala Ser Gly Leu Glu Tyr Asp Gln Phe
435 440 445
ctc agc gac ccg gct cac cca gtg cct ttc acc gaa gct acg gct acg 1452
Leu Ser Asp Pro Ala His Pro Val Pro Phe Thr Glu Ala Thr Ala Thr
450 455 460
ggc atg acc cgc gag tac atg acc gac gac cag cgc ttc gcc agc cgc 1500
Gly Met Thr Arg Glu Tyr Met Thr Asp Asp Gln Arg Phe Ala Ser Arg
465 470 475 480
cgc ccc gac gtg ctg acc tac cag acc gaa gcg ctt acc gag gac atg 1548
Arg Pro Asp Val Leu Thr Tyr Gln Thr Glu Ala Leu Thr Glu Asp Met
485 490 495
acg ctg gct ggc cct atc gag gcg ctg ttg cag gta gcc acc acc ggc 1596
Thr Leu Ala Gly Pro Ile Glu Ala Leu Leu Gln Val Ala Thr Thr Gly
500 505 510
acc gat gcc gac tgg gta gtg aag att att gat gtg tac ccc gac gat 1644
Thr Asp Ala Asp Trp Val Val Lys Ile Ile Asp Val Tyr Pro Asp Asp
515 520 525
acg ccc aac aac ccc agc acg aac ccc gcc gtg aaa ctg ggc ggc tac 1692
Thr Pro Asn Asn Pro Ser Thr Asn Pro Ala Val Lys Leu Gly Gly Tyr
530 535 540
cag cag atg gtt cgc tcc gag gtg atg cgc ggt cgt ttc cgc aac agc 1740
Gln Gln Met Val Arg Ser Glu Val Met Arg Gly Arg Phe Arg Asn Ser
545 550 555 560
ttc tcc aag ccc gaa gcc ttt gta ccg gaa cag gta acg gcc gtg ccc 1788
Phe Ser Lys Pro Glu Ala Phe Val Pro Glu Gln Val Thr Ala Val Pro
565 570 575
ttc acg gtg cag gac ctg tgc cac acc ttc cgg aaa gga cac cgc ctg 1836
Phe Thr Val Gln Asp Leu Cys His Thr Phe Arg Lys Gly His Arg Leu
580 585 590
atg gtg cag gtg caa agc agc tgg ttc ccg att gtt gac cgc aac ccg 1884
Met Val Gln Val Gln Ser Ser Trp Phe Pro Ile Val Asp Arg Asn Pro
595 600 605
cag acc ttc gta ccc aat att ttc gag gcc gat gag aag gat ttc cag 1932
Gln Thr Phe Val Pro Asn Ile Phe Glu Ala Asp Glu Lys Asp Phe Gln
610 615 620
gcc gcc acg cat cgg ctg tac cat tcg ccg gcg cat agc tcg cag ctc 1980
Ala Ala Thr His Arg Leu Tyr His Ser Pro Ala His Ser Ser Gln Leu
625 630 635 640
acg ttg cgc gtt ctg taggccactc taaacaggct cgg 2018
Thr Leu Arg Val Leu
645
<210>23
<211>645
<212>PRT
<213>Taxeobacter gelupurpurascens
<400>23
Met Pro Tyr Ser Phe Pro Lys Val Ala Ala Leu Ser Gly Leu Leu Val
1 5 10 15
Ala Gly Leu Ser Gly Ala His Ala Gln Thr Pro Val Thr Tyr Pro Leu
20 25 30
Ala Ser Glu Ala Glu Lys Ala Gln Leu Ala Val Val Leu Ala Asp Thr
35 40 45
Ala Tyr Ile Lys Glu Arg Tyr Thr Lys Thr Glu Tyr Gln Ile Pro Met
50 55 60
Arg Asp Gly Val Lys Leu Tyr Thr Ile Val Tyr Ala Pro Asn Asp Ala
65 70 75 80
Asn Lys Val Lys Tyr Pro Ile Leu Leu Asn Arg Thr Pro Tyr Ala Ile
85 90 95
Gly Pro Tyr Gly Pro Gly Lys Tyr Lys Leu Asn Leu Gly Pro Ser Ser
100 105 110
Thr Met Met His Glu Gly Tyr Ile Phe Ala Tyr Gln Asp Val Arg Gly
115 120 125
Arg Tyr Met Ser Glu Gly Glu Phe Val Asp Val Arg Pro Glu Lys Asp
130 135 l40
Met His Lys Gly Lys Asn Asp Ile Asp Glu Gly Thr Asp Thr Tyr Asp
145 150 155 160
Thr Ile Glu Trp Leu Leu Lys His Gly Pro Lys Asn Asn Gly Arg Val
165 170 175
Gly Gln Trp Gly Ile Ser Tyr Pro Gly Tyr Tyr Thr Ala Thr Gly Leu
180 185 190
Leu Ser Arg His Lys Ala Leu Lys Ala Ser Ser Pro Gln Ala Pro Ile
195 200 205
Ala Asp Trp Phe Trp Asp Asp Phe His His Asn Gly Ala Phe Phe Leu
210 215 220
Pro His Ala Phe Asn Phe Leu Ala Ser Phe Gly Leu Ala Arg Pro Gln
225 230 235 240
Pro Thr Pro Thr Gly Asn Pro Gly Phe Lys His Gly Thr Pro Asp Gly
245 250 255
Tyr Asp Phe Phe Leu Lys Met Gly Pro Leu Lys Asn Ala Asp Ala Asn
260 265 270
Tyr Tyr Lys Gly Lys Val Ala Phe Trp Asn Glu Met Ala Ser His Pro
275 280 285
Asn Tyr Asp Glu Phe Trp Gln Ala Arg Asn Leu Arg Pro His Leu Lys
290 295 300
Asn Leu Asn Lys Gly Thr Ala Val Leu Thr Val Gly Gly Phe Asn Asp
305 310 315 320
Ala Glu Asp Leu Phe Gly Ala Leu Lys Thr Tyr Glu Ser Ile Glu Lys
325 330 335
Gln Asn Pro Gly Met Arg Asn Gly Leu Val Met Gly Pro Trp Val His
340 345 350
Gly Gly Trp Ala Arg Gly Thr Gly Glu Met Val Gly Asn Val Ala Tyr
355 360 365
Gly Glu Ser Pro Ser Leu Tyr Tyr Gln Lys Gln Ile Glu Ala Pro Phe
370 375 380
Phe Lys Ser Tyr Leu Lys Asp Gly Lys Pro Ala Ala Thr Pro Glu Ala
385 390 395 400
Thr Ile Phe Glu Ser Gly Thr Asn Arg Trp Arg Ser Phe Glu Thr Trp
405 410 415
Pro Pro Lys Glu Ala Lys Glu Arg Thr Leu Tyr Phe Gln Ser Ala Gly
420 425 430
Lys Ile Gly Phe Glu Lys Pro Ala Ser Gly Leu Glu Tyr Asp Gln Phe
435 440 445
Leu Ser Asp Pro Ala His Pro Val pro Phe Thr Glu Ala Thr Ala Thr
450 455 460
Gly Met Thr Arg Glu Tyr Met Thr Asp Asp Gln Arg Phe Ala Ser Arg
465 470 475 480
Arg Pro Asp Val Leu Thr Tyr Gln Thr Glu Ala Leu Thr Glu Asp Met
485 490 495
Thr Leu Ala Gly Pro Ile Glu Ala Leu Leu Gln Val Ala Thr Thr Gly
500 505 510
Thr Asp Ala Asp Trp Val Val Lys Ile Ile Asp Val Tyr Pro Asp Asp
515 520 525
Thr Pro Asn Asn Pro Ser Thr Asn Pro Ala Val Lys Leu Gly Gly Tyr
530 535 540
Gln Gln Met Val Arg Ser Glu Val Met Arg Gly Arg Phe Arg Asn Ser
545 550 555 560
Phe Ser Lys Pro Glu Ala Phe Val Pro Glu Gln Val Thr Ala Val Pro
565 570 575
Phe Thr Val Gln Asp Leu Cys His Thr Phe Arg Lys Gly His Arg Leu
580 585 590
Met Val Gln Val Gln Ser Ser Trp Phe Pro Ile Val Asp Arg Asn Pro
595 600 605
Gln Thr Phe Val Pro Asn Ile Phe Glu Ala Asp Glu Lys Asp Phe Gln
610 615 620
Ala Ala Thr His Arg Leu Tyr His Ser Pro Ala His Ser Ser Gln Leu
625 630 635 640
Thr Leu Arg Val Leu
645
<210>24
<211>1931
<212>DNA
<213〉extra large round bacteria
<220>
<221>CDS
<222>(29)..(1888)
<223>
<400>24
cccaaagcat taacaaaata atttagtc atg aaa cac tgttac aaa ctt ctg 52
Met Lys His Cys Tyr Lys Leu Leu
1 5
gtc ttt tac aca tta ttt ttg atg acc aca aac tgg gct tta tca caa 100
Val Phe Tyr Thr Leu Phe Leu Met Thr Thr Asn Trp Ala Leu Ser Gln
10 15 20
gcc att aat gga tat gat aag gca gcc tat gac att cct atg cga gat 148
Ala Ile Asn Gly Tyr Asp Lys Ala Ala Tyr Asp Ile Pro Met Arg Asp
25 30 35 40
gga gtt cac ctt cac acc atc gtc tat agc ccc aaa gat tta tcg cag 196
Gly Val His Leu His Thr Ile Val Tyr Ser Pro Lys Asp Leu Ser Gln
45 50 55
ccc tat cct ata ttg atg caa agg aca cct tac agc gcc ggc cct tat 244
Pro Tyr Pro Ile Leu Met Gln Arg Thr Pro Tyr Ser Ala Gly Pro Tyr
60 65 70
ggt cct gga aat atg aaa aat aag ctt ggc cct tct cag ttt tta atg 292
Gly Pro Gly Asn Met Lys Asn Lys Leu Gly Pro Ser Gln Phe Leu Met
75 80 85
aac gat ggc tat ata ttt gtt tac cag gat gta aga ggg cgg tgg atg 340
Asn Asp Gly Tyr Ile Phe Val Tyr Gln Asp Val Arg Gly Arg Trp Met
90 95 100
tcg gaa gga tcc tat gac aac atg cgc cct acc cta tcc aaa tca gaa 388
Ser Glu Gly Ser Tyr Asp Asn Met Arg Pro Thr Leu Ser Lys Ser Glu
105 110 115 120
aga aat tcc aac caa ata gac gaa agc aca gac acc tat gat acc ata 436
Arg Asn Ser Asn Gln Ile Asp Glu Ser Thr Asp Thr Tyr Asp Thr Ile
125 130 135
gaa tgg ttg ctc gcc aat atc aaa aat cac aat gaa aaa gta ggc cta 484
Glu Trp Leu Leu Ala Asn Ile Lys Asn His Asn Glu Lys Val Gly Leu
140 145 150
tgg gga atc agc tat ccc gga ttt tat agt gct gca gcc ctt cct ttt 532
Trp Gly Ile Ser Tyr Pro Gly Phe Tyr Ser Ala Ala Ala Leu Pro Phe
155 160 165
gcc cat cca aac ctg aaa gcc gtt tcc cct caa gca ccc ata ggg gat 580
Ala His Pro Asn Leu Lys Ala Val Ser Pro Gln Ala Pro Ile Gly Asp
170 175 180
ttt tac ttt gat gat ttt cat cat aac ggt gct tac tta tta agt tat 628
Phe Tyr Phe Asp Asp Phe His His Asn Gly Ala Tyr Leu Leu Ser Tyr
185 190 195 200
tgg ttg gcc act tct gtt ttc ggc tac caa aaa gac ggc cct aca cag 676
Trp Leu Ala Thr Ser Val Phe Gly Tyr Gln Lys Asp Gly Pro Thr Gln
205 210 215
gaa gca tgg tat ggc atg gtg aat ccg gaa aca aat gac ggc tat cag 724
Glu Ala Trp Tyr Gly Met Val Asn Pro Glu Thr Asn Asp Gly Tyr Gln
220 225 230
ttt ttt atg gat atg ggg cca tta aaa aat gcc gat aaa tgg tat ggt 772
Phe Phe Met Asp Met Gly Pro Leu Lys Asn Ala Asp Lys Trp Tyr Gly
235 240 245
gaa gac aat ttt ttc tgg caa caa ctt aaa aac aat cct gat tac aac 820
Glu Asp Asn Phe Phe Trp Gln Gln Leu Lys Asn Asn Pro Asp Tyr Asn
250 255 260
gct ttc tgg caa aag aga agt att attcct cac tta aaa gaa gtg aag 868
Ala Phe Trp Gln Lys Arg Ser Ile Ile Pro His Leu Lys Glu Val Lys
265 270 275 280
cct gca gtt tta acc gtt ggg ggc tgg ttt gat gca gaa gat ctc tat 916
Pro Ala Val Leu Thr Val Gly Gly Trp Phe Asp Ala Glu Asp Leu Tyr
285 290 295
gga cca ctt aca att tat aaa acc att gaa aaa aat aat cct gag acc 964
Gly Pro Leu Thr Ile Tyr Lys Thr Ile Glu Lys Asn Asn Pro Glu Thr
300 305 310
tac aat acc att gtc atg ggc cct tgg tcc cac gga gat tgg tca agg 1012
Tyr Asn Thr Ile Val Met Gly Pro Trp Ser His Gly Asp Trp Ser Arg
315 320 325
gaa cct gga tca cag gtc att tca aat att tat ttt ggt gat tct atc 1060
Glu Pro Gly Ser Gln Val Ile Ser Asn Ile Tyr Phe Gly Asp Ser Ile
330 335 340
tcc aca tgg tat caa aaa aat ata gaa cgt gtt ttt ttc aat cat ttt 1108
Ser Thr Trp Tyr Gln Lys Asn Ile Glu Arg Val Phe Phe Asn His Phe
345 350 355 360
cta aaa gaa tcc gaa aat agc aat cct gcc ctt cct gaa gcc tac atg 1156
Leu Lys Glu Ser Glu Asn Ser Asn Pro Ala Leu Pro Glu Ala Tyr Met
365 370 375
ttt gat acc gga aaa cat aaa tgg gaa aaa ttt gac gat tgg cct cct 1204
Phe Asp Thr Gly Lys His Lys Trp Glu Lys Phe Asp Asp Trp Pro Pro
380 385 390
aaa gaa agc caa tgg aaa agc ttt tac ttt caa gag aaa gga gag tta 1252
Lys Glu Ser Gln Trp Lys Ser Phe Tyr Phe Gln Glu Lys Gly Glu Leu
395 400 405
act gag gta aca cct gag gga aat agg ttt act acc tat gtc tca gac 1300
Thr Glu Val Thr Pro Glu Gly Asn Arg Phe Thr Thr Tyr Val Ser Asp
410 415 420
ccc tct aat cct gtc ccc tat agt caa gat att aaa cta aac ttc act 1348
Pro Ser Asn Pro Val Pro Tyr Ser Gln Asp Ile Lys Leu Asn Phe Thr
425 430 435 440
ccg aga aaa tac atg gcc gat gac cag cga ttt gca gcc aga aga ccg 1396
Pro Arg Lys Tyr Met Ala Asp Asp Gln Arg Phe Ala Ala Arg Arg Pro
445 450 455
gac gta ctg acc ttt acg agc gaa gta tta agt caa gac atg acg ctt 1444
Asp Val Leu Thr Phe Thr Ser Glu Val Leu Ser Gln Asp Met Thr Leu
460 465 470
gcg ggg gaa gtc atg gca aac tta aaa gtt gcc act tca caa act gat 1492
Ala Gly Glu Val Met Ala Asn Leu Lys Val Ala Thr Ser Gln Thr Asp
475 480 485
gct gat tgg gta gtt aaa atc atc gat ata ttt ccc gga gat cag cca 1540
Ala Asp Trp Val Val Lys Ile Ile Asp Ile Phe Pro Gly Asp Gln Pro
490 495 500
aat cat gcc tat gtt tta gat ggg gtg gac atg ggc aat tac cac cta 1588
Asn His Ala Tyr Val Leu Asp Gly Val Asp Met Gly Asn Tyr His Leu
505 510 5l5 520
atg gtt cgt tca gag gta att aga ggg agg tat aga gaa agt ttt gag 1636
Met Val Arg Ser Glu Val Ile Arg Gly Arg Tyr Arg Glu Ser Phe Glu
525 530 535
ttt cct aaa ccc ttt gtt cct gat caa atc act gct gtt gat ttc agg 1684
Phe Pro Lys Pro Phe Val Pro Asp Gln Ile Thr Ala Val Asp Phe Arg
540 545 550
tta caa gat ctt ttc cat act ttc aaa aag ggg cataaa att caa ata 1732
Leu Gln Asp Leu Phe His Thr Phe Lys Lys Gly His Lys Ile Gln Ile
555 560 565
caa ata caa agt act tgg ttt ccc cta att gat cga aat ccc caa aaa 1780
Gln Ile Gln Ser Thr Trp Phe Pro Leu Ile Asp Arg Asn Pro Gln Lys
570 575 580
tat gta caa aac ata ttt gaa gct gag gaa gcc gat ttt gtc aaa gcc 1828
Tyr Val Gln Asn Ile Phe Glu Ala Glu Glu Ala Asp Phe Val Lys Ala
585 590 595 600
acc cat agg gtt ttt cat aca gaa aag ttt gcc agc aaa att gaa gta 1876
Thr His Arg Val Phe His Thr Glu Lys Phe Ala Ser Lys Ile Glu Val
605 610 615
atg gtt ctt cct tagaattaga atggtttaaa attactattt gtagcagaag ata 1931
Met Val Leu Pro
620
<210>25
<211>620
<212>PRT
<213〉extra large round bacteria
<400>25
Met Lys His Cys Tyr Lys Leu Leu Val Phe Tyr Thr Leu Phe Leu Met
1 5 10 15
Thr Thr Asn Trp Ala Leu Ser Gln Ala Ile Asn Gly Tyr Asp Lys Ala
20 25 30
Ala Tyr Asp Ile Pro Met Arg Asp Gly Val His Leu His Thr Ile Val
35 40 45
Tyr Ser Pro Lys Asp Leu Ser Gln Pro Tyr Pro Ile Leu Met Gln Arg
50 55 60
Thr Pro Tyr Ser Ala Gly Pro Tyr Gly Pro Gly Asn Met Lys Asn Lys
65 70 75 80
Leu Gly Pro Ser Gln Phe Leu Met Asn Asp Gly Tyr Ile Phe Val Tyr
85 90 95
Gln Asp Val Arg Gly Arg Trp Met Ser Glu Gly Ser Tyr Asp Asn Met
100 105 110
Arg Pro Thr Leu Ser Lys Ser Glu Arg Asn Ser Asn Gln Ile Asp Glu
115 120 125
Ser Thr Asp Thr Tyr Asp Thr Ile Glu Trp Leu Leu Ala Asn Ile Lys
130 135 140
Asn His Asn Glu Lys Val Gly Leu Trp Gly Ile Ser Tyr Pro Gly Phe
145 150 155 160
Tyr Ser Ala Ala Ala Leu Pro Phe Ala His Pro Asn Leu Lys Ala Val
165 170 175
Ser Pro Gln Ala Pro Ile Gly Asp Phe Tyr Phe Asp Asp Phe His His
180 185 190
Asn Gly Ala Tyr Leu Leu Ser Tyr Trp Leu Ala Thr Ser Val Phe Gly
195 200 205
Tyr Gln Lys Asp Gly Pro Thr Gln Glu Ala Trp Tyr Gly Met Val Asn
210 215 220
Pro Glu Thr Asn Asp Gly Tyr Gln Phe Phe Met Asp Met Gly Pro Leu
225 230 235 240
Lys Asn Ala Asp Lys Trp Tyr Gly Glu Asp Asn Phe Phe Trp Gln Gln
245 250 255
Leu Lys Asn Asn Pro Asp Tyr Asn Ala Phe Trp Gln Lys Arg Ser Ile
260 265 270
Ile Pro His Leu Lys Glu Val Lys Pro Ala Val Leu Thr Val Gly Gly
275 280 285
Trp Phe Asp Ala Glu Asp Leu Tyr Gly Pro Leu Thr Ile Tyr Lys Thr
290 295 300
Ile Glu Lys Asn Asn Pro Glu Thr Tyr Asn Thr Ile Val Met Gly Pro
305 310 315 320
Trp Ser His Gly Asp Trp Ser Arg Glu Pro Gly Ser Gln Val Ile Ser
325 330 335
Asn Ile Tyr Phe Gly Asp Ser Ile Ser Thr Trp Tyr Gln Lys Asn Ile
340 345 350
Glu Arg Val Phe Phe Asn His Phe Leu Lys Glu Ser Glu Asn Ser Asn
355 360 365
Pro Ala Leu Pro Glu Ala Tyr Met Phe Asp Thr Gly Lys His Lys Trp
370 375 380
Glu Lys Phe Asp Asp Trp Pro Pro Lys Glu Ser Gln Trp Lys Ser Phe
385 390 395 400
Tyr Phe Gln Glu Lys Gly Glu Leu Thr Glu Val Thr Pro Glu Gly Asn
405 410 415
Arg Phe Thr Thr Tyr Val Ser Asp Pro Ser Asn Pro Val Pro Tyr Ser
420 425 430
Gln Asp Ile Lys Leu Asn Phe Thr Pro Arg Lys Tyr Met Ala Asp Asp
435 440 445
Gln Arg Phe Ala Ala Arg Arg Pro Asp Val Leu Thr Phe Thr Ser Glu
450 455 460
Val Leu Ser Gln Asp Met Thr Leu Ala Gly Glu Val Met Ala Asn Leu
465 470 475 480
Lys Val Ala Thr Ser Gln Thr Asp Ala Asp Trp Val Val Lys Ile Ile
485 490 495
Asp Ile Phe Pro Gly Asp Gln Pro Asn His Ala Tyr Val Leu Asp Gly
500 505 510
Val Asp Met Gly Asn Tyr His Leu Met Val Arg Ser Glu Val Ile Arg
515 520 525
Gly Arg Tyr Arg Glu Ser Phe Glu Phe Pro Lys Pro Phe Val Pro Asp
530 535 540
Gln Ile rhr Ala Val Asp Phe Arg Leu Gln Asp Leu Phe His Thr Phe
545 550 555 560
Lys Lys Gly His Lys Ile Gln Ile Gln Ile Gln Ser Thr Trp Phe Pro
565 570 575
Leu Ile Asp Arg Asn Pro Gln Lys Tyr Val Gln Asn Ile Phe Glu Ala
580 585 590
Glu Glu Ala Asp Phe Val Lys Ala Thr His Arg Val Phe His Thr Glu
595 600 605
Lys Phe Ala Ser Lys Ile Glu Val Met Val Leu Pro
610 615 620
<210>26
<211>2036
<212>DNA
<213>Psycloserpens burtonensis
<220>
<221>CDS
<222>(61)..(1992)
<223>
<400>26
catattcgta aaatagctat aagtttttgt aaatttagtc aatcaaaattttaaatgtaa 60
atg aag act ctt ttt aaa ttg ttg ctc cta ttt gta ttt gtt cta acg 108
Met Lys Thr Leu Phe Lys Leu Leu Leu Leu Phe Val Phe Val Leu Thr
1 5 10 15
tct tgt aat aag gcc aac aaa gac gct act gaa att gtg aaa acc gaa 156
Ser Cys Asn Lys Ala Asn Lys Asp Ala Thr Glu Ile Val Lys Thr Glu
20 25 30
gta gaa gat act tac gtt aaa gat aat tat aac aaa caa gag gtg act 204
Val Glu Asp Thr Tyr Val Lys Asp Asn Tyr Asn Lys Gln Glu Val Thr
35 40 45
att gaa atg cgc gat ggt ata aaa ctt cac acg acc att tat tca cca 252
Ile Glu Met Arg Asp Gly Ile Lys Leu His Thr Thr Ile Tyr Ser Pro
50 55 60
aaa gat gaa agt cag acc tat cct att tta atg atg aga aca cca tat 300
Lys Asp Glu Ser Gln Thr Tyr Pro Ile Leu Met Met Arg Thr Pro Tyr
65 70 75 80
agt tct caa cct tat ggt gac aat gag ttt aag acg aaa att ggt cct 348
Ser Ser Gln Pro Tyr Gly Asp Asn Glu Phe Lys Thr Lys Ile Gly Pro
85 90 95
aat gtt cat tta atg aaa gaa ggg aat att gtt gtg tat caa gat gta 396
Asn Val His Leu Met Lys Glu Gly Asn Ile Val Val Tyr Gln Asp Val
100 105 110
cga ggt cgt tgg atg agt gaa ggt gtc tat gat aat atg cgt gct tat 444
Arg Gly Arg Trp Met Ser Glu Gly Val Tyr Asp Asn Met Arg Ala Tyr
115 120 125
atc cca aat aaa aca gag gat tct caa att gat gag gca tca gac act 492
Ile Pro Asn Lys Thr Glu Asp Ser Gln Ile Asp Glu Ala Ser Asp Thr
130 135 140
tat gac acg att gac tgg ctg gta aat aac gta gaa aat aat aac ggg 540
Tyr Asp Thr Ile Asp Trp Leu Val Asn Asn Val Glu Asn Asn Asn Gly
145 150 155 160
aat gtt ggt act tgg gga att tca tat cct ggt ttt tat gct aca tat 588
Asn Val Gly Thr Trp Gly Ile Ser Tyr Pro Gly Phe Tyr Ala Thr Tyr
165 170 175
tct act ata gac gca cac cca gct tta aaa gca gca tcg cct caa gcg 636
Ser Thr Ile Asp Ala His Pro Ala Leu Lys Ala Ala Ser Pro Gln Ala
180 185 190
tgt att gga gat ttc ttt ttt gac gat ttt cat cat aat ggt gct ttt 684
Cys Ile Gly Asp Phe Phe Phe Asp Asp Phe His His Asn Gly Ala Phe
195 200 205
tta tta agt tat ttt aga gca gtg tct tta ttt ggt acg aca aaa gat 732
Leu Leu Ser Tyr Phe Arg Ala Val Ser Leu Phe Gly Thr Thr Lys Asp
210 215 220
aaa cct aca gat tct gct tgg tat aag ttt cca gaa atg aaa aca caa 780
Lys Pro Thr Asp Ser Ala Trp Tyr Lys Phe Pro Glu Met Lys Thr Gln
225 230 235 240
gat caa tat caa ttt ttt ctt gat gct gga cct tta agt aat ttg aac 828
Asp Gln Tyr Gln Phe Phe Leu Asp Ala Gly Pro Leu Ser Asn Leu Asn
245 250 255
aag tat ttc caa tat gac aca cca gac gac aca tct gta tcc aag tct 876
Lys Tyr Phe Gln Tyr Asp Thr Pro Asp Asp Thr Ser Val Ser Lys Ser
260 265 270
gat agg ata gat gat gtg ttt tgg aaa gaa att gta gag cat cca aac 924
Asp Arg Ile Asp Asp Val Phe Trp Lys Glu Ile Val Glu His Pro Asn
275 280 285
tac gat acg ata tgg aaa tct aaa ggt tta att caa aac cta aaa gat 972
Tyr Asp Thr Ile Trp Lys Ser Lys Gly Leu Ile Gln Asn Leu Lys Asp
290 295 300
att aag cca agt gta gcg aca atg att gtg gga ggg tta ttt gat gcc 1020
Ile Lys Pro Ser Val Ala Thr Met Ile Val Gly Gly Leu Phe Asp Ala
305 310 315 320
gaa gat tta tat ggg cca ttt gaa act tat aaa acg ata gaa aaa cat 1068
Glu Asp Leu Tyr Gly Pro Phe Glu Thr Tyr Lys Thr Ile Glu Lys His
325 330 335
aat cct gat aat tat aat att atg gtt ttt ggg cct tgg gat cat ggt 1116
Asn Pro Asp Asn Tyr Asn Ile Met Val Phe Gly Pro Trp Asp His Gly
340 345 350
cgt tgg gct agg agt gac gtt aaa aat tat gtt gga aat tat ttc ttc 1164
Arg Trp Ala Arg Ser Asp Val Lys Asn Tyr Val Gly Asn Tyr Phe Phe
355 360 365
gga gat tct ata tct cta aaa ttt caa cgt gat gtt gaa acg aag ttt 1212
Gly Asp Ser Ile Ser Leu Lys Phe Gln Arg Asp Val Glu Thr Lys Phe
370 375 380
ttt aat cat ttt tta aaa gga aaa ggc gac aag aac tca ggg tta cca 1260
Phe Asn His Phe Leu Lys Gly Lys Gly Asp Lys Asn Ser Gly Leu Pro
385 390 395 400
gaa gca tat gta ttt gat tct ggt aaa aag gaa tgg agt agc ttt gac 1308
Glu Ala Tyr Val Phe Asp Ser Gly Lys Lys Glu Trp Ser Ser Phe Asp
405 410 415
agc tgg cct cca aag caa gca gaa aaa caa gcc atg tat ctt aat gcc 1356
Ser Trp Pro Pro Lys Gln Ala Glu Lys Gln Ala Met Tyr Leu Asn Ala
420 425 430
aac caa gag cta tca gat tca aaa aaa gga aat act agt gag aca ttt 1404
Asn Gln Glu Leu Ser Asp Ser Lys Lys Gly Asn Thr Ser Glu Thr Phe
435 440 445
gtt agt gat tta aaa cgc cct gta cct tat tcc gaa gat att aaa aca 1452
Val Ser Asp Leu Lys Arg Pro Val Pro Tyr Ser Glu Asp Ile Lys Thr
450 455 460
gtt ttc aca cca cga aaa tac atg aca gac gat cag cgt ttt gca gca 1500
Val Phe Thr Pro Arg Lys Tyr Met Thr Asp Asp Gln Arg Phe Ala Ala
465 470 475 480
cga cgt cct gat gtt ctt ata ttt gag acc gat att ctt gag gaa gat 1548
Arg Arg Pro Asp Val Leu Ile Phe Glu Thr Asp Ile Leu Glu Glu Asp
485 490 495
ata acc tta gct ggt gat att tta gcg cag ctt aat gtg tca act aca 1596
Ile Thr Leu Ala Gly Asp Ile Leu Ala Gln Leu Asn Val Ser Thr Thr
500 505 510
ggg aca gat gca gat tgg att gtc aaa ata gta gat gtt cat cca gca 1644
Gly Thr Asp Ala Asp Trp Ile Val Lys Ile Val Asp Val His Pro Ala
515 520 525
gat gct gag gag caa aaa gaa ggt atg caa gac cat tta tca atg agt 1692
Asp Ala Glu Glu Gln Lys Glu Gly Met Gln Asp His Leu Ser Met Ser
530 535 540
aat tat cat ttg atg gtg agg agt gaa gtg atg cgc ggt cgt ttt aga 1740
Asn Tyr His Leu Met Val Arg Ser Glu Val Met Arg Gly Arg Phe Arg
545 550 555 560
aat agt ttt gaa aac cca gag cca ttt gtg cca aac caa cca aca gat 1788
Asn Ser Phe Glu Asn Pro Glu Pro Phe Val Pro Asn Gln Pro Thr Asp
565 570 575
gtc aat atc aag tta caa gat gta cat cat aca ttt aaa aaa ggt cac 1836
Val Asn Ile Lys Leu Gln Asp Val His His Thr Phe Lys Lys Gly His
580 585 590
aaa tta caa gtg caa gtt cag agt acg tgg ttt cca ctt att gat ttg 1884
Lys Leu Gln Val Gln Val Gln Ser Thr Trp Phe Pro Leu Ile Asp Leu
595 600 605
aac ccg caa aca ttt gtg cct aat att tat aaa gca aaa gaa agc gat 1932
Asn Pro Gln Thr Phe Val Pro Asn Ile Tyr Lys Ala Lys Glu Ser Asp
610 615 620
ttt aaa acc caa aca cat tcg gtt ttt aac gat tct aaa att gag ttt 1980
Phe Lys Thr Gln Thr His Ser Val Phe Asn Asp Ser Lys Ile Glu Phe
625 630 635 640
acg gtt ttg aaa taagagtaga tgactaaatt tgccaaggta gatttagtct tttt 2036
Thr Val Leu Lys
<210>27
<211>644
<212>PRT
<213>Psycloserpens burtonensis
<400>27
Met Lys Thr Leu Phe Lys Leu Leu Leu Leu Phe Val Phe Val Leu Thr
1 5 10 15
Ser Cys Asn Lys Ala Asn Lys Asp Ala Thr Glu Ile Val Lys Thr Glu
20 25 30
Val Glu Asp Thr Tyr Val Lys Asp Asn Tyr Asn Lys Gln Glu Val Thr
35 40 45
Ile Glu Met Arg Asp Gly Ile Lys Leu His Thr Thr Ile Tyr Ser Pro
50 55 60
Lys Asp Glu Ser Gln Thr Tyr Pro Ile Leu Met Met Arg Thr Pro Tyr
65 70 75 80
Ser Ser Gln Pro Tyr Gly Asp Asn Glu Phe Lys Thr Lys Ile Gly Pro
85 90 95
Asn Val His Leu Met Lys Glu Gly Asn Ile Val Val Tyr Gln Asp Val
100 105 110
Arg Gly Arg Trp Met Ser Glu Gly Val Tyr Asp Asn Met Arg Ala Tyr
115 120 125
Ile Pro Asn Lys Thr Glu Asp Ser Gln Ile Asp Glu Ala Ser Asp Thr
130 135 140
Tyr Asp Thr Ile Asp Trp Leu Val Asn Asn Val Glu Asn Asn Asn Gly
145 150 155 160
Asn Val Gly Thr Trp Gly Ile Ser Tyr Pro Gly Phe Tyr Ala Thr Tyr
165 170 175
Ser Thr Ile Asp Ala His Pro Ala Leu Lys Ala Ala Ser Pro Gln Ala
180 185 190
Cys Ile Gly Asp Phe Phe Phe Asp Asp Phe His His Asn Gly Ala Phe
195 200 205
Leu Leu Ser Tyr Phe Arg Ala Val Ser Leu Phe Gly Thr Thr Lys Asp
210 215 220
Lys Pro Thr Asp Ser Ala Trp Tyr Lys Phe Pro Glu Met Lys Thr Gln
225 230 235 240
Asp Gln Tyr Gln Phe Phe Leu Asp Ala Gly Pro Leu Ser Asn Leu Asn
245 250 255
Lys Tyr Phe Gln Tyr Asp Thr Pro Asp Asp Thr Ser Val Ser Lys Ser
260 265 270
Asp Arg Ile Asp Asp Val Phe Trp Lys Glu Ile Val Glu His Pro Asn
275 280 285
Tyr Asp Thr Ile Trp Lys Ser Lys Gly Leu Ile Gln Asn Leu Lys Asp
290 295 300
Ile Lys Pro Ser Val Ala Thr Met Ile Val Gly Gly Leu Phe Asp Ala
305 310 315 320
Glu Asp Leu Tyr Gly Pro Phe Glu Thr Tyr Lys Thr Ile Glu Lys His
325 330 335
Asn Pro Asp Asn Tyr Asn Ile Met Val Phe Gly Pro Trp Asp His Gly
340 345 350
Arg Trp Ala Arg Ser Asp Val Lys Asn Tyr Val Gly Asn Tyr Phe Phe
355 360 365
Gly Asp Ser Ile Ser Leu Lys Phe Gln Arg Asp Val Glu Thr Lys Phe
370 375 380
Phe Asn His Phe Leu Lys Gly Lys Gly Asp Lys Asn Ser Gly Leu Pro
385 390 395 400
Glu Ala Tyr Val Phe Asp Ser Gly Lys Lys Glu Trp Ser Ser Phe Asp
405 410 415
Ser Trp Pro Pro Lys Gln Ala Glu Lys Gln Ala Met Tyr Leu Asn Ala
420 425 430
Asn Gln Glu Leu Ser Asp Ser Lys Lys Gly Asn Thr Ser Glu Thr Phe
435 440 445
Val Ser Asp Leu Lys Arg Pro Val Pro Tyr Ser Glu Asp Ile Lys Thr
450 455 460
Val Phe Thr Pro Arg Lys Tyr Met Thr Asp Asp Gln Arg Phe Ala Ala
465 470 475 480
Arg Arg Pro Asp Val Leu Ile Phe Glu Thr Asp Ile Leu Glu Glu Asp
485 490 495
Ile Thr Leu Ala Gly Asp Ile Leu Ala Gln Leu Asn Val Ser Thr Thr
500 505 510
Gly Thr Asp Ala Asp Trp Ile Val Lys Ile Val Asp Val His Pro Ala
515 520 525
Asp Ala Glu Glu Gln Lys Glu Gly Met Gln Asp His Leu Ser Met Ser
530 535 540
Asn Tyr His Leu Met Val Arg Ser Glu Val Met Arg Gly Arg Phe Arg
545 550 555 560
Asn Ser Phe Glu Asn Pro Glu Pro Phe Val Pro Asn Gln Pro Thr Asp
565 570 575
Val Asn Ile Lys Leu Gln Asp Val His His Thr Phe Lys Lys Gly His
580 585 590
Lys Leu Gln Val Gln Val Gln Ser Thr Trp Phe Pro Leu Ile Asp Leu
595 600 605
Asn Pro Gln Thr Phe Val Pro Asn Ile Tyr Lys Ala Lys Glu Ser Asp
610 615 620
Phe Lys Thr Gln Thr His Ser Val Phe Asn Asp Ser Lys Ile Glu Phe
625 630 635 640
Thr Val Leu Lys

Claims (16)

1. coding is selected from (C) and protein DNA (O), and wherein said protein has the aminoacid sequence as giving a definition:
(C) aminoacid sequence of forming by the 21-619 amino acids residue of SEQ ID NO:12, or
(O) aminoacid sequence of forming by SEQ ID NO:12.
2. recombinant DNA that comprises according to the DNA of claim 1.
3. transformant that comprises according to the recombinant DNA of claim 2.
4. method of producing peptide-forming enzyme comprises:
In substratum, be suitable for producing under the condition of peptide-forming enzyme, cultivate according to the transformant of claim 3 one period and
In substratum and/or transformant, accumulate peptide-forming enzyme.
5. method of producing dipeptides comprises:
In substratum, be suitable in culture producing under the condition of peptide-forming enzyme, cultivate according to the transformant of claim 3 one period and
Culture is mixed with carboxyl composition and amine component,, synthesize dipeptides by by the coded promoted enzyme catalysis of peptide-forming enzyme of described DNA.
6. according to the method for the production dipeptides of claim 5, wherein said cell is the microorganism that is generated the ability of dipeptides by carboxyl composition and amine component that has that belongs to Sphingobacterium.
7. according to the method for the production dipeptides of claim 5 or 6, wherein said cell is isolating from described culture.
8. according to the method for the production dipeptides of claim 5 or 6, wherein said cell is treated microorganism cells product.
9. be selected from (c) and DNA (o), wherein said DNA has the base sequence as giving a definition:
(c) base sequence of forming by the 121-1917 bit base of SEQ ID NO:11, or
(o) base sequence of forming by the 61-1917 bit base of SEQ ID NO:11.
10. recombinant DNA that comprises according to the DNA of claim 9.
11. transformant that comprises according to the recombinant DNA of claim 10.
12. a method of producing peptide-forming enzyme comprises:
In substratum, be suitable for producing under the condition of peptide-forming enzyme, cultivate according to the transformant of claim 11 one period and
In substratum and/or transformant, accumulate peptide-forming enzyme.
13. a method of producing dipeptides comprises:
In substratum, be suitable in culture producing under the condition of peptide-forming enzyme, cultivate according to the transformant of claim 11 one period and
Culture is mixed with carboxyl composition and amine component,, synthesize dipeptides by by the coded promoted enzyme catalysis of peptide-forming enzyme of described DNA.
14. according to the method for the production dipeptides of claim 13, wherein said cell is the microorganism that is generated the ability of dipeptides by carboxyl composition and amine component that has that belongs to Sphingobacterium.
15. according to the method for the production dipeptides of claim 13 or 14, wherein said cell is isolating from described culture.
16. according to the method for the production dipeptides of claim 13 or 14, wherein said cell is treated microorganism cells product.
CNB038224607A 2002-07-26 2003-07-25 Novel peptide synthase gene Expired - Lifetime CN100379868C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2189572002 2002-07-26
JP2002218957 2002-07-26
JP218957/2002 2002-07-26
JP16765/2003 2003-01-24
JP167652003 2003-01-24

Related Child Applications (5)

Application Number Title Priority Date Filing Date
CNA2007100936755A Division CN101067126A (en) 2002-07-26 2003-07-25 Novel peptide synthase gene
CN200710093669XA Division CN101067124B (en) 2002-07-26 2003-07-25 Novel peptide synthase gene
CNA2007100936740A Division CN101067125A (en) 2002-07-26 2003-07-25 Novel peptide synthase gene
CNA2007100936774A Division CN101186904A (en) 2002-07-26 2003-07-25 Novel peptide-forming enzyme gene
CNA200710093676XA Division CN101186903A (en) 2002-07-26 2003-07-25 Novel peptide-forming enzyme gene

Publications (2)

Publication Number Publication Date
CN1688698A CN1688698A (en) 2005-10-26
CN100379868C true CN100379868C (en) 2008-04-09

Family

ID=35306331

Family Applications (6)

Application Number Title Priority Date Filing Date
CNA2007100936774A Pending CN101186904A (en) 2002-07-26 2003-07-25 Novel peptide-forming enzyme gene
CNA2007100936740A Pending CN101067125A (en) 2002-07-26 2003-07-25 Novel peptide synthase gene
CNA200710093676XA Pending CN101186903A (en) 2002-07-26 2003-07-25 Novel peptide-forming enzyme gene
CNB038224607A Expired - Lifetime CN100379868C (en) 2002-07-26 2003-07-25 Novel peptide synthase gene
CN200710093669XA Expired - Lifetime CN101067124B (en) 2002-07-26 2003-07-25 Novel peptide synthase gene
CNA2007100936755A Pending CN101067126A (en) 2002-07-26 2003-07-25 Novel peptide synthase gene

Family Applications Before (3)

Application Number Title Priority Date Filing Date
CNA2007100936774A Pending CN101186904A (en) 2002-07-26 2003-07-25 Novel peptide-forming enzyme gene
CNA2007100936740A Pending CN101067125A (en) 2002-07-26 2003-07-25 Novel peptide synthase gene
CNA200710093676XA Pending CN101186903A (en) 2002-07-26 2003-07-25 Novel peptide-forming enzyme gene

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN200710093669XA Expired - Lifetime CN101067124B (en) 2002-07-26 2003-07-25 Novel peptide synthase gene
CNA2007100936755A Pending CN101067126A (en) 2002-07-26 2003-07-25 Novel peptide synthase gene

Country Status (1)

Country Link
CN (6) CN101186904A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116640819B (en) * 2023-07-20 2023-10-13 凯莱英生命科学技术(天津)有限公司 Preparation method of alpha-amino acid lipid acyltransferase and application of alpha-amino acid lipid acyltransferase in dipeptide synthesis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061050A1 (en) * 1998-05-29 1999-12-02 Merck & Co., Inc. MURD PROTEIN AND GENE OF $i(PSEUDOMONAS AERUGINOSA)
WO2000058478A1 (en) * 1999-03-29 2000-10-05 Holland Sweetener Company V.O.F. MICROBIOLOGICAL PRODUCTION METHOD FOR α-L-ASPARTYL-L-PHENYLALANINE

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061050A1 (en) * 1998-05-29 1999-12-02 Merck & Co., Inc. MURD PROTEIN AND GENE OF $i(PSEUDOMONAS AERUGINOSA)
WO2000058478A1 (en) * 1999-03-29 2000-10-05 Holland Sweetener Company V.O.F. MICROBIOLOGICAL PRODUCTION METHOD FOR α-L-ASPARTYL-L-PHENYLALANINE

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Enzymatic peptide synthesis by the recombinantproline-specific endopeptidase from Flavobacterium meningosepticum and its mutationally altered Cys-556 variant.. Krieg F等.Appl.Microbiol.Biotechnol.,Vol.42 No.6. 1995 *

Also Published As

Publication number Publication date
CN101186904A (en) 2008-05-28
CN1688698A (en) 2005-10-26
CN101067125A (en) 2007-11-07
CN101067126A (en) 2007-11-07
CN101067124B (en) 2011-07-27
CN101067124A (en) 2007-11-07
CN101186903A (en) 2008-05-28

Similar Documents

Publication Publication Date Title
JP5641023B2 (en) Novel peptide synthase gene
US7749742B2 (en) Method for producing tripeptides and/or peptides longer than tripeptides
CN100379868C (en) Novel peptide synthase gene
US20040204577A1 (en) Novel peptide-forming enzyme gene
CN100387702C (en) Mutant microorganism and method for producing peptide using the same
CN100362109C (en) Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20080409

CX01 Expiry of patent term